data_2kv5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kv5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--O 1.232 0.144 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.1 mtm -55.6 -43.11 75.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 111.223 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t -79.38 -2.85 43.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.933 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.3 tp -100.91 -18.94 16.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.341 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 9' ' ' ILE . 6.4 p -91.2 -46.61 14.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.605 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 6.8 tp -73.6 -30.42 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.577 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.424 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -57.87 -61.69 6.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.632 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 27.9 Cg_endo -62.6 -52.08 2.71 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.65 2.233 . . . . 0.0 112.746 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.605 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -50.39 -27.48 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.889 0.376 . . . . 0.0 111.552 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.64 -70.72 0.23 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -55.43 -23.01 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.33 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.23 -28.72 39.57 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.628 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.3 mp -85.66 -30.07 23.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.78 0.324 . . . . 0.0 110.997 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.3 -57.77 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.18 0.514 . . . . 0.0 110.278 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.2 mt -48.81 -28.78 3.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.894 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -77.54 -41.24 39.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.567 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.0 ttp -51.29 -40.55 59.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.552 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.569 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -84.31 -32.64 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.687 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.69 -29.93 65.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.44 -43.45 56.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.092 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 21' ' ' ILE . 6.4 t -55.7 -31.51 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.187 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.3 mt -61.47 -17.85 56.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.475 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -153.45 30.4 0.48 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.699 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.771 179.859 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.231 0.116 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.7 -50.9 17.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.751 0.31 . . . . 0.0 111.543 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.2 t -66.34 -19.98 65.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.9 tp -89.74 -14.35 34.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.2 t -95.4 -62.29 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.963 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.569 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 9.0 tp -59.4 -21.2 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.75 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.416 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -69.6 -63.07 2.12 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.691 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 29.2 Cg_endo -62.71 -45.54 13.55 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.558 2.172 . . . . 0.0 112.537 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.569 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -55.79 -22.69 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.539 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.98 -68.43 0.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.7 p -50.34 -26.97 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.418 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.78 -33.85 45.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.589 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.11 -30.18 28.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 111.016 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -74.33 -57.11 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.21 0.528 . . . . 0.0 110.318 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.5 mt -47.56 -29.91 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.903 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -80.52 -44.68 18.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.659 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.4 ttt -50.07 -38.2 37.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.604 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.571 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.71 -35.34 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.377 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.5 t -56.67 -28.7 61.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.713 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -75.85 -42.08 50.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.146 179.389 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.8 t -56.63 -32.53 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.186 0.517 . . . . 0.0 110.14 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.66 -19.62 50.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.194 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -153.46 33.83 0.46 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.397 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . 10.6 pt-20 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.7 mmt -52.1 -46.36 65.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.768 0.318 . . . . 0.0 111.138 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.6 t -71.73 -17.74 62.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.932 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 tt -89.65 -14.49 34.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.021 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.72 -62.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 110.989 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.567 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 9.1 tp -59.41 -22.01 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.731 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.418 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -68.31 -63.16 2.54 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.74 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 28.8 Cg_endo -62.73 -47.48 8.89 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.561 2.174 . . . . 0.0 112.574 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.567 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -52.81 -25.64 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.462 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -66.35 -68.8 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 21.2 t -51.35 -25.89 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.402 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.59 -35.6 28.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.592 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.64 -30.48 46.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.728 0.299 . . . . 0.0 110.951 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -73.37 -49.61 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.172 0.511 . . . . 0.0 110.378 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -50.52 -32.79 19.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.846 -179.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.89 -41.55 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.526 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.45 ' O ' HG23 ' A' ' 24' ' ' VAL . 5.1 ttt -51.75 -28.39 15.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.612 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.526 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -107.99 -38.19 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.404 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.7 t -56.56 -27.73 58.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 0.0 110.235 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -29.79 27.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.099 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 20' ' ' MET . 42.2 t -61.26 -33.44 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.168 0.509 . . . . 0.0 110.051 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.53 -11.95 5.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.349 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -153.18 27.01 0.52 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.758 0.313 . . . . 0.0 111.409 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 mmt -57.58 -46.06 84.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.883 0.373 . . . . 0.0 110.898 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 p -70.18 -19.38 63.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.797 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.414 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 18.0 tp -87.93 -14.98 37.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 12' ' ' ILE . 19.8 t -97.18 -64.11 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.886 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.418 ' HA ' HG23 ' A' ' 12' ' ' ILE . 9.9 tp -54.1 -23.64 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.888 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.416 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -70.82 -63.29 1.62 Allowed Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 17.8 Cg_endo -59.0 -36.51 96.62 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.621 2.214 . . . . 0.0 112.961 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.418 HG23 ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -69.59 -25.96 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 111.175 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -65.39 -66.21 0.58 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.801 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.66 -26.8 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.424 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.14 -32.29 49.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.557 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mp -84.93 -29.83 24.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.702 0.287 . . . . 0.0 110.941 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -74.96 -57.71 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.239 0.542 . . . . 0.0 110.332 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.7 mt -47.84 -30.69 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.777 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.92 -41.46 51.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.648 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 ttt -51.23 -41.37 60.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.476 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.564 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.5 -35.34 8.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.335 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.6 t -56.65 -28.9 61.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.74 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 27' ' ' GLU . 6.4 mpt_? -75.16 -42.21 56.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.156 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.6 t -57.33 -31.99 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 110.061 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.0 mt -59.97 -18.81 48.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.099 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -153.4 33.49 0.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.219 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 23' ' ' ARG . 14.0 pt-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.915 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.547 0.213 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.4 ttp -49.14 -47.59 45.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.769 0.319 . . . . 0.0 111.332 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 t -68.11 -19.91 64.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.861 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 tt -90.89 -14.81 31.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.944 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 t -94.73 -60.7 2.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.016 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.57 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 8.7 tp -61.23 -23.06 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.66 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.412 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -66.94 -62.61 3.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.717 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 28.7 Cg_endo -62.8 -48.47 6.89 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.58 2.187 . . . . 0.0 112.553 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.57 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -52.33 -26.2 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.477 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.01 -69.82 0.29 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.425 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.3 -24.27 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.316 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.81 -29.38 47.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.561 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.5 mt -86.28 -29.33 23.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -78.34 -57.58 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.119 0.485 . . . . 0.0 110.428 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.1 mt -47.28 -34.38 6.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.9 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -70.87 -39.94 72.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.573 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 30.1 ttp -50.57 -26.49 5.35 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.694 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.577 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.6 -38.51 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.961 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.3 t -50.5 -36.41 33.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.27 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -36.69 39.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.411 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 21' ' ' ILE . 18.8 t -53.71 -29.34 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.185 0.517 . . . . 0.0 110.117 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mp -72.39 3.7 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.171 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -153.1 12.93 0.5 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.768 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 120.888 0.375 . . . . 0.0 110.929 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.1 mtp -56.88 -44.32 82.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.75 0.31 . . . . 0.0 111.052 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 t -78.29 -3.6 43.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.0 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.45 -18.63 16.61 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.343 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 9' ' ' ILE . 5.7 p -91.91 -46.74 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.39 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.587 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 6.9 tp -72.92 -29.73 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.618 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -58.98 -61.16 8.37 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.692 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 29.1 Cg_endo -62.88 -50.9 3.41 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.629 2.219 . . . . 0.0 112.683 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.587 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -52.53 -25.0 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 111.605 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.85 -69.84 0.24 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.728 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -48.0 -28.46 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.407 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.36 -40.46 10.05 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.497 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.56 -30.48 70.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.869 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -76.18 -52.82 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.184 0.516 . . . . 0.0 110.3 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.66 -30.33 31.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.767 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -76.92 -40.95 45.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.596 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.3 ttm -51.35 -41.95 60.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.57 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.74 -35.46 8.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.36 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.6 t -56.45 -29.1 61.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.765 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -75.0 -44.25 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.131 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 21' ' ' ILE . 6.7 t -53.9 -33.68 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.224 0.535 . . . . 0.0 110.119 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.9 -19.68 52.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.247 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -153.5 34.29 0.45 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.442 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.5 mm-40 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.5 mtm -55.4 -43.97 75.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.18 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 t -77.88 -5.15 50.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.992 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.7 tt -97.97 -19.95 17.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.319 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 9' ' ' ILE . 5.0 p -91.74 -46.62 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.372 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.608 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 6.8 tp -73.22 -30.22 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.558 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -58.29 -61.38 7.65 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.667 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 28.5 Cg_endo -62.56 -51.5 3.21 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.67 2.247 . . . . 0.0 112.716 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.608 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -52.11 -25.56 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.859 0.361 . . . . 0.0 111.494 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -64.46 -69.5 0.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.711 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -52.26 -25.77 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.371 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.28 -32.33 52.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.566 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.67 -30.02 23.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.021 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -75.13 -55.94 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 110.451 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 mt -46.74 -33.56 4.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.866 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.81 -39.81 69.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.578 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.418 ' O ' HG23 ' A' ' 24' ' ' VAL . 16.0 ttp -52.22 -25.22 8.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.662 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.562 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.35 -36.98 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.883 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.7 t -54.12 -28.94 42.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.1 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.35 -31.2 20.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.403 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 21' ' ' ILE . 41.1 t -55.08 -32.97 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 mt -67.21 -3.47 7.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.065 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -153.29 22.27 0.55 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.355 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.889 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.5 mtt -53.52 -48.14 69.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.807 0.337 . . . . 0.0 111.131 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 t -73.05 -13.55 61.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.785 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.416 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 2.4 tt -88.25 -19.09 27.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.427 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 12' ' ' ILE . 2.9 p -96.86 -49.34 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.2 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.45 ' N ' ' CG1' ' A' ' 8' ' ' VAL . 8.8 tp -62.48 -29.24 46.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.728 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -66.67 -60.26 6.73 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.943 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 37.6 Cg_endo -65.25 -28.89 55.44 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.59 2.193 . . . . 0.0 113.419 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -77.83 -30.74 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 0.0 111.116 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -72.74 -66.08 0.71 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.942 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 20.5 t -57.23 -21.25 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.12 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.14 -26.48 44.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mp -89.42 -29.65 18.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.313 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.73 -58.98 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.207 0.527 . . . . 0.0 110.098 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 15.0 mt -49.69 -29.09 6.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.708 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.21 -40.82 51.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.507 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.7 ttm -51.51 -41.04 60.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.521 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.566 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -84.84 -31.9 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.737 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 p -58.44 -29.85 66.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.891 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 5.6 mpt_? -74.39 -42.5 59.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.144 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.2 t -56.44 -32.18 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.217 0.532 . . . . 0.0 110.197 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.54 -19.46 57.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.279 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -153.49 33.25 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.809 0.338 . . . . 0.0 111.44 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 20.3 pt-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -47.63 72.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.741 0.305 . . . . 0.0 111.175 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.0 t -74.53 -8.96 58.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.965 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tt -94.2 -18.83 21.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.302 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.547 ' O ' HG21 ' A' ' 12' ' ' ILE . 3.5 p -96.39 -44.21 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.351 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.444 ' HA ' HG21 ' A' ' 12' ' ' ILE . 7.7 tp -70.96 -20.6 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.986 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.401 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -75.75 -62.02 0.82 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 34.8 Cg_endo -64.56 -22.03 65.29 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.625 2.217 . . . . 0.0 113.202 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.547 HG21 ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -75.6 -29.81 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 0.0 111.111 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.05 -68.28 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.437 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -53.25 -24.98 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.349 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.76 -32.2 51.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.616 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.82 -29.23 23.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 t -76.38 -57.27 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.135 0.493 . . . . 0.0 110.346 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.4 mt -47.64 -34.65 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.724 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -68.14 -38.22 81.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.505 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.7 ttm -52.7 -46.12 67.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.511 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.564 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -89.16 -35.63 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.458 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -56.69 -27.43 58.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.72 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 27' ' ' GLU . 6.8 mpt_? -74.89 -44.3 49.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.168 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.02 -32.44 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.235 0.54 . . . . 0.0 110.01 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.9 mt -60.28 -18.92 52.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -153.43 33.44 0.46 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.839 0.352 . . . . 0.0 111.391 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.7 pt-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.28 -39.0 69.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.718 0.294 . . . . 0.0 111.098 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 t -84.7 4.82 30.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.976 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.408 ' O ' ' HG2' ' A' ' 11' ' ' PRO . 1.2 tt -112.33 -16.87 12.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.289 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 9' ' ' ILE . 4.8 p -92.86 -45.9 14.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.275 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.589 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 6.3 tp -77.81 -27.25 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.713 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.546 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . . . -62.85 -62.5 5.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.294 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 10' ' ' ALA . 44.5 Cg_exo -56.56 -52.27 7.35 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.248 1.966 . . . . 0.0 112.255 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.589 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.7 pp -54.22 -24.16 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.52 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.8 -70.58 0.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.762 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -51.3 -26.86 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.362 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.52 -32.14 47.94 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 mp -83.67 -29.94 27.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.726 0.298 . . . . 0.0 110.96 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 t -75.86 -57.51 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.14 0.495 . . . . 0.0 110.372 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -47.19 -30.35 2.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.837 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -76.25 -41.06 50.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.599 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.5 ttt -51.46 -41.49 60.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.47 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.571 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.77 -35.43 8.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.366 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.8 t -56.38 -28.95 60.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.729 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 27' ' ' GLU . 5.8 mpt_? -74.98 -43.14 55.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.121 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -56.07 -32.37 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.245 0.545 . . . . 0.0 110.117 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.3 mt -60.51 -18.83 54.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.288 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -153.49 32.85 0.46 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.496 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.624 0.249 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.63 -45.37 38.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 111.46 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -69.27 -18.44 63.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.211 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.1 tp -98.39 -14.82 19.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.256 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 t -100.28 10.2 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.739 0.304 . . . . 0.0 111.078 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 36.3 mm -125.89 -54.38 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . . . -44.8 -53.34 15.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.88 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.429 ' HD3' ' CB ' ' A' ' 10' ' ' ALA . 33.6 Cg_exo -61.4 -43.56 27.44 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.588 2.192 . . . . 0.0 112.876 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -28.01 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.799 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -69.19 -66.6 0.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.375 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 11.6 p -54.41 -22.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.375 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.61 -33.42 19.26 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.701 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.78 -32.5 46.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 111.014 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 t -71.75 -50.23 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.246 0.546 . . . . 0.0 110.23 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.402 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -52.2 -30.34 26.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.824 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.77 -42.64 27.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.71 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 ttt -50.42 -41.09 51.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.561 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.567 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.9 -35.49 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.371 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.3 t -56.61 -29.05 61.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.749 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -75.32 -43.11 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.176 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.6 t -55.28 -33.11 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 110.118 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.0 mt -59.91 -19.51 52.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.212 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -153.47 34.13 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.377 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . 7.1 pt-20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 8.5 ttm -53.82 -44.91 70.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.755 0.312 . . . . 0.0 111.163 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 t -75.44 -15.29 60.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.806 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 tp -97.25 -5.58 36.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.397 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 p -81.29 -26.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.581 0.229 . . . . 0.0 111.547 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.443 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 1.6 tp -120.82 -6.1 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -79.95 -63.2 0.37 Allowed Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 37.4 Cg_endo -66.13 -40.63 15.04 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.608 2.205 . . . . 0.0 112.925 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -60.75 -28.13 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 0.0 111.12 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.97 -70.12 0.28 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.278 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 p -55.77 -23.01 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.201 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.63 60.34 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.599 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -92.4 -30.11 15.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.75 0.309 . . . . 0.0 110.97 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 t -74.24 -54.63 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.156 0.503 . . . . 0.0 110.232 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.0 mt -47.36 -30.04 2.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.85 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.52 -47.94 18.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.578 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.6 ttp -45.31 -43.32 10.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.627 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.577 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -81.45 -33.09 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.316 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.0 t -56.68 -28.37 60.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -74.61 -45.17 46.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.098 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -54.67 -32.08 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.181 0.515 . . . . 0.0 110.017 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.3 mt -61.51 -17.63 55.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.104 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -153.35 32.92 0.46 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.288 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.0 mmt -50.23 -47.08 55.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.823 0.344 . . . . 0.0 111.175 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.5 t -67.74 -20.05 65.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.928 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 tt -90.97 -15.4 29.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.97 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.5 t -95.21 -60.09 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.588 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 8.6 tp -61.45 -22.88 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.648 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.409 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -67.34 -62.45 3.57 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.645 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 27.7 Cg_endo -62.2 -47.55 9.88 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.558 2.172 . . . . 0.0 112.473 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -55.11 -23.66 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.463 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.59 -65.75 0.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -49.55 -27.69 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.41 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.7 -33.99 45.19 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.9 -30.19 28.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.653 0.263 . . . . 0.0 110.983 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -74.45 -56.8 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.194 0.521 . . . . 0.0 110.326 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 mt -47.47 -29.87 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.9 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -81.34 -45.44 16.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.699 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ttm -50.4 -38.67 44.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.567 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.565 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.91 -35.27 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.376 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.8 t -56.63 -28.65 60.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.76 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -76.11 -41.81 49.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.214 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 21' ' ' ILE . 6.3 t -56.97 -32.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.106 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.95 -19.22 50.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.168 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -153.46 33.53 0.46 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.845 0.355 . . . . 0.0 111.338 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . 5.2 pt-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.0 ttp -49.81 -47.83 51.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.715 0.293 . . . . 0.0 111.209 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.6 t -67.03 -21.34 65.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.67 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 2.2 tt -88.98 -14.68 36.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.717 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 12' ' ' ILE . 22.6 t -97.03 -63.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.744 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.41 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 9.6 tp -55.06 -23.48 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.818 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.422 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -70.53 -63.15 1.76 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.925 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 17.8 Cg_endo -58.94 -36.65 96.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.656 2.237 . . . . 0.0 112.956 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -69.73 -25.59 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.43 -63.7 1.04 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.734 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.6 t -48.85 -27.52 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.566 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.19 -35.18 30.91 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.624 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mp -79.87 -31.15 40.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.706 0.288 . . . . 0.0 110.969 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 t -71.31 -48.7 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.185 0.517 . . . . 0.0 110.292 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.1 -32.03 21.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.856 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -75.63 -40.98 55.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.646 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.2 ttp -51.64 -25.19 6.6 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.725 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.56 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -113.6 -37.1 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.922 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.2 t -52.53 -28.77 22.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.745 0.307 . . . . 0.0 111.168 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -29.82 21.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.366 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 26' ' ' ASP . 11.2 t -64.34 -22.73 31.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.5 13.23 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.514 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 24' ' ' VAL . 19.7 t0 -153.53 -50.54 0.1 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.794 0.331 . . . . 0.0 110.783 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.464 0.238 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.609 179.6 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.611 0.243 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 -46.14 31.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 111.45 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 t -67.78 -19.81 65.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.051 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.07 -21.06 22.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 12' ' ' ILE . 40.6 t -83.44 -8.06 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.448 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.612 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 17.3 mm -123.99 -35.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.303 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -50.39 -60.99 4.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 29.7 Cg_endo -63.8 -54.63 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.56 2.173 . . . . 0.0 113.038 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.612 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.7 pp -51.51 -30.07 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 111.848 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -61.42 -72.68 0.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.772 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -52.83 -24.95 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.355 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.0 -32.3 49.8 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.605 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 mp -85.28 -30.58 23.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.69 0.281 . . . . 0.0 110.984 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -74.07 -55.92 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.309 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mt -47.05 -30.34 2.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.909 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -79.53 -44.84 20.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.6 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.453 ' O ' HG22 ' A' ' 24' ' ' VAL . 5.1 ttt -50.45 -26.53 5.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.684 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.542 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -105.89 -37.8 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.383 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.7 t -56.26 -26.61 52.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.329 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -30.57 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.115 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 20' ' ' MET . 45.2 t -59.3 -34.6 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.012 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mt -59.44 -13.11 7.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.287 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -153.18 28.92 0.5 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 120.8 0.333 . . . . 0.0 111.314 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.889 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -49.09 52.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.73 0.3 . . . . 0.0 111.213 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -69.99 -18.77 63.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.748 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 1.0 OUTLIER -91.72 -9.29 44.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' HG21 ' A' ' 12' ' ' ILE . 19.9 t -102.93 -62.72 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.861 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.415 ' HA ' HG21 ' A' ' 12' ' ' ILE . 10.0 tp -53.59 -24.95 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.828 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -71.23 -63.15 1.54 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.846 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 18.4 Cg_endo -58.83 -36.11 97.53 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.641 2.227 . . . . 0.0 113.075 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.421 HG21 ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -69.18 -27.93 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 111.076 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.44 -70.07 0.27 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.447 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -54.42 -23.73 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.351 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.3 -32.43 31.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.617 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.87 -29.45 32.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 111.049 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.52 -60.17 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.212 0.529 . . . . 0.0 110.275 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mt -49.03 -31.94 8.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.732 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.94 -41.35 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.604 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.8 ttp -50.0 -52.85 30.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.305 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.565 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -74.63 -36.83 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.3 t -54.45 -26.09 28.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.025 0.441 . . . . 0.0 109.99 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 27' ' ' GLU . 2.2 mmt85 -82.19 -36.67 27.06 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.085 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.5 t -54.13 -32.93 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.37 0.605 . . . . 0.0 109.597 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.75 -7.14 31.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.375 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -153.36 25.34 0.53 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.77 0.319 . . . . 0.0 111.451 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 23' ' ' ARG . 3.3 mm-40 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.962 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.9 mmm -51.85 -46.44 64.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.693 0.282 . . . . 0.0 111.136 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 t -72.34 -17.11 61.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.952 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.5 tp -89.91 -13.93 35.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.048 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.27 -62.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.861 0.363 . . . . 0.0 111.086 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.583 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 8.5 tp -60.28 -21.91 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.641 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -67.52 -63.0 2.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.688 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 26.9 Cg_endo -62.04 -48.44 8.37 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.542 2.161 . . . . 0.0 112.473 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.583 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -53.08 -28.78 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.327 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.06 -72.66 0.14 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.114 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 12.6 p -54.84 -26.82 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.883 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.48 -28.6 73.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.298 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mt -99.13 -24.42 14.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.633 0.254 . . . . 0.0 111.311 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 t -85.05 -58.65 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.087 0.47 . . . . 0.0 110.704 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -49.44 -28.74 5.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.805 -179.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -78.11 -45.85 22.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.483 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.1 ttt -47.76 -44.34 28.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.594 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.571 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -78.93 -33.18 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.443 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.5 t -56.11 -28.78 59.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -74.58 -44.79 49.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 21' ' ' ILE . 4.7 t -54.64 -31.65 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.186 0.517 . . . . 0.0 110.018 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.66 -17.46 60.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.241 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -153.48 32.19 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.802 0.334 . . . . 0.0 111.52 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.5 mm-40 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.558 0.218 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -32.09 30.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.746 0.308 . . . . 0.0 111.375 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.9 t -87.44 -1.44 57.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.474 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.34 -6.21 10.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.233 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 12' ' ' ILE . 23.5 t -94.79 -23.88 5.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.582 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.621 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 19.8 mm -124.5 -40.72 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.604 0.24 . . . . 0.0 111.507 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.478 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -49.46 -53.99 34.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 41.2 Cg_endo -68.59 -52.28 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.308 2.005 . . . . 0.0 112.868 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.621 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.8 pp -55.04 -29.86 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.762 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -61.94 -71.96 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.799 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.2 t -52.66 -25.52 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.296 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.4 -30.01 42.54 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 mt -83.64 -30.38 26.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -76.67 -57.81 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.149 0.499 . . . . 0.0 110.537 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.4 mt -47.1 -34.95 6.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.997 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.22 -39.59 71.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.619 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 ttt -50.87 -26.29 5.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.689 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.57 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.86 -37.82 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.033 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.1 t -51.87 -29.9 21.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.286 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.43 -31.83 21.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.869 0.366 . . . . 0.0 110.458 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 21' ' ' ILE . 11.3 t -61.19 -23.64 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.343 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.407 ' CD1' HD12 ' A' ' 21' ' ' ILE . 3.6 mp -75.17 13.49 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.627 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -153.38 -38.62 0.1 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.7 0.286 . . . . 0.0 111.297 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.148 179.888 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 8.7 ttm -49.02 -48.14 44.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.309 . . . . 0.0 111.265 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -67.91 -20.04 65.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.805 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 tp -90.42 -14.53 32.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.23 -61.36 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.98 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.568 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 9.1 tp -60.11 -21.7 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.745 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.415 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -69.0 -62.87 2.46 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.72 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 29.1 Cg_endo -62.87 -46.86 9.85 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.6 2.2 . . . . 0.0 112.555 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.568 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -53.14 -24.98 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.504 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.42 -69.34 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -49.7 -27.21 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.385 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.12 -37.92 23.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.607 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.25 -30.25 60.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.29 . . . . 0.0 111.003 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -73.83 -49.67 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.169 0.509 . . . . 0.0 110.503 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.93 -30.53 10.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.941 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.69 -40.53 55.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.57 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.8 ttt -52.16 -41.54 62.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.406 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.567 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.89 -35.38 8.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.365 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.7 t -56.11 -29.03 60.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.739 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -74.86 -43.12 56.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.123 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.1 t -56.18 -32.36 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.225 0.536 . . . . 0.0 110.1 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.8 mt -60.26 -19.2 53.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.301 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -153.46 33.08 0.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.45 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.9 mmm -56.23 -37.64 69.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.774 0.321 . . . . 0.0 111.003 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 4.0 t -86.93 7.19 28.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.898 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.7 mt -118.39 -10.97 10.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.133 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 12' ' ' ILE . 8.7 p -85.03 -29.58 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.601 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 1.6 tp -125.24 -34.91 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.443 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -53.9 -57.72 16.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 35.2 Cg_endo -65.48 -53.1 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.249 1.966 . . . . 0.0 112.843 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -51.29 -29.01 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 0.0 111.64 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -72.19 0.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.503 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -54.87 -23.56 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.289 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -30.67 56.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.54 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 mt -88.49 -29.8 19.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.768 0.318 . . . . 0.0 111.007 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -76.0 -53.83 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.091 0.472 . . . . 0.0 110.589 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.7 mt -46.22 -30.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.078 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.04 -47.89 15.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.641 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 ttt -45.82 -41.71 11.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.6 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.564 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -82.03 -33.05 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.418 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.5 t -56.7 -29.28 62.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -74.24 -46.03 44.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.104 179.306 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.6 t -52.91 -32.61 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.253 0.549 . . . . 0.0 110.027 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.1 mt -62.48 -17.52 59.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.325 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -153.5 32.44 0.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.772 0.32 . . . . 0.0 111.527 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 3.6 mm-40 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.907 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 mtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.832 0.348 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.79 14.5 21.06 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.639 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.548 ' C ' ' O ' ' A' ' 2' ' ' LYS . 44.2 t0 -23.8 -50.39 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 110.765 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 2' ' ' LYS . 7.7 mp -117.78 -19.73 9.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.06 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.41 ' HB2' ' HA ' ' A' ' 2' ' ' LYS . 4.1 mtm -55.6 -43.11 75.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 111.223 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t -79.38 -2.85 43.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.933 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.3 tp -100.91 -18.94 16.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.341 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 9' ' ' ILE . 6.4 p -91.2 -46.61 14.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.605 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 6.8 tp -73.6 -30.42 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.577 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.424 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -57.87 -61.69 6.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.632 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 27.9 Cg_endo -62.6 -52.08 2.71 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.65 2.233 . . . . 0.0 112.746 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.605 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -50.39 -27.48 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.889 0.376 . . . . 0.0 111.552 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.64 -70.72 0.23 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -55.43 -23.01 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.33 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.23 -28.72 39.57 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.628 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.3 mp -85.66 -30.07 23.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.78 0.324 . . . . 0.0 110.997 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.3 -57.77 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.18 0.514 . . . . 0.0 110.278 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.2 mt -48.81 -28.78 3.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.894 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -77.54 -41.24 39.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.567 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.0 ttp -51.29 -40.55 59.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.552 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.569 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -84.31 -32.64 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.687 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.69 -29.93 65.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.44 -43.45 56.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.092 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 21' ' ' ILE . 6.4 t -55.7 -31.51 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.187 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.3 mt -61.47 -17.85 56.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.475 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -153.45 30.4 0.48 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.699 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.09 71.18 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.771 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -78.65 -75.03 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -114.04 144.42 43.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -94.88 -50.61 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.6 m -176.7 147.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -92.42 117.05 29.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.797 0.332 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.86 14.58 20.99 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.678 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.545 ' C ' ' O ' ' A' ' 2' ' ' LYS . 34.5 t0 -23.33 -49.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.904 0.383 . . . . 0.0 111.057 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 2' ' ' LYS . 2.8 mm? -117.79 -28.74 5.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.309 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.456 ' HB2' ' HA ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -46.7 -50.9 17.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.751 0.31 . . . . 0.0 111.543 -179.389 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.406 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 5.2 t -66.34 -19.98 65.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.9 tp -89.74 -14.35 34.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.2 t -95.4 -62.29 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.963 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.569 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 9.0 tp -59.4 -21.2 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.75 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -69.6 -63.07 2.12 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.691 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 29.2 Cg_endo -62.71 -45.54 13.55 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.558 2.172 . . . . 0.0 112.537 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.569 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -55.79 -22.69 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.539 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.98 -68.43 0.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.7 p -50.34 -26.97 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.418 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.78 -33.85 45.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.589 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -83.11 -30.18 28.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 111.016 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -74.33 -57.11 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.21 0.528 . . . . 0.0 110.318 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.5 mt -47.56 -29.91 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.903 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -80.52 -44.68 18.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.659 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.4 ttt -50.07 -38.2 37.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.604 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.571 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.71 -35.34 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.377 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.5 t -56.67 -28.7 61.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.713 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -75.85 -42.08 50.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.146 179.389 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.8 t -56.63 -32.53 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.186 0.517 . . . . 0.0 110.14 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.66 -19.62 50.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.194 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -153.46 33.83 0.46 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.397 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . 10.6 pt-20 -68.95 -33.07 73.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -143.82 162.12 36.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t70 60.29 93.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -96.71 128.22 43.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 m -114.63 -39.2 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -70.2 147.23 50.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.866 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttm . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.804 0.335 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.77 14.46 21.09 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.658 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.8 t70 -23.97 -50.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.076 0.465 . . . . 0.0 110.648 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 2' ' ' LYS . 6.8 mp -117.62 -20.9 8.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.832 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.7 mmt -52.1 -46.36 65.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.768 0.318 . . . . 0.0 111.138 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.6 t -71.73 -17.74 62.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.932 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 tt -89.65 -14.49 34.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.021 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -94.72 -62.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 110.989 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.567 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 9.1 tp -59.41 -22.01 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.731 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.418 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -68.31 -63.16 2.54 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.74 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 28.8 Cg_endo -62.73 -47.48 8.89 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.561 2.174 . . . . 0.0 112.574 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.567 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -52.81 -25.64 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.462 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -66.35 -68.8 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 21.2 t -51.35 -25.89 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.402 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.59 -35.6 28.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.592 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.64 -30.48 46.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.728 0.299 . . . . 0.0 110.951 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -73.37 -49.61 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.172 0.511 . . . . 0.0 110.378 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -50.52 -32.79 19.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.846 -179.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.89 -41.55 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.526 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.45 ' O ' HG23 ' A' ' 24' ' ' VAL . 5.1 ttt -51.75 -28.39 15.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.612 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.526 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -107.99 -38.19 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.404 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.7 t -56.56 -27.73 58.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 0.0 110.235 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -29.79 27.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.099 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 20' ' ' MET . 42.2 t -61.26 -33.44 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.168 0.509 . . . . 0.0 110.051 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.53 -11.95 5.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.349 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -153.18 27.01 0.52 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.758 0.313 . . . . 0.0 111.409 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -62.14 -43.33 99.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -176.16 151.75 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.99 140.93 56.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -60.14 151.11 27.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.9 p -112.58 31.05 6.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.48 -173.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.904 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtp . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.539 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.44 21.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.676 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.539 ' C ' ' O ' ' A' ' 2' ' ' LYS . 4.6 t0 -24.25 -51.12 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.042 0.448 . . . . 0.0 110.619 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 2' ' ' LYS . 3.9 mt -117.83 -14.87 10.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.026 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 mmt -57.58 -46.06 84.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.883 0.373 . . . . 0.0 110.898 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 p -70.18 -19.38 63.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.797 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.414 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 18.0 tp -87.93 -14.98 37.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 12' ' ' ILE . 19.8 t -97.18 -64.11 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.886 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.418 ' HA ' HG23 ' A' ' 12' ' ' ILE . 9.9 tp -54.1 -23.64 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.888 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -70.82 -63.29 1.62 Allowed Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 17.8 Cg_endo -59.0 -36.51 96.62 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.621 2.214 . . . . 0.0 112.961 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.418 HG23 ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -69.59 -25.96 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 111.175 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -65.39 -66.21 0.58 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.801 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -50.66 -26.8 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.424 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.14 -32.29 49.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.557 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mp -84.93 -29.83 24.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.702 0.287 . . . . 0.0 110.941 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -74.96 -57.71 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.239 0.542 . . . . 0.0 110.332 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.7 mt -47.84 -30.69 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.777 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.92 -41.46 51.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.648 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 ttt -51.23 -41.37 60.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.476 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.564 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.5 -35.34 8.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.335 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.6 t -56.65 -28.9 61.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.74 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 27' ' ' GLU . 6.4 mpt_? -75.16 -42.21 56.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.156 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.6 t -57.33 -31.99 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 110.061 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.0 mt -59.97 -18.81 48.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.099 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -153.4 33.49 0.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.219 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 23' ' ' ARG . 14.0 pt-20 -71.14 -35.89 71.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.915 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.98 162.77 5.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -152.68 170.83 19.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.45 -48.38 7.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.4 t 61.79 152.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -112.34 -35.26 5.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.895 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.8 mtm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.84 0.352 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.9 14.5 20.93 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.663 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' A' ' 2' ' ' LYS . 8.2 t0 -23.88 -51.5 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.106 0.479 . . . . 0.0 110.494 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 2' ' ' LYS . 7.1 mp -117.67 -22.91 7.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.509 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.4 ttp -49.14 -47.59 45.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.769 0.319 . . . . 0.0 111.332 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.406 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 9.6 t -68.11 -19.91 64.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.861 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 tt -90.89 -14.81 31.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.944 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 t -94.73 -60.7 2.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.016 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.57 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 8.7 tp -61.23 -23.06 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.66 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.412 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -66.94 -62.61 3.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.717 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 28.7 Cg_endo -62.8 -48.47 6.89 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.58 2.187 . . . . 0.0 112.553 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.57 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -52.33 -26.2 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.477 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.01 -69.82 0.29 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.425 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.3 -24.27 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.316 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.81 -29.38 47.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.561 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.5 mt -86.28 -29.33 23.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -78.34 -57.58 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.119 0.485 . . . . 0.0 110.428 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.1 mt -47.28 -34.38 6.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.9 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -70.87 -39.94 72.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.573 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 30.1 ttp -50.57 -26.49 5.35 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.694 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.577 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.6 -38.51 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.961 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.3 t -50.5 -36.41 33.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.27 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -36.69 39.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.411 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 21' ' ' ILE . 18.8 t -53.71 -29.34 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.185 0.517 . . . . 0.0 110.117 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mp -72.39 3.7 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.171 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -153.1 12.93 0.5 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.768 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.75 30.65 4.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.888 0.375 . . . . 0.0 110.929 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.37 -37.71 18.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.78 121.47 16.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -104.05 -35.15 8.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.6 p -174.47 36.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -114.41 91.54 3.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mttp . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.906 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.781 0.324 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.55 21.03 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.635 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.548 ' C ' ' O ' ' A' ' 2' ' ' LYS . 11.5 t0 -23.83 -49.86 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.08 0.467 . . . . 0.0 110.72 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 2' ' ' LYS . 4.2 mp -117.66 -16.2 10.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.973 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.1 mtp -56.88 -44.32 82.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.75 0.31 . . . . 0.0 111.052 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.402 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 3.3 t -78.29 -3.6 43.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.0 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.45 -18.63 16.61 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.343 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 9' ' ' ILE . 5.7 p -91.91 -46.74 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.39 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.587 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 6.9 tp -72.92 -29.73 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.618 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -58.98 -61.16 8.37 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.692 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 29.1 Cg_endo -62.88 -50.9 3.41 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.629 2.219 . . . . 0.0 112.683 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.587 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -52.53 -25.0 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 111.605 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.85 -69.84 0.24 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.728 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -48.0 -28.46 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.407 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.36 -40.46 10.05 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.497 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.56 -30.48 70.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.869 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -76.18 -52.82 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.184 0.516 . . . . 0.0 110.3 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.66 -30.33 31.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.767 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -76.92 -40.95 45.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.596 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.3 ttm -51.35 -41.95 60.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.57 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.74 -35.46 8.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.36 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.6 t -56.45 -29.1 61.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.765 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -75.0 -44.25 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.131 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 21' ' ' ILE . 6.7 t -53.9 -33.68 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.224 0.535 . . . . 0.0 110.119 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.9 -19.68 52.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.247 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -153.5 34.29 0.45 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.442 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.5 mm-40 -79.15 -46.5 17.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.21 112.1 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -126.09 162.12 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.55 157.5 15.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -144.36 -55.71 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -133.15 106.69 7.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.796 0.331 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.75 14.38 21.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.718 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.545 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.6 t0 -23.86 -50.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.069 0.461 . . . . 0.0 110.699 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 2' ' ' LYS . 7.1 mp -117.78 -19.21 9.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.989 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.5 mtm -55.4 -43.97 75.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.18 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.407 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 3.3 t -77.88 -5.15 50.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.992 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.7 tt -97.97 -19.95 17.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.319 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 9' ' ' ILE . 5.0 p -91.74 -46.62 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.372 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.608 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 6.8 tp -73.22 -30.22 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.558 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -58.29 -61.38 7.65 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.667 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 28.5 Cg_endo -62.56 -51.5 3.21 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.67 2.247 . . . . 0.0 112.716 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.608 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -52.11 -25.56 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.859 0.361 . . . . 0.0 111.494 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -64.46 -69.5 0.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.711 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -52.26 -25.77 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.371 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.28 -32.33 52.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.566 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.67 -30.02 23.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.021 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -75.13 -55.94 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 110.451 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 mt -46.74 -33.56 4.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.866 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.81 -39.81 69.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.578 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.418 ' O ' HG23 ' A' ' 24' ' ' VAL . 16.0 ttp -52.22 -25.22 8.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.662 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.562 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.35 -36.98 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.883 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.7 t -54.12 -28.94 42.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.1 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.35 -31.2 20.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.403 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 21' ' ' ILE . 41.1 t -55.08 -32.97 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 mt -67.21 -3.47 7.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.065 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -153.29 22.27 0.55 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.355 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.47 92.57 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.889 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 63.53 141.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -60.07 147.3 39.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -168.76 80.17 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 t -85.73 117.58 24.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 -112.39 -35.3 5.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.925 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpp? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.849 0.357 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.541 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.83 14.47 21.02 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.614 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 2' ' ' LYS . 11.9 t70 -23.94 -51.14 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.038 0.447 . . . . 0.0 110.693 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 2' ' ' LYS . 4.3 mp -117.77 -19.77 9.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.945 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.5 mtt -53.52 -48.14 69.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.807 0.337 . . . . 0.0 111.131 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 t -73.05 -13.55 61.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.785 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.416 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 2.4 tt -88.25 -19.09 27.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.427 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 12' ' ' ILE . 2.9 p -96.86 -49.34 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.2 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.45 ' N ' ' CG1' ' A' ' 8' ' ' VAL . 8.8 tp -62.48 -29.24 46.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.728 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -66.67 -60.26 6.73 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.943 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 37.6 Cg_endo -65.25 -28.89 55.44 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.59 2.193 . . . . 0.0 113.419 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -77.83 -30.74 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 0.0 111.116 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -72.74 -66.08 0.71 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.942 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 20.5 t -57.23 -21.25 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.12 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.14 -26.48 44.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mp -89.42 -29.65 18.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.313 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.73 -58.98 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.207 0.527 . . . . 0.0 110.098 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 15.0 mt -49.69 -29.09 6.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.708 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.21 -40.82 51.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.507 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.7 ttm -51.51 -41.04 60.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.521 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.566 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -84.84 -31.9 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.737 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 p -58.44 -29.85 66.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.891 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 5.6 mpt_? -74.39 -42.5 59.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.144 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.2 t -56.44 -32.18 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.217 0.532 . . . . 0.0 110.197 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.54 -19.46 57.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.279 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -153.49 33.25 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.809 0.338 . . . . 0.0 111.44 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 20.3 pt-20 -63.48 -31.34 72.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.04 127.14 49.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.933 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -172.38 168.82 5.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -103.92 141.73 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.73 106.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.933 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -95.37 -179.61 4.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mtp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.852 0.358 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.553 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -108.25 14.36 25.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.73 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.553 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.7 t0 -24.68 -51.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.108 0.48 . . . . 0.0 110.618 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 2' ' ' LYS . 4.6 mp -117.66 -17.89 9.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.712 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -47.63 72.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.741 0.305 . . . . 0.0 111.175 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.0 t -74.53 -8.96 58.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.965 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tt -94.2 -18.83 21.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.302 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.547 ' O ' HG21 ' A' ' 12' ' ' ILE . 3.5 p -96.39 -44.21 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.351 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.444 ' HA ' HG21 ' A' ' 12' ' ' ILE . 7.7 tp -70.96 -20.6 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.986 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.401 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -75.75 -62.02 0.82 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 34.8 Cg_endo -64.56 -22.03 65.29 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.625 2.217 . . . . 0.0 113.202 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.547 HG21 ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -75.6 -29.81 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 0.0 111.111 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.05 -68.28 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.437 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -53.25 -24.98 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.349 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.76 -32.2 51.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.616 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.82 -29.23 23.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 t -76.38 -57.27 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.135 0.493 . . . . 0.0 110.346 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.4 mt -47.64 -34.65 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.724 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -68.14 -38.22 81.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.505 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.7 ttm -52.7 -46.12 67.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.511 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.564 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -89.16 -35.63 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.458 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -56.69 -27.43 58.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.72 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 27' ' ' GLU . 6.8 mpt_? -74.89 -44.3 49.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.168 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.02 -32.44 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.235 0.54 . . . . 0.0 110.01 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.9 mt -60.28 -18.92 52.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -153.43 33.44 0.46 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.839 0.352 . . . . 0.0 111.391 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.7 pt-20 -59.51 -31.41 69.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -159.4 -45.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -98.12 -174.55 2.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -140.54 146.1 37.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.7 m -109.37 176.2 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -102.54 -34.85 8.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.7 mttp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.926 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.804 0.335 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.85 14.41 20.99 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.639 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 2' ' ' LYS . 9.4 t0 -24.18 -51.2 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.089 0.471 . . . . 0.0 110.484 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 2' ' ' LYS . 4.9 mp -117.63 -18.62 9.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.616 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.28 -39.0 69.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.718 0.294 . . . . 0.0 111.098 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.407 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 3.6 t -84.7 4.82 30.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.976 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.408 ' O ' ' HG2' ' A' ' 11' ' ' PRO . 1.2 tt -112.33 -16.87 12.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.289 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 9' ' ' ILE . 4.8 p -92.86 -45.9 14.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.275 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.589 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 6.3 tp -77.81 -27.25 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.713 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.546 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . . . -62.85 -62.5 5.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.294 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 10' ' ' ALA . 44.5 Cg_exo -56.56 -52.27 7.35 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.248 1.966 . . . . 0.0 112.255 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.589 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.7 pp -54.22 -24.16 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.52 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.8 -70.58 0.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.762 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -51.3 -26.86 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.362 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.52 -32.14 47.94 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 mp -83.67 -29.94 27.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.726 0.298 . . . . 0.0 110.96 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 t -75.86 -57.51 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.14 0.495 . . . . 0.0 110.372 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -47.19 -30.35 2.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.837 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -76.25 -41.06 50.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.599 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.5 ttt -51.46 -41.49 60.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.47 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.571 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.77 -35.43 8.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.366 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.8 t -56.38 -28.95 60.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.729 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 27' ' ' GLU . 5.8 mpt_? -74.98 -43.14 55.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.121 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -56.07 -32.37 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.245 0.545 . . . . 0.0 110.117 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.3 mt -60.51 -18.83 54.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.288 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -153.49 32.85 0.46 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.496 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.8 mm-40 -87.88 55.0 3.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -113.71 36.13 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -75.39 86.5 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.34 35.76 1.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.9 t -85.36 95.91 9.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -128.9 32.22 4.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.796 0.332 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.551 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.81 14.47 21.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.687 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.551 ' C ' ' O ' ' A' ' 2' ' ' LYS . 4.5 t0 -24.04 -50.78 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.141 0.496 . . . . 0.0 110.493 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 2' ' ' LYS . 1.3 mt -117.55 -23.69 7.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.415 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.63 -45.37 38.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 111.46 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -69.27 -18.44 63.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.211 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.1 tp -98.39 -14.82 19.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.256 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 t -100.28 10.2 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.739 0.304 . . . . 0.0 111.078 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 36.3 mm -125.89 -54.38 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . . . -44.8 -53.34 15.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.88 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.429 ' HD3' ' CB ' ' A' ' 10' ' ' ALA . 33.6 Cg_exo -61.4 -43.56 27.44 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.588 2.192 . . . . 0.0 112.876 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -28.01 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.799 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -69.19 -66.6 0.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.375 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 11.6 p -54.41 -22.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.375 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.61 -33.42 19.26 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.701 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.78 -32.5 46.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 111.014 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 t -71.75 -50.23 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.246 0.546 . . . . 0.0 110.23 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.402 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -52.2 -30.34 26.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.824 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.77 -42.64 27.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.71 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 ttt -50.42 -41.09 51.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.561 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.567 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.9 -35.49 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.371 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.3 t -56.61 -29.05 61.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.749 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -75.32 -43.11 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.176 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.6 t -55.28 -33.11 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 110.118 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.0 mt -59.91 -19.51 52.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.212 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -153.47 34.13 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.377 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . 7.1 pt-20 -66.81 -174.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -106.34 143.5 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -128.12 167.21 17.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.949 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.81 81.63 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 m -65.11 98.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.17 -31.57 21.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 tptt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.862 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mmm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.853 0.358 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.35 21.03 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.658 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' A' ' 2' ' ' LYS . 35.8 t0 -24.28 -51.39 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.127 0.489 . . . . 0.0 110.507 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 2' ' ' LYS . 9.1 mp -117.66 -19.66 9.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.67 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 8.5 ttm -53.82 -44.91 70.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.755 0.312 . . . . 0.0 111.163 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.4 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 5.5 t -75.44 -15.29 60.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.806 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 tp -97.25 -5.58 36.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.397 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 p -81.29 -26.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.581 0.229 . . . . 0.0 111.547 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.443 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 1.6 tp -120.82 -6.1 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -79.95 -63.2 0.37 Allowed Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 37.4 Cg_endo -66.13 -40.63 15.04 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.608 2.205 . . . . 0.0 112.925 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -60.75 -28.13 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 0.0 111.12 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.97 -70.12 0.28 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.278 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 p -55.77 -23.01 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.201 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.63 60.34 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.599 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -92.4 -30.11 15.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.75 0.309 . . . . 0.0 110.97 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 t -74.24 -54.63 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.156 0.503 . . . . 0.0 110.232 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.0 mt -47.36 -30.04 2.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.85 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.52 -47.94 18.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.578 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.6 ttp -45.31 -43.32 10.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.627 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.577 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -81.45 -33.09 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.316 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.0 t -56.68 -28.37 60.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -74.61 -45.17 46.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.098 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -54.67 -32.08 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.181 0.515 . . . . 0.0 110.017 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.3 mt -61.51 -17.63 55.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.104 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -153.35 32.92 0.46 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.288 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -69.06 70.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 60.01 83.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -80.38 -175.13 4.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -87.96 115.9 25.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.5 p -176.52 79.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -103.66 -35.01 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.886 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.842 0.354 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.83 14.52 21.02 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.674 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.542 ' C ' ' O ' ' A' ' 2' ' ' LYS . 2.7 t0 -24.0 -50.18 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.06 0.457 . . . . 0.0 110.694 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 2' ' ' LYS . 4.8 mp -117.68 -22.41 8.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.782 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.0 mmt -50.23 -47.08 55.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.823 0.344 . . . . 0.0 111.175 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.407 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 9.5 t -67.74 -20.05 65.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.928 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 tt -90.97 -15.4 29.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.97 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.5 t -95.21 -60.09 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.588 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 8.6 tp -61.45 -22.88 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.648 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.409 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -67.34 -62.45 3.57 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.645 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 27.7 Cg_endo -62.2 -47.55 9.88 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.558 2.172 . . . . 0.0 112.473 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -55.11 -23.66 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.463 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.59 -65.75 0.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -49.55 -27.69 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.41 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.7 -33.99 45.19 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.9 -30.19 28.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.653 0.263 . . . . 0.0 110.983 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -74.45 -56.8 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.194 0.521 . . . . 0.0 110.326 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 mt -47.47 -29.87 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.9 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -81.34 -45.44 16.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.699 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ttm -50.4 -38.67 44.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.567 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.565 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.91 -35.27 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.376 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.8 t -56.63 -28.65 60.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.76 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -76.11 -41.81 49.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.214 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 21' ' ' ILE . 6.3 t -56.97 -32.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.106 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.95 -19.22 50.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.168 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -153.46 33.53 0.46 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.845 0.355 . . . . 0.0 111.338 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . 5.2 pt-20 -62.61 -33.51 75.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -60.33 -30.6 69.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.58 37.28 16.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -98.72 31.5 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.3 m -117.98 44.76 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -59.41 113.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 tttp . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.92 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.809 0.337 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.536 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.84 14.46 21.0 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.711 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 2' ' ' LYS . 24.3 t0 -24.14 -51.34 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.094 0.473 . . . . 0.0 110.513 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 2' ' ' LYS . 5.7 mp -117.62 -21.68 8.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.601 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.0 ttp -49.81 -47.83 51.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.715 0.293 . . . . 0.0 111.209 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.406 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 10.6 t -67.03 -21.34 65.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.67 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 2.2 tt -88.98 -14.68 36.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.717 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 12' ' ' ILE . 22.6 t -97.03 -63.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.744 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.41 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 9.6 tp -55.06 -23.48 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.818 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.422 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -70.53 -63.15 1.76 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.925 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 17.8 Cg_endo -58.94 -36.65 96.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.656 2.237 . . . . 0.0 112.956 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -69.73 -25.59 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.43 -63.7 1.04 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.734 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.6 t -48.85 -27.52 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.566 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.19 -35.18 30.91 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.624 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mp -79.87 -31.15 40.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.706 0.288 . . . . 0.0 110.969 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 t -71.31 -48.7 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.185 0.517 . . . . 0.0 110.292 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.1 -32.03 21.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.856 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -75.63 -40.98 55.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.646 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.2 ttp -51.64 -25.19 6.6 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.725 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.56 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -113.6 -37.1 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.922 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.2 t -52.53 -28.77 22.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.745 0.307 . . . . 0.0 111.168 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -29.82 21.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.366 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 26' ' ' ASP . 11.2 t -64.34 -22.73 31.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.5 13.23 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.514 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 24' ' ' VAL . 19.7 t0 -153.53 -50.54 0.1 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.794 0.331 . . . . 0.0 110.783 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 41.51 83.14 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.609 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -71.31 115.26 10.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.69 131.35 55.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.65 -47.75 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.4 p -126.37 105.93 9.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.8 mtp85 -69.28 109.65 4.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.9 mptt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.926 179.948 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptp . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.859 0.361 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.8 14.48 21.05 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.702 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' A' ' 2' ' ' LYS . 23.8 t0 -23.96 -51.2 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.135 0.493 . . . . 0.0 110.482 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 2' ' ' LYS . 4.6 mp -117.53 -23.72 7.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.442 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 -46.14 31.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 111.45 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.402 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 14.9 t -67.78 -19.81 65.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.051 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.07 -21.06 22.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 12' ' ' ILE . 40.6 t -83.44 -8.06 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.448 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.612 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 17.3 mm -123.99 -35.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.303 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -50.39 -60.99 4.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 29.7 Cg_endo -63.8 -54.63 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.56 2.173 . . . . 0.0 113.038 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.612 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.7 pp -51.51 -30.07 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 111.848 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -61.42 -72.68 0.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.772 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -52.83 -24.95 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.355 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.0 -32.3 49.8 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.605 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.4 mp -85.28 -30.58 23.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.69 0.281 . . . . 0.0 110.984 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -74.07 -55.92 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.309 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mt -47.05 -30.34 2.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.909 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -79.53 -44.84 20.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.6 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.453 ' O ' HG22 ' A' ' 24' ' ' VAL . 5.1 ttt -50.45 -26.53 5.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.684 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.542 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -105.89 -37.8 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.383 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.7 t -56.26 -26.61 52.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.329 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -30.57 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.115 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 20' ' ' MET . 45.2 t -59.3 -34.6 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.012 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mt -59.44 -13.11 7.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.287 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -153.18 28.92 0.5 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 120.8 0.333 . . . . 0.0 111.314 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -60.36 -173.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.98 64.05 7.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.29 51.0 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t0 60.7 107.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 p -147.47 136.25 22.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -36.34 82.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mttp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.835 179.968 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.833 0.349 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.557 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.88 14.58 20.97 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.63 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.557 ' C ' ' O ' ' A' ' 2' ' ' LYS . 25.6 t70 -24.02 -51.26 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.111 0.482 . . . . 0.0 110.545 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 2' ' ' LYS . 8.2 mp -117.66 -21.11 8.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.642 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -49.09 52.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.73 0.3 . . . . 0.0 111.213 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -69.99 -18.77 63.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.748 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 1.0 OUTLIER -91.72 -9.29 44.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' HG21 ' A' ' 12' ' ' ILE . 19.9 t -102.93 -62.72 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.861 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.415 ' HA ' HG21 ' A' ' 12' ' ' ILE . 10.0 tp -53.59 -24.95 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.828 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -71.23 -63.15 1.54 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.846 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 18.4 Cg_endo -58.83 -36.11 97.53 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.641 2.227 . . . . 0.0 113.075 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.421 HG21 ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -69.18 -27.93 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 111.076 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.44 -70.07 0.27 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.447 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -54.42 -23.73 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.351 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.3 -32.43 31.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.617 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.87 -29.45 32.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 111.049 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.52 -60.17 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.212 0.529 . . . . 0.0 110.275 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mt -49.03 -31.94 8.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.732 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.94 -41.35 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.604 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.8 ttp -50.0 -52.85 30.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.305 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.565 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -74.63 -36.83 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.3 t -54.45 -26.09 28.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.025 0.441 . . . . 0.0 109.99 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 27' ' ' GLU . 2.2 mmt85 -82.19 -36.67 27.06 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.085 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.5 t -54.13 -32.93 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.37 0.605 . . . . 0.0 109.597 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.75 -7.14 31.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.375 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -153.36 25.34 0.53 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.77 0.319 . . . . 0.0 111.451 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 23' ' ' ARG . 3.3 mm-40 -66.85 119.08 11.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.962 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -88.62 99.36 12.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -129.09 70.71 1.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.8 88.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.5 p -60.08 -70.24 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 59.46 -178.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mtp . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.777 0.322 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.556 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.45 21.03 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.671 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.556 ' C ' ' O ' ' A' ' 2' ' ' LYS . 38.1 t70 -24.12 -50.45 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.073 0.463 . . . . 0.0 110.644 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -117.65 -21.93 8.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.885 178.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.9 mmm -51.85 -46.44 64.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.693 0.282 . . . . 0.0 111.136 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.404 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 6.7 t -72.34 -17.11 61.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.952 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.5 tp -89.91 -13.93 35.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.048 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.27 -62.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.861 0.363 . . . . 0.0 111.086 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.583 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 8.5 tp -60.28 -21.91 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.641 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -67.52 -63.0 2.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.688 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 26.9 Cg_endo -62.04 -48.44 8.37 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.542 2.161 . . . . 0.0 112.473 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.583 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -53.08 -28.78 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.327 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.06 -72.66 0.14 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.114 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 12.6 p -54.84 -26.82 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.883 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.48 -28.6 73.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.298 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mt -99.13 -24.42 14.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.633 0.254 . . . . 0.0 111.311 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 t -85.05 -58.65 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.087 0.47 . . . . 0.0 110.704 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -49.44 -28.74 5.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.805 -179.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -78.11 -45.85 22.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.483 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.1 ttt -47.76 -44.34 28.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.594 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.571 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -78.93 -33.18 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.443 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.5 t -56.11 -28.78 59.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -74.58 -44.79 49.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 21' ' ' ILE . 4.7 t -54.64 -31.65 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.186 0.517 . . . . 0.0 110.018 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.66 -17.46 60.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.241 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -153.48 32.19 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.802 0.334 . . . . 0.0 111.52 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.5 mm-40 -74.55 -31.3 62.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -76.11 -173.63 2.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -141.11 178.46 7.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.09 78.92 2.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 m 60.47 32.29 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mmt85 -74.45 163.9 27.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.942 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.888 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpp? . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.878 0.37 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.547 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.8 14.45 21.06 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.669 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -23.89 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.128 0.49 . . . . 0.0 110.495 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 2' ' ' LYS . 5.6 mp -117.55 -21.73 8.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.476 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -32.09 30.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.746 0.308 . . . . 0.0 111.375 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.403 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 7.9 t -87.44 -1.44 57.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.474 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.34 -6.21 10.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.233 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 12' ' ' ILE . 23.5 t -94.79 -23.88 5.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.582 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.621 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 19.8 mm -124.5 -40.72 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.604 0.24 . . . . 0.0 111.507 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.478 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -49.46 -53.99 34.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 41.2 Cg_endo -68.59 -52.28 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.308 2.005 . . . . 0.0 112.868 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.621 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.8 pp -55.04 -29.86 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.762 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -61.94 -71.96 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.799 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.2 t -52.66 -25.52 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.296 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.4 -30.01 42.54 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 mt -83.64 -30.38 26.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 t -76.67 -57.81 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.149 0.499 . . . . 0.0 110.537 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.4 mt -47.1 -34.95 6.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.997 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.22 -39.59 71.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.619 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 ttt -50.87 -26.29 5.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.689 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.57 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.86 -37.82 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.033 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.1 t -51.87 -29.9 21.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.286 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.43 -31.83 21.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.869 0.366 . . . . 0.0 110.458 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 21' ' ' ILE . 11.3 t -61.19 -23.64 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.343 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.407 ' CD1' HD12 ' A' ' 21' ' ' ILE . 3.6 mp -75.17 13.49 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.627 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -153.38 -38.62 0.1 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.7 0.286 . . . . 0.0 111.297 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -47.96 166.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -59.99 165.12 3.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -153.71 -176.44 5.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.99 138.51 58.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -162.99 179.82 7.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -105.81 31.53 4.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.9 tttp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.902 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.791 0.329 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.546 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.78 14.47 21.07 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.669 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 2' ' ' LYS . 23.9 t0 -24.01 -51.11 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.105 0.479 . . . . 0.0 110.541 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 2' ' ' LYS . 5.6 mp -117.58 -22.42 8.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.564 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 8.7 ttm -49.02 -48.14 44.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.309 . . . . 0.0 111.265 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -67.91 -20.04 65.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.805 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 tp -90.42 -14.53 32.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.23 -61.36 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.98 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.568 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 9.1 tp -60.11 -21.7 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.745 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . . . -69.0 -62.87 2.46 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.72 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 29.1 Cg_endo -62.87 -46.86 9.85 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.6 2.2 . . . . 0.0 112.555 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.568 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -53.14 -24.98 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.504 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.42 -69.34 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -49.7 -27.21 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.385 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.12 -37.92 23.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.607 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.25 -30.25 60.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.29 . . . . 0.0 111.003 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -73.83 -49.67 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.169 0.509 . . . . 0.0 110.503 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.93 -30.53 10.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.941 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.69 -40.53 55.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.57 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.8 ttt -52.16 -41.54 62.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.406 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.567 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.89 -35.38 8.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.365 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.7 t -56.11 -29.03 60.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.739 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -74.86 -43.12 56.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.123 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.1 t -56.18 -32.36 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.225 0.536 . . . . 0.0 110.1 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.8 mt -60.26 -19.2 53.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.301 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -153.46 33.08 0.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.45 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.8 mm-40 -87.65 136.91 32.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.932 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.34 130.23 45.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -108.25 35.9 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -81.59 102.22 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.18 -68.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.2 mtm105 -77.11 85.98 3.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.8 tttp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.891 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.778 0.323 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.49 21.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.636 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.542 ' C ' ' O ' ' A' ' 2' ' ' LYS . 24.0 t0 -23.84 -49.83 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.047 0.451 . . . . 0.0 110.705 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 2' ' ' LYS . 6.4 mp -117.6 -17.48 9.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.914 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.9 mmm -56.23 -37.64 69.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.774 0.321 . . . . 0.0 111.003 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 4.0 t -86.93 7.19 28.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.898 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.7 mt -118.39 -10.97 10.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.133 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 12' ' ' ILE . 8.7 p -85.03 -29.58 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.601 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 1.6 tp -125.24 -34.91 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.443 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -53.9 -57.72 16.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 35.2 Cg_endo -65.48 -53.1 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.249 1.966 . . . . 0.0 112.843 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -51.29 -29.01 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 0.0 111.64 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -72.19 0.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.503 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -54.87 -23.56 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.289 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -30.67 56.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.54 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 mt -88.49 -29.8 19.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.768 0.318 . . . . 0.0 111.007 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 t -76.0 -53.83 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.091 0.472 . . . . 0.0 110.589 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.7 mt -46.22 -30.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.078 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.04 -47.89 15.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.641 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 ttt -45.82 -41.71 11.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.6 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.564 ' CD1' ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -82.03 -33.05 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.418 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.5 t -56.7 -29.28 62.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -74.24 -46.03 44.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.104 179.306 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.6 t -52.91 -32.61 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.253 0.549 . . . . 0.0 110.027 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.1 mt -62.48 -17.52 59.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.325 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -153.5 32.44 0.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.772 0.32 . . . . 0.0 111.527 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 3.6 mm-40 -98.89 31.63 2.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.907 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -97.2 -31.03 12.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.54 113.82 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.49 -176.79 3.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 p -115.4 -45.64 2.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -143.17 -46.81 0.3 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.893 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--O 1.232 0.144 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.1 mtm -55.6 -43.11 75.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 111.223 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t -79.38 -2.85 43.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.933 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.3 tp -100.91 -18.94 16.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.341 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 9' ' ' ILE . 6.4 p -91.2 -46.61 14.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 12' ' ' ILE . 6.8 tp -73.6 -30.42 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.577 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.629 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -57.87 -61.69 6.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.632 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 27.9 Cg_endo -62.6 -52.08 2.71 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.65 2.233 . . . . 0.0 112.746 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.785 ' O ' HD13 ' A' ' 16' ' ' LEU . 2.6 pp -50.39 -27.48 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.889 0.376 . . . . 0.0 111.552 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.869 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -66.64 -70.72 0.23 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 179.573 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.841 HG12 HD12 ' A' ' 18' ' ' LEU . 21.3 t -55.43 -23.01 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.33 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.23 -28.72 39.57 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.628 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.785 HD13 ' O ' ' A' ' 12' ' ' ILE . 8.3 mp -85.66 -30.07 23.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.78 0.324 . . . . 0.0 110.997 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -77.3 -57.77 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.18 0.514 . . . . 0.0 110.278 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.841 HD12 HG12 ' A' ' 14' ' ' VAL . 11.2 mt -48.81 -28.78 3.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.894 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -77.54 -41.24 39.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.567 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.0 ttp -51.29 -40.55 59.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.552 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.842 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -84.31 -32.64 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.687 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.517 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -57.69 -29.93 65.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.859 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.44 -43.45 56.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.092 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 24' ' ' VAL . 6.4 t -55.7 -31.51 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.187 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 22' ' ' SER . 16.3 mt -61.47 -17.85 56.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.475 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -153.45 30.4 0.48 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.699 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.771 179.859 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.8 mm? . . . . . 0 C--O 1.231 0.116 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.7 -50.9 17.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.751 0.31 . . . . 0.0 111.543 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 5.2 t -66.34 -19.98 65.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.9 tp -89.74 -14.35 34.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 4' ' ' LEU . 25.2 t -95.4 -62.29 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.963 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.828 HD12 HD11 ' A' ' 12' ' ' ILE . 9.0 tp -59.4 -21.2 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.75 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.633 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -69.6 -63.07 2.12 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.691 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.633 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 29.2 Cg_endo -62.71 -45.54 13.55 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.558 2.172 . . . . 0.0 112.537 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.828 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -55.79 -22.69 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.539 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.853 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.2 t80 -63.98 -68.43 0.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.694 HG22 HD12 ' A' ' 18' ' ' LEU . 11.7 p -50.34 -26.97 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.418 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.78 -33.85 45.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.589 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.7 mm? -83.11 -30.18 28.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 111.016 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.33 -57.11 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.21 0.528 . . . . 0.0 110.318 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.694 HD12 HG22 ' A' ' 14' ' ' VAL . 7.5 mt -47.56 -29.91 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.903 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -80.52 -44.68 18.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.659 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.4 ttt -50.07 -38.2 37.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.604 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.843 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.71 -35.34 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.377 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.643 ' HA ' HD12 ' A' ' 25' ' ' LEU . 27.5 t -56.67 -28.7 61.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.713 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -75.85 -42.08 50.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.146 179.389 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.8 t -56.63 -32.53 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.186 0.517 . . . . 0.0 110.14 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.7 mt -59.66 -19.62 50.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.194 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -153.46 33.83 0.46 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.397 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . 10.6 pt-20 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.779 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.8 mp . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.7 mmt -52.1 -46.36 65.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.768 0.318 . . . . 0.0 111.138 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 8.6 t -71.73 -17.74 62.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.932 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.656 ' O ' HD23 ' A' ' 7' ' ' LEU . 3.9 tt -89.65 -14.49 34.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.021 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 4' ' ' LEU . 21.9 t -94.72 -62.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 110.989 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.795 HD12 HD11 ' A' ' 12' ' ' ILE . 9.1 tp -59.41 -22.01 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.731 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.636 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -68.31 -63.16 2.54 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.74 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 28.8 Cg_endo -62.73 -47.48 8.89 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.561 2.174 . . . . 0.0 112.574 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.795 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -52.81 -25.64 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.462 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.861 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.2 t80 -66.35 -68.8 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 21.2 t -51.35 -25.89 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.402 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.534 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -79.59 -35.6 28.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.592 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.4 mm? -78.64 -30.48 46.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.728 0.299 . . . . 0.0 110.951 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -73.37 -49.61 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.172 0.511 . . . . 0.0 110.378 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.534 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -50.52 -32.79 19.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.846 -179.455 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.89 -41.55 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.526 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 5.1 ttt -51.75 -28.39 15.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.612 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.802 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -107.99 -38.19 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.404 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.467 ' HA ' HD12 ' A' ' 25' ' ' LEU . 40.7 t -56.56 -27.73 58.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 0.0 110.235 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -29.79 27.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.099 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' MET . 42.2 t -61.26 -33.44 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.168 0.509 . . . . 0.0 110.051 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 22' ' ' SER . 3.9 mt -59.53 -11.95 5.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.349 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -153.18 27.01 0.52 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.758 0.313 . . . . 0.0 111.409 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.893 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.9 mt . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 mmt -57.58 -46.06 84.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.883 0.373 . . . . 0.0 110.898 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 p -70.18 -19.38 63.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.797 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.431 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 18.0 tp -87.93 -14.98 37.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 4' ' ' LEU . 19.8 t -97.18 -64.11 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.886 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.42 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 9.9 tp -54.1 -23.64 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.888 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.636 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -70.82 -63.29 1.62 Allowed Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.636 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 17.8 Cg_endo -59.0 -36.51 96.62 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.621 2.214 . . . . 0.0 112.961 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.785 ' O ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.59 -25.96 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 111.175 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.854 ' O ' HG23 ' A' ' 17' ' ' VAL . 7.2 t80 -65.39 -66.21 0.58 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.801 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.766 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -50.66 -26.8 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.424 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.14 -32.29 49.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.557 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 12' ' ' ILE . 4.2 mp -84.93 -29.83 24.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.702 0.287 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.96 -57.71 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.239 0.542 . . . . 0.0 110.332 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.766 HD12 HG12 ' A' ' 14' ' ' VAL . 7.7 mt -47.84 -30.69 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.777 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.92 -41.46 51.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.648 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 ttt -51.23 -41.37 60.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.476 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.841 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.5 -35.34 8.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.335 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.559 ' HA ' HD12 ' A' ' 25' ' ' LEU . 41.6 t -56.65 -28.9 61.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.74 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 27' ' ' GLU . 6.4 mpt_? -75.16 -42.21 56.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.156 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.769 HG13 ' OE2' ' A' ' 27' ' ' GLU . 5.6 t -57.33 -31.99 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 110.061 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.0 mt -59.97 -18.81 48.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.099 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -153.4 33.49 0.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.219 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.769 ' OE2' HG13 ' A' ' 24' ' ' VAL . 14.0 pt-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.915 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.724 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.1 mp . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.547 0.213 . . . . 0.0 111.509 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.4 ttp -49.14 -47.59 45.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.769 0.319 . . . . 0.0 111.332 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 9.6 t -68.11 -19.91 64.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.861 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.537 ' O ' HD23 ' A' ' 7' ' ' LEU . 2.2 tt -90.89 -14.81 31.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.944 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 4' ' ' LEU . 24.5 t -94.73 -60.7 2.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.016 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.767 HD12 HD11 ' A' ' 12' ' ' ILE . 8.7 tp -61.23 -23.06 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.66 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.63 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -66.94 -62.61 3.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.717 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.63 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 28.7 Cg_endo -62.8 -48.47 6.89 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.58 2.187 . . . . 0.0 112.553 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.767 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -52.33 -26.2 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.477 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.848 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -67.01 -69.82 0.29 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.425 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.84 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -54.3 -24.27 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.316 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.81 -29.38 47.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.561 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.5 mt -86.28 -29.33 23.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -78.34 -57.58 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.119 0.485 . . . . 0.0 110.428 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.84 HD12 HG12 ' A' ' 14' ' ' VAL . 13.1 mt -47.28 -34.38 6.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.9 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -70.87 -39.94 72.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.573 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 30.1 ttp -50.57 -26.49 5.35 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.694 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.84 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.6 -38.51 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.961 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.453 ' N ' HD13 ' A' ' 21' ' ' ILE . 32.3 t -50.5 -36.41 33.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.27 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -36.69 39.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.411 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' A' ' 21' ' ' ILE . 18.8 t -53.71 -29.34 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.185 0.517 . . . . 0.0 110.117 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mp -72.39 3.7 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.171 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -153.1 12.93 0.5 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.768 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 120.888 0.375 . . . . 0.0 110.929 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.1 mtp -56.88 -44.32 82.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.75 0.31 . . . . 0.0 111.052 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 t -78.29 -3.6 43.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.0 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.45 -18.63 16.61 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.343 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 9' ' ' ILE . 5.7 p -91.91 -46.74 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.39 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.71 HD12 HD11 ' A' ' 12' ' ' ILE . 6.9 tp -72.92 -29.73 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.618 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -58.98 -61.16 8.37 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.692 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 29.1 Cg_endo -62.88 -50.9 3.41 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.629 2.219 . . . . 0.0 112.683 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.746 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.6 pp -52.53 -25.0 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 111.605 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.844 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -62.85 -69.84 0.24 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.728 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 11' ' ' PRO . 11.5 p -48.0 -28.46 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.407 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.669 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -82.36 -40.46 10.05 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.497 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.746 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.8 mm? -67.56 -30.48 70.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.869 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -76.18 -52.82 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.184 0.516 . . . . 0.0 110.3 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.669 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -52.66 -30.33 31.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.767 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -76.92 -40.95 45.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.596 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.3 ttm -51.35 -41.95 60.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.83 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.74 -35.46 8.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.36 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.476 ' HA ' HD12 ' A' ' 25' ' ' LEU . 42.6 t -56.45 -29.1 61.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.765 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -75.0 -44.25 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.131 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.7 t -53.9 -33.68 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.224 0.535 . . . . 0.0 110.119 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 22' ' ' SER . 16.5 mt -59.9 -19.68 52.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.247 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -153.5 34.29 0.45 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.442 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.5 mm-40 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.5 mtm -55.4 -43.97 75.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.18 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 3.3 t -77.88 -5.15 50.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.992 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 7' ' ' LEU . 2.7 tt -97.97 -19.95 17.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.319 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 9' ' ' ILE . 5.0 p -91.74 -46.62 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.372 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.695 HD12 HD11 ' A' ' 12' ' ' ILE . 6.8 tp -73.22 -30.22 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.558 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.618 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -58.29 -61.38 7.65 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.667 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 28.5 Cg_endo -62.56 -51.5 3.21 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.67 2.247 . . . . 0.0 112.716 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.715 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.6 pp -52.11 -25.56 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.859 0.361 . . . . 0.0 111.494 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.849 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -64.46 -69.5 0.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.711 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -52.26 -25.77 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.371 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.28 -32.33 52.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.566 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.6 mm? -85.67 -30.02 23.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.021 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -75.13 -55.94 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 110.451 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.722 HD12 HG12 ' A' ' 14' ' ' VAL . 8.1 mt -46.74 -33.56 4.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.866 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.81 -39.81 69.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.578 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.457 ' O ' HG23 ' A' ' 24' ' ' VAL . 16.0 ttp -52.22 -25.22 8.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.662 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.824 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.35 -36.98 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.883 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.406 ' N ' HD13 ' A' ' 21' ' ' ILE . 28.7 t -54.12 -28.94 42.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.1 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.35 -31.2 20.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.403 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 21' ' ' ILE . 41.1 t -55.08 -32.97 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 mt -67.21 -3.47 7.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.065 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -153.29 22.27 0.55 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.355 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.889 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.5 mtt -53.52 -48.14 69.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.807 0.337 . . . . 0.0 111.131 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 t -73.05 -13.55 61.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.785 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.431 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 2.4 tt -88.25 -19.09 27.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.427 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 12' ' ' ILE . 2.9 p -96.86 -49.34 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.2 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.45 ' N ' ' CG1' ' A' ' 8' ' ' VAL . 8.8 tp -62.48 -29.24 46.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.728 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.617 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -66.67 -60.26 6.73 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.943 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 37.6 Cg_endo -65.25 -28.89 55.44 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.59 2.193 . . . . 0.0 113.419 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.819 ' O ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -77.83 -30.74 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 0.0 111.116 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.893 ' O ' HG23 ' A' ' 17' ' ' VAL . 25.3 t80 -72.74 -66.08 0.71 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.942 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.96 HG12 HD12 ' A' ' 18' ' ' LEU . 20.5 t -57.23 -21.25 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.12 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.14 -26.48 44.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mp -89.42 -29.65 18.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.313 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -77.73 -58.98 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.207 0.527 . . . . 0.0 110.098 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.96 HD12 HG12 ' A' ' 14' ' ' VAL . 15.0 mt -49.69 -29.09 6.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.708 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.21 -40.82 51.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.507 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.7 ttm -51.51 -41.04 60.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.521 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.843 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -84.84 -31.9 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.737 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.539 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.2 p -58.44 -29.85 66.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.891 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 5.6 mpt_? -74.39 -42.5 59.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.144 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.2 t -56.44 -32.18 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.217 0.532 . . . . 0.0 110.197 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.9 mt -60.54 -19.46 57.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.279 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -153.49 33.25 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.809 0.338 . . . . 0.0 111.44 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 20.3 pt-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -47.63 72.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.741 0.305 . . . . 0.0 111.175 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.0 t -74.53 -8.96 58.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.965 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.533 ' O ' HD23 ' A' ' 7' ' ' LEU . 3.3 tt -94.2 -18.83 21.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.302 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 9' ' ' ILE . 3.5 p -96.39 -44.21 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.351 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.439 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 7.7 tp -70.96 -20.6 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.986 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -75.75 -62.02 0.82 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 34.8 Cg_endo -64.56 -22.03 65.29 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.625 2.217 . . . . 0.0 113.202 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.792 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -75.6 -29.81 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 0.0 111.111 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.879 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -66.05 -68.28 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.437 179.665 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.809 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -53.25 -24.98 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.349 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.76 -32.2 51.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.616 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 12' ' ' ILE . 6.2 mp -85.82 -29.23 23.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.5 t -76.38 -57.27 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.135 0.493 . . . . 0.0 110.346 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.809 HD12 HG12 ' A' ' 14' ' ' VAL . 11.4 mt -47.64 -34.65 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.724 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -68.14 -38.22 81.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.505 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.7 ttm -52.7 -46.12 67.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.511 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.844 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -89.16 -35.63 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.458 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.61 ' HA ' HD12 ' A' ' 25' ' ' LEU . 48.3 t -56.69 -27.43 58.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.72 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 27' ' ' GLU . 6.8 mpt_? -74.89 -44.3 49.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.168 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.02 -32.44 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.235 0.54 . . . . 0.0 110.01 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 22' ' ' SER . 18.9 mt -60.28 -18.92 52.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -153.43 33.44 0.46 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.839 0.352 . . . . 0.0 111.391 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.7 pt-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.28 -39.0 69.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.718 0.294 . . . . 0.0 111.098 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 t -84.7 4.82 30.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.976 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.468 ' O ' HD23 ' A' ' 7' ' ' LEU . 1.2 tt -112.33 -16.87 12.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.289 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 9' ' ' ILE . 4.8 p -92.86 -45.9 14.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.275 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.648 HD12 HD11 ' A' ' 12' ' ' ILE . 6.3 tp -77.81 -27.25 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.713 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.947 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -62.85 -62.5 5.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.294 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 44.5 Cg_exo -56.56 -52.27 7.35 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.248 1.966 . . . . 0.0 112.255 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.75 ' O ' HD13 ' A' ' 16' ' ' LEU . 2.7 pp -54.22 -24.16 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.52 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.842 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -63.8 -70.58 0.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.762 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.83 HG22 HD12 ' A' ' 18' ' ' LEU . 11.6 p -51.3 -26.86 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.362 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.52 -32.14 47.94 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 12' ' ' ILE . 9.0 mp -83.67 -29.94 27.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.726 0.298 . . . . 0.0 110.96 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.5 t -75.86 -57.51 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.14 0.495 . . . . 0.0 110.372 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.83 HD12 HG22 ' A' ' 14' ' ' VAL . 6.4 mt -47.19 -30.35 2.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.837 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -76.25 -41.06 50.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.599 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.5 ttt -51.46 -41.49 60.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.47 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.836 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.77 -35.43 8.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.366 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.577 ' HA ' HD12 ' A' ' 25' ' ' LEU . 40.8 t -56.38 -28.95 60.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.729 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 27' ' ' GLU . 5.8 mpt_? -74.98 -43.14 55.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.121 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -56.07 -32.37 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.245 0.545 . . . . 0.0 110.117 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.3 mt -60.51 -18.83 54.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.288 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -153.49 32.85 0.46 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.496 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.901 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.3 mt . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.624 0.249 . . . . 0.0 111.415 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.63 -45.37 38.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 111.46 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -69.27 -18.44 63.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.211 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.1 tp -98.39 -14.82 19.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.256 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 4' ' ' LEU . 3.4 t -100.28 10.2 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.739 0.304 . . . . 0.0 111.078 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 36.3 mm -125.89 -54.38 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.748 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -44.8 -53.34 15.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.88 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 33.6 Cg_exo -61.4 -43.56 27.44 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.588 2.192 . . . . 0.0 112.876 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.753 ' O ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -76.1 -28.01 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.799 -179.233 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.901 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -69.19 -66.6 0.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.375 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 10' ' ' ALA . 11.6 p -54.41 -22.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.375 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.614 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -84.61 -33.42 19.26 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.701 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.78 -32.5 46.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 111.014 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.8 t -71.75 -50.23 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.246 0.546 . . . . 0.0 110.23 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.614 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -52.2 -30.34 26.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.824 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.77 -42.64 27.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.71 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 ttt -50.42 -41.09 51.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.561 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.836 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.9 -35.49 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.371 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.511 ' HA ' HD12 ' A' ' 25' ' ' LEU . 40.3 t -56.61 -29.05 61.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.749 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -75.32 -43.11 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.176 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.6 t -55.28 -33.11 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 110.118 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.0 mt -59.91 -19.51 52.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.212 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -153.47 34.13 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.377 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . 7.1 pt-20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.768 ' O ' HG12 ' A' ' 8' ' ' VAL . 8.5 ttm -53.82 -44.91 70.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.755 0.312 . . . . 0.0 111.163 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 5.5 t -75.44 -15.29 60.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.806 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 tp -97.25 -5.58 36.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.397 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 5' ' ' MET . 5.4 p -81.29 -26.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.581 0.229 . . . . 0.0 111.547 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.467 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 1.6 tp -120.82 -6.1 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.664 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -79.95 -63.2 0.37 Allowed Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.664 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 37.4 Cg_endo -66.13 -40.63 15.04 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.608 2.205 . . . . 0.0 112.925 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.768 ' O ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -60.75 -28.13 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 0.0 111.12 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.881 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -67.97 -70.12 0.28 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.278 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.812 HG22 HD12 ' A' ' 18' ' ' LEU . 10.9 p -55.77 -23.01 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.201 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.63 60.34 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.599 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -92.4 -30.11 15.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.75 0.309 . . . . 0.0 110.97 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.7 t -74.24 -54.63 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.156 0.503 . . . . 0.0 110.232 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.812 HD12 HG22 ' A' ' 14' ' ' VAL . 11.0 mt -47.36 -30.04 2.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.85 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.52 -47.94 18.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.578 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.6 ttp -45.31 -43.32 10.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.627 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.837 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -81.45 -33.09 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.316 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.594 ' HA ' HD12 ' A' ' 25' ' ' LEU . 27.0 t -56.68 -28.37 60.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -74.61 -45.17 46.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.098 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 24' ' ' VAL . 3.8 t -54.67 -32.08 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.181 0.515 . . . . 0.0 110.017 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.594 HD12 ' HA ' ' A' ' 22' ' ' SER . 18.3 mt -61.51 -17.63 55.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.104 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -153.35 32.92 0.46 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.288 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.717 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.8 mp . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.0 mmt -50.23 -47.08 55.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.823 0.344 . . . . 0.0 111.175 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 9.5 t -67.74 -20.05 65.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.928 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 7' ' ' LEU . 2.3 tt -90.97 -15.4 29.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.97 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 4' ' ' LEU . 23.5 t -95.21 -60.09 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.792 HD12 HD11 ' A' ' 12' ' ' ILE . 8.6 tp -61.45 -22.88 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.648 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.624 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -67.34 -62.45 3.57 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.645 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 27.7 Cg_endo -62.2 -47.55 9.88 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.558 2.172 . . . . 0.0 112.473 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.792 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -55.11 -23.66 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.463 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.845 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.4 t80 -64.59 -65.75 0.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.75 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -49.55 -27.69 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.41 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.7 -33.99 45.19 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.673 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.6 mm? -82.9 -30.19 28.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.653 0.263 . . . . 0.0 110.983 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.45 -56.8 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.194 0.521 . . . . 0.0 110.326 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 14' ' ' VAL . 6.3 mt -47.47 -29.87 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.9 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -81.34 -45.44 16.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.699 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ttm -50.4 -38.67 44.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.567 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.843 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.91 -35.27 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.376 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.538 ' HA ' HD12 ' A' ' 25' ' ' LEU . 27.8 t -56.63 -28.65 60.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.76 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -76.11 -41.81 49.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.214 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.3 t -56.97 -32.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.106 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.3 mt -59.95 -19.22 50.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.168 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -153.46 33.53 0.46 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.845 0.355 . . . . 0.0 111.338 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . 5.2 pt-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.741 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.7 mp . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.0 ttp -49.81 -47.83 51.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.715 0.293 . . . . 0.0 111.209 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.6 t -67.03 -21.34 65.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.67 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.471 ' O ' HD23 ' A' ' 7' ' ' LEU . 2.2 tt -88.98 -14.68 36.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.717 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 4' ' ' LEU . 22.6 t -97.03 -63.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.744 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 9.6 tp -55.06 -23.48 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.818 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.63 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -70.53 -63.15 1.76 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.925 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.63 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 17.8 Cg_endo -58.94 -36.65 96.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.656 2.237 . . . . 0.0 112.956 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.77 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.73 -25.59 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.871 ' O ' HG23 ' A' ' 17' ' ' VAL . 5.4 t80 -65.43 -63.7 1.04 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.734 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.6 t -48.85 -27.52 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.566 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.529 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -79.19 -35.18 30.91 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.624 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 12' ' ' ILE . 3.0 mp -79.87 -31.15 40.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.706 0.288 . . . . 0.0 110.969 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.8 t -71.31 -48.7 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.185 0.517 . . . . 0.0 110.292 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.529 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -51.1 -32.03 21.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.856 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -75.63 -40.98 55.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.646 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.423 ' O ' HG23 ' A' ' 24' ' ' VAL . 19.2 ttp -51.64 -25.19 6.6 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.725 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.837 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -113.6 -37.1 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.922 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.414 ' N ' HD13 ' A' ' 21' ' ' ILE . 28.2 t -52.53 -28.77 22.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.745 0.307 . . . . 0.0 111.168 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -29.82 21.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.366 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 21' ' ' ILE . 11.2 t -64.34 -22.73 31.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.5 13.23 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.514 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 24' ' ' VAL . 19.7 t0 -153.53 -50.54 0.1 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.794 0.331 . . . . 0.0 110.783 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.464 0.238 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.609 179.6 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.553 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.6 mp . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.611 0.243 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 -46.14 31.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 111.45 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 14.9 t -67.78 -19.81 65.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.051 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.07 -21.06 22.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 4' ' ' LEU . 40.6 t -83.44 -8.06 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.448 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.623 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 17.3 mm -123.99 -35.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.303 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -50.39 -60.99 4.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 29.7 Cg_endo -63.8 -54.63 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.56 2.173 . . . . 0.0 113.038 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.718 ' O ' HD13 ' A' ' 16' ' ' LEU . 2.7 pp -51.51 -30.07 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 111.848 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.836 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -61.42 -72.68 0.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.772 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.786 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -52.83 -24.95 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.355 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.0 -32.3 49.8 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.605 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 12' ' ' ILE . 9.4 mp -85.28 -30.58 23.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.69 0.281 . . . . 0.0 110.984 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.07 -55.92 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.309 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.786 HD12 HG12 ' A' ' 14' ' ' VAL . 6.0 mt -47.05 -30.34 2.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.909 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -79.53 -44.84 20.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.6 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.569 ' O ' HG23 ' A' ' 24' ' ' VAL . 5.1 ttt -50.45 -26.53 5.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.684 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.815 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -105.89 -37.8 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.383 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 25' ' ' LEU . 28.7 t -56.26 -26.61 52.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.329 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -30.57 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.115 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 20' ' ' MET . 45.2 t -59.3 -34.6 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.012 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 22' ' ' SER . 4.3 mt -59.44 -13.11 7.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.287 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -153.18 28.92 0.5 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 120.8 0.333 . . . . 0.0 111.314 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.889 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.896 ' O ' HG23 ' A' ' 8' ' ' VAL . 8.2 mp . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -49.09 52.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.73 0.3 . . . . 0.0 111.213 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -69.99 -18.77 63.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.748 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 1.0 OUTLIER -91.72 -9.29 44.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 4' ' ' LEU . 19.9 t -102.93 -62.72 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.861 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.0 tp -53.59 -24.95 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.828 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.635 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -71.23 -63.15 1.54 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.846 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.635 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 18.4 Cg_endo -58.83 -36.11 97.53 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.641 2.227 . . . . 0.0 113.075 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.78 ' O ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.18 -27.93 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 111.076 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.883 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -66.44 -70.07 0.27 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.447 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.948 HG22 HD12 ' A' ' 18' ' ' LEU . 11.5 p -54.42 -23.73 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.351 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.3 -32.43 31.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.617 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.87 -29.45 32.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 111.049 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.5 t -77.52 -60.17 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.212 0.529 . . . . 0.0 110.275 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.948 HD12 HG22 ' A' ' 14' ' ' VAL . 6.9 mt -49.03 -31.94 8.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.732 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.94 -41.35 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.604 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.8 ttp -50.0 -52.85 30.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.305 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.834 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -74.63 -36.83 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.472 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.472 ' N ' HD13 ' A' ' 21' ' ' ILE . 43.3 t -54.45 -26.09 28.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.025 0.441 . . . . 0.0 109.99 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 27' ' ' GLU . 2.2 mmt85 -82.19 -36.67 27.06 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.085 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 21' ' ' ILE . 40.5 t -54.13 -32.93 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.37 0.605 . . . . 0.0 109.597 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.75 -7.14 31.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.375 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -153.36 25.34 0.53 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.77 0.319 . . . . 0.0 111.451 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 23' ' ' ARG . 3.3 mm-40 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.962 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.9 mmm -51.85 -46.44 64.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.693 0.282 . . . . 0.0 111.136 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 6.7 t -72.34 -17.11 61.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.952 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.5 tp -89.91 -13.93 35.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.048 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 4' ' ' LEU . 22.1 t -94.27 -62.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.861 0.363 . . . . 0.0 111.086 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.756 HD12 HD11 ' A' ' 12' ' ' ILE . 8.5 tp -60.28 -21.91 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.641 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.627 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -67.52 -63.0 2.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.688 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 26.9 Cg_endo -62.04 -48.44 8.37 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.542 2.161 . . . . 0.0 112.473 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.756 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -53.08 -28.78 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.327 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.834 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -65.06 -72.66 0.14 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.114 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 18' ' ' LEU . 12.6 p -54.84 -26.82 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.883 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.48 -28.6 73.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.298 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mt -99.13 -24.42 14.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.633 0.254 . . . . 0.0 111.311 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.3 t -85.05 -58.65 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.087 0.47 . . . . 0.0 110.704 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -49.44 -28.74 5.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.805 -179.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -78.11 -45.85 22.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.483 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.1 ttt -47.76 -44.34 28.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.594 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.848 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -78.93 -33.18 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.443 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.603 ' HA ' HD12 ' A' ' 25' ' ' LEU . 26.5 t -56.11 -28.78 59.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -74.58 -44.79 49.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 t -54.64 -31.65 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.186 0.517 . . . . 0.0 110.018 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.603 HD12 ' HA ' ' A' ' 22' ' ' SER . 17.4 mt -62.66 -17.46 60.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.241 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -153.48 32.19 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.802 0.334 . . . . 0.0 111.52 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.5 mm-40 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.852 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.6 mp . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.558 0.218 . . . . 0.0 111.476 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -32.09 30.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.746 0.308 . . . . 0.0 111.375 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.681 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 7.9 t -87.44 -1.44 57.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.474 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -118.34 -6.21 10.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.233 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 4' ' ' LEU . 23.5 t -94.79 -23.88 5.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.582 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.633 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 19.8 mm -124.5 -40.72 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.604 0.24 . . . . 0.0 111.507 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -49.46 -53.99 34.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 41.2 Cg_endo -68.59 -52.28 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.308 2.005 . . . . 0.0 112.868 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.633 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.8 pp -55.04 -29.86 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.762 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.845 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -61.94 -71.96 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.799 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.723 HG12 HD12 ' A' ' 18' ' ' LEU . 24.2 t -52.66 -25.52 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.296 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.4 -30.01 42.54 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 12' ' ' ILE . 9.7 mt -83.64 -30.38 26.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 110.933 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -76.67 -57.81 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.149 0.499 . . . . 0.0 110.537 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.723 HD12 HG12 ' A' ' 14' ' ' VAL . 7.4 mt -47.1 -34.95 6.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.997 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.22 -39.59 71.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.619 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 ttt -50.87 -26.29 5.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.689 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.839 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.86 -37.82 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.033 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.454 ' N ' HD13 ' A' ' 21' ' ' ILE . 29.1 t -51.87 -29.9 21.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.286 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.43 -31.83 21.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.869 0.366 . . . . 0.0 110.458 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.448 HG23 ' HA ' ' A' ' 21' ' ' ILE . 11.3 t -61.19 -23.64 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.343 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 mp -75.17 13.49 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.627 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -153.38 -38.62 0.1 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.7 0.286 . . . . 0.0 111.297 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.148 179.888 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.741 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.6 mp . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 8.7 ttm -49.02 -48.14 44.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.309 . . . . 0.0 111.265 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 8.7 t -67.91 -20.04 65.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.805 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 tp -90.42 -14.53 32.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 4' ' ' LEU . 24.8 t -95.23 -61.36 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.98 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.766 HD12 HD11 ' A' ' 12' ' ' ILE . 9.1 tp -60.11 -21.7 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.745 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.643 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -69.0 -62.87 2.46 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.72 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.643 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 29.1 Cg_endo -62.87 -46.86 9.85 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.6 2.2 . . . . 0.0 112.555 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.766 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -53.14 -24.98 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.504 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.871 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -64.42 -69.34 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 11' ' ' PRO . 11.5 p -49.7 -27.21 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.385 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.573 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -79.12 -37.92 23.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.607 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 12' ' ' ILE . 4.0 mm? -75.25 -30.25 60.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.29 . . . . 0.0 111.003 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -73.83 -49.67 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.169 0.509 . . . . 0.0 110.503 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.573 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -49.93 -30.53 10.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.941 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.69 -40.53 55.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.57 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.8 ttt -52.16 -41.54 62.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.406 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.838 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.89 -35.38 8.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.365 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.569 ' HA ' HD12 ' A' ' 25' ' ' LEU . 29.7 t -56.11 -29.03 60.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.739 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -74.86 -43.12 56.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.123 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.1 t -56.18 -32.36 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.225 0.536 . . . . 0.0 110.1 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 22' ' ' SER . 14.8 mt -60.26 -19.2 53.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.301 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -153.46 33.08 0.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.45 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.9 mmm -56.23 -37.64 69.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.774 0.321 . . . . 0.0 111.003 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.762 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 4.0 t -86.93 7.19 28.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.898 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.7 mt -118.39 -10.97 10.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.133 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 12' ' ' ILE . 8.7 p -85.03 -29.58 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.619 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 1.6 tp -125.24 -34.91 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -53.9 -57.72 16.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 35.2 Cg_endo -65.48 -53.1 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.249 1.966 . . . . 0.0 112.843 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.619 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -51.29 -29.01 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 0.0 111.64 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.86 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -64.71 -72.19 0.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.503 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.66 HG12 HD12 ' A' ' 18' ' ' LEU . 21.7 t -54.87 -23.56 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.289 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -30.67 56.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.54 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 12' ' ' ILE . 8.1 mt -88.49 -29.8 19.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.768 0.318 . . . . 0.0 111.007 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -76.0 -53.83 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.091 0.472 . . . . 0.0 110.589 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 HG12 ' A' ' 14' ' ' VAL . 10.7 mt -46.22 -30.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.078 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.04 -47.89 15.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.641 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 ttt -45.82 -41.71 11.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.6 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.832 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -82.03 -33.05 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.418 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.524 ' HA ' HD12 ' A' ' 25' ' ' LEU . 26.5 t -56.7 -29.28 62.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -74.24 -46.03 44.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.104 179.306 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 24' ' ' VAL . 4.6 t -52.91 -32.61 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.253 0.549 . . . . 0.0 110.027 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 22' ' ' SER . 18.1 mt -62.48 -17.52 59.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.325 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -153.5 32.44 0.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.772 0.32 . . . . 0.0 111.527 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 3.6 mm-40 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.907 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 mtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.832 0.348 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.79 14.5 21.06 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.639 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.548 ' C ' ' O ' ' A' ' 2' ' ' LYS . 44.2 t0 -23.8 -50.39 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 110.765 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 2' ' ' LYS . 7.7 mp -117.78 -19.73 9.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.06 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.1 mtm -55.6 -43.11 75.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 111.223 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t -79.38 -2.85 43.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.933 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.3 tp -100.91 -18.94 16.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.341 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 9' ' ' ILE . 6.4 p -91.2 -46.61 14.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 12' ' ' ILE . 6.8 tp -73.6 -30.42 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.577 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.629 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -57.87 -61.69 6.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.632 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 27.9 Cg_endo -62.6 -52.08 2.71 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.65 2.233 . . . . 0.0 112.746 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.785 ' O ' HD13 ' A' ' 16' ' ' LEU . 2.6 pp -50.39 -27.48 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.889 0.376 . . . . 0.0 111.552 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.869 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -66.64 -70.72 0.23 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 179.573 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.841 HG12 HD12 ' A' ' 18' ' ' LEU . 21.3 t -55.43 -23.01 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.33 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.23 -28.72 39.57 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.628 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.785 HD13 ' O ' ' A' ' 12' ' ' ILE . 8.3 mp -85.66 -30.07 23.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.78 0.324 . . . . 0.0 110.997 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -77.3 -57.77 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.18 0.514 . . . . 0.0 110.278 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.841 HD12 HG12 ' A' ' 14' ' ' VAL . 11.2 mt -48.81 -28.78 3.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.894 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -77.54 -41.24 39.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.567 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.0 ttp -51.29 -40.55 59.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.552 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.842 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -84.31 -32.64 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.687 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.517 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -57.69 -29.93 65.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.859 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.44 -43.45 56.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.092 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 24' ' ' VAL . 6.4 t -55.7 -31.51 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.187 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 22' ' ' SER . 16.3 mt -61.47 -17.85 56.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.475 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -153.45 30.4 0.48 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.699 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.09 71.18 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.771 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -78.65 -75.03 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -114.04 144.42 43.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -94.88 -50.61 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.6 m -176.7 147.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -92.42 117.05 29.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.797 0.332 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.86 14.58 20.99 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.678 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.573 ' C ' HD22 ' A' ' 4' ' ' LEU . 34.5 t0 -23.33 -49.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.904 0.383 . . . . 0.0 111.057 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.8 mm? -117.79 -28.74 5.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.309 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.447 ' HB2' ' HA ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -46.7 -50.9 17.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.751 0.31 . . . . 0.0 111.543 -179.389 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 5.2 t -66.34 -19.98 65.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.9 tp -89.74 -14.35 34.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 4' ' ' LEU . 25.2 t -95.4 -62.29 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.963 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.828 HD12 HD11 ' A' ' 12' ' ' ILE . 9.0 tp -59.4 -21.2 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.75 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.633 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -69.6 -63.07 2.12 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.691 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.633 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 29.2 Cg_endo -62.71 -45.54 13.55 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.558 2.172 . . . . 0.0 112.537 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.828 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -55.79 -22.69 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.539 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.853 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.2 t80 -63.98 -68.43 0.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.694 HG22 HD12 ' A' ' 18' ' ' LEU . 11.7 p -50.34 -26.97 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.418 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.78 -33.85 45.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.589 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.7 mm? -83.11 -30.18 28.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 111.016 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.33 -57.11 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.21 0.528 . . . . 0.0 110.318 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.694 HD12 HG22 ' A' ' 14' ' ' VAL . 7.5 mt -47.56 -29.91 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.903 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -80.52 -44.68 18.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.659 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.4 ttt -50.07 -38.2 37.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.604 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.843 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.71 -35.34 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.377 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.643 ' HA ' HD12 ' A' ' 25' ' ' LEU . 27.5 t -56.67 -28.7 61.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.713 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -75.85 -42.08 50.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.146 179.389 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.8 t -56.63 -32.53 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.186 0.517 . . . . 0.0 110.14 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.7 mt -59.66 -19.62 50.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.194 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -153.46 33.83 0.46 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.397 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . 10.6 pt-20 -68.95 -33.07 73.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -143.82 162.12 36.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t70 60.29 93.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -96.71 128.22 43.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 m -114.63 -39.2 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -70.2 147.23 50.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.866 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttm . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.804 0.335 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.77 14.46 21.09 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.658 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.8 t70 -23.97 -50.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.076 0.465 . . . . 0.0 110.648 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.779 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.8 mp -117.62 -20.9 8.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.832 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.7 mmt -52.1 -46.36 65.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.768 0.318 . . . . 0.0 111.138 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 8.6 t -71.73 -17.74 62.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.932 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.656 ' O ' HD23 ' A' ' 7' ' ' LEU . 3.9 tt -89.65 -14.49 34.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.021 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 4' ' ' LEU . 21.9 t -94.72 -62.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 110.989 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.795 HD12 HD11 ' A' ' 12' ' ' ILE . 9.1 tp -59.41 -22.01 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.731 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.636 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -68.31 -63.16 2.54 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.74 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 28.8 Cg_endo -62.73 -47.48 8.89 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.561 2.174 . . . . 0.0 112.574 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.795 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -52.81 -25.64 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.462 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.861 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.2 t80 -66.35 -68.8 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 21.2 t -51.35 -25.89 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.402 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.534 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -79.59 -35.6 28.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.592 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.4 mm? -78.64 -30.48 46.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.728 0.299 . . . . 0.0 110.951 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -73.37 -49.61 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.172 0.511 . . . . 0.0 110.378 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.534 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -50.52 -32.79 19.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.846 -179.455 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.89 -41.55 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.526 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 5.1 ttt -51.75 -28.39 15.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.612 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.802 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -107.99 -38.19 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.404 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.467 ' HA ' HD12 ' A' ' 25' ' ' LEU . 40.7 t -56.56 -27.73 58.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 0.0 110.235 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -29.79 27.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.099 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' MET . 42.2 t -61.26 -33.44 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.168 0.509 . . . . 0.0 110.051 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 22' ' ' SER . 3.9 mt -59.53 -11.95 5.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.349 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -153.18 27.01 0.52 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.758 0.313 . . . . 0.0 111.409 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -62.14 -43.33 99.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -176.16 151.75 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.99 140.93 56.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -60.14 151.11 27.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.9 p -112.58 31.05 6.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.48 -173.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.904 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtp . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.539 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.44 21.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.676 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.544 ' C ' HD23 ' A' ' 4' ' ' LEU . 4.6 t0 -24.25 -51.12 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.042 0.448 . . . . 0.0 110.619 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.893 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.9 mt -117.83 -14.87 10.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.026 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 mmt -57.58 -46.06 84.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.883 0.373 . . . . 0.0 110.898 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 p -70.18 -19.38 63.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.797 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.431 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 18.0 tp -87.93 -14.98 37.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 4' ' ' LEU . 19.8 t -97.18 -64.11 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.886 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.42 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 9.9 tp -54.1 -23.64 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.888 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.636 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -70.82 -63.29 1.62 Allowed Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.636 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 17.8 Cg_endo -59.0 -36.51 96.62 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.621 2.214 . . . . 0.0 112.961 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.59 -25.96 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 111.175 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.854 ' O ' HG23 ' A' ' 17' ' ' VAL . 7.2 t80 -65.39 -66.21 0.58 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.801 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.766 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -50.66 -26.8 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.424 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.14 -32.29 49.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.557 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 12' ' ' ILE . 4.2 mp -84.93 -29.83 24.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.702 0.287 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.96 -57.71 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.239 0.542 . . . . 0.0 110.332 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.766 HD12 HG12 ' A' ' 14' ' ' VAL . 7.7 mt -47.84 -30.69 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.777 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.92 -41.46 51.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.648 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 ttt -51.23 -41.37 60.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.476 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.841 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.5 -35.34 8.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.335 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.559 ' HA ' HD12 ' A' ' 25' ' ' LEU . 41.6 t -56.65 -28.9 61.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.74 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 27' ' ' GLU . 6.4 mpt_? -75.16 -42.21 56.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.156 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.769 HG13 ' OE2' ' A' ' 27' ' ' GLU . 5.6 t -57.33 -31.99 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 110.061 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.0 mt -59.97 -18.81 48.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.099 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -153.4 33.49 0.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.219 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.769 ' OE2' HG13 ' A' ' 24' ' ' VAL . 14.0 pt-20 -71.14 -35.89 71.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.915 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.98 162.77 5.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -152.68 170.83 19.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.45 -48.38 7.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.4 t 61.79 152.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -112.34 -35.26 5.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.895 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.8 mtm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.84 0.352 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.9 14.5 20.93 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.663 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' A' ' 2' ' ' LYS . 8.2 t0 -23.88 -51.5 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.106 0.479 . . . . 0.0 110.494 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.724 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.1 mp -117.67 -22.91 7.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.509 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.4 ttp -49.14 -47.59 45.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.769 0.319 . . . . 0.0 111.332 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 9.6 t -68.11 -19.91 64.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.861 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.537 ' O ' HD23 ' A' ' 7' ' ' LEU . 2.2 tt -90.89 -14.81 31.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.944 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 4' ' ' LEU . 24.5 t -94.73 -60.7 2.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.016 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.767 HD12 HD11 ' A' ' 12' ' ' ILE . 8.7 tp -61.23 -23.06 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.66 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.63 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -66.94 -62.61 3.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.717 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.63 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 28.7 Cg_endo -62.8 -48.47 6.89 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.58 2.187 . . . . 0.0 112.553 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.767 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -52.33 -26.2 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.477 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.848 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -67.01 -69.82 0.29 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.425 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.84 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -54.3 -24.27 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.316 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.81 -29.38 47.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.561 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.5 mt -86.28 -29.33 23.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -78.34 -57.58 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.119 0.485 . . . . 0.0 110.428 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.84 HD12 HG12 ' A' ' 14' ' ' VAL . 13.1 mt -47.28 -34.38 6.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.9 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -70.87 -39.94 72.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.573 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 30.1 ttp -50.57 -26.49 5.35 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.694 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.84 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.6 -38.51 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.961 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.453 ' N ' HD13 ' A' ' 21' ' ' ILE . 32.3 t -50.5 -36.41 33.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.27 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -36.69 39.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.411 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' A' ' 21' ' ' ILE . 18.8 t -53.71 -29.34 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.185 0.517 . . . . 0.0 110.117 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mp -72.39 3.7 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.171 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -153.1 12.93 0.5 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.768 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.75 30.65 4.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.888 0.375 . . . . 0.0 110.929 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.37 -37.71 18.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.78 121.47 16.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -104.05 -35.15 8.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.6 p -174.47 36.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -114.41 91.54 3.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mttp . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.906 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.781 0.324 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.55 21.03 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.635 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.749 ' OD1' HD12 ' A' ' 4' ' ' LEU . 11.5 t0 -23.83 -49.86 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.08 0.467 . . . . 0.0 110.72 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.749 HD12 ' OD1' ' A' ' 3' ' ' ASP . 4.2 mp -117.66 -16.2 10.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.973 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.1 mtp -56.88 -44.32 82.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.75 0.31 . . . . 0.0 111.052 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.402 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 3.3 t -78.29 -3.6 43.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.0 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.45 -18.63 16.61 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.343 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 9' ' ' ILE . 5.7 p -91.91 -46.74 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.39 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.71 HD12 HD11 ' A' ' 12' ' ' ILE . 6.9 tp -72.92 -29.73 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.618 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -58.98 -61.16 8.37 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.692 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 29.1 Cg_endo -62.88 -50.9 3.41 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.629 2.219 . . . . 0.0 112.683 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.746 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.6 pp -52.53 -25.0 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 111.605 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.844 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -62.85 -69.84 0.24 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.728 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 11' ' ' PRO . 11.5 p -48.0 -28.46 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.407 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.669 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -82.36 -40.46 10.05 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.497 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.746 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.8 mm? -67.56 -30.48 70.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.869 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -76.18 -52.82 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.184 0.516 . . . . 0.0 110.3 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.669 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -52.66 -30.33 31.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.767 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -76.92 -40.95 45.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.596 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.3 ttm -51.35 -41.95 60.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.83 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.74 -35.46 8.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.36 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.476 ' HA ' HD12 ' A' ' 25' ' ' LEU . 42.6 t -56.45 -29.1 61.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.765 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -75.0 -44.25 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.131 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.7 t -53.9 -33.68 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.224 0.535 . . . . 0.0 110.119 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 22' ' ' SER . 16.5 mt -59.9 -19.68 52.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.247 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -153.5 34.29 0.45 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.442 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.5 mm-40 -79.15 -46.5 17.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.21 112.1 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -126.09 162.12 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.55 157.5 15.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -144.36 -55.71 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -133.15 106.69 7.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.796 0.331 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.75 14.38 21.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.718 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.545 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.6 t0 -23.86 -50.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.069 0.461 . . . . 0.0 110.699 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 2' ' ' LYS . 7.1 mp -117.78 -19.21 9.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.989 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.489 ' HE2' ' HA ' ' A' ' 2' ' ' LYS . 29.5 mtm -55.4 -43.97 75.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.18 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 3.3 t -77.88 -5.15 50.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.992 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.511 ' O ' HD23 ' A' ' 7' ' ' LEU . 2.7 tt -97.97 -19.95 17.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.319 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 9' ' ' ILE . 5.0 p -91.74 -46.62 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.372 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.695 HD12 HD11 ' A' ' 12' ' ' ILE . 6.8 tp -73.22 -30.22 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.558 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.618 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -58.29 -61.38 7.65 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.667 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 28.5 Cg_endo -62.56 -51.5 3.21 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.67 2.247 . . . . 0.0 112.716 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.715 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.6 pp -52.11 -25.56 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.859 0.361 . . . . 0.0 111.494 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.849 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -64.46 -69.5 0.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.711 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -52.26 -25.77 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.371 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.28 -32.33 52.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.566 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.6 mm? -85.67 -30.02 23.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.021 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -75.13 -55.94 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 110.451 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.722 HD12 HG12 ' A' ' 14' ' ' VAL . 8.1 mt -46.74 -33.56 4.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.866 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.81 -39.81 69.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.578 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.457 ' O ' HG23 ' A' ' 24' ' ' VAL . 16.0 ttp -52.22 -25.22 8.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.662 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.824 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.35 -36.98 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.883 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.406 ' N ' HD13 ' A' ' 21' ' ' ILE . 28.7 t -54.12 -28.94 42.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.1 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.35 -31.2 20.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.403 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 21' ' ' ILE . 41.1 t -55.08 -32.97 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 mt -67.21 -3.47 7.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.065 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -153.29 22.27 0.55 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.355 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.47 92.57 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.889 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 63.53 141.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -60.07 147.3 39.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -168.76 80.17 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 t -85.73 117.58 24.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 -112.39 -35.3 5.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.925 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpp? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.849 0.357 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.541 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.83 14.47 21.02 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.614 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.674 ' OD1' HD12 ' A' ' 4' ' ' LEU . 11.9 t70 -23.94 -51.14 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.038 0.447 . . . . 0.0 110.693 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.674 HD12 ' OD1' ' A' ' 3' ' ' ASP . 4.3 mp -117.77 -19.77 9.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.945 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.5 mtt -53.52 -48.14 69.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.807 0.337 . . . . 0.0 111.131 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 t -73.05 -13.55 61.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.785 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.431 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 2.4 tt -88.25 -19.09 27.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.427 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 12' ' ' ILE . 2.9 p -96.86 -49.34 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.2 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.45 ' N ' ' CG1' ' A' ' 8' ' ' VAL . 8.8 tp -62.48 -29.24 46.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.728 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.617 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -66.67 -60.26 6.73 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.943 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 37.6 Cg_endo -65.25 -28.89 55.44 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.59 2.193 . . . . 0.0 113.419 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.819 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -77.83 -30.74 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 0.0 111.116 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.893 ' O ' HG23 ' A' ' 17' ' ' VAL . 25.3 t80 -72.74 -66.08 0.71 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.942 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.96 HG12 HD12 ' A' ' 18' ' ' LEU . 20.5 t -57.23 -21.25 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.12 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.14 -26.48 44.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mp -89.42 -29.65 18.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.313 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -77.73 -58.98 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.207 0.527 . . . . 0.0 110.098 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.96 HD12 HG12 ' A' ' 14' ' ' VAL . 15.0 mt -49.69 -29.09 6.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.708 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.21 -40.82 51.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.507 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.7 ttm -51.51 -41.04 60.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.521 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.843 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -84.84 -31.9 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.737 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.539 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.2 p -58.44 -29.85 66.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.891 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 5.6 mpt_? -74.39 -42.5 59.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.144 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.2 t -56.44 -32.18 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.217 0.532 . . . . 0.0 110.197 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.9 mt -60.54 -19.46 57.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.279 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -153.49 33.25 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.809 0.338 . . . . 0.0 111.44 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 20.3 pt-20 -63.48 -31.34 72.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.04 127.14 49.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.933 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -172.38 168.82 5.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -103.92 141.73 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.73 106.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.933 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -95.37 -179.61 4.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mtp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.852 0.358 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.553 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -108.25 14.36 25.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.73 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.553 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.7 t0 -24.68 -51.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.108 0.48 . . . . 0.0 110.618 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 2' ' ' LYS . 4.6 mp -117.66 -17.89 9.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.712 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -47.63 72.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.741 0.305 . . . . 0.0 111.175 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.0 t -74.53 -8.96 58.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.965 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.533 ' O ' HD23 ' A' ' 7' ' ' LEU . 3.3 tt -94.2 -18.83 21.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.302 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 9' ' ' ILE . 3.5 p -96.39 -44.21 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.351 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.439 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 7.7 tp -70.96 -20.6 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.986 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -75.75 -62.02 0.82 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 34.8 Cg_endo -64.56 -22.03 65.29 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.625 2.217 . . . . 0.0 113.202 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.792 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -75.6 -29.81 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 0.0 111.111 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.879 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -66.05 -68.28 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.437 179.665 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.809 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -53.25 -24.98 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.349 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.76 -32.2 51.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.616 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 12' ' ' ILE . 6.2 mp -85.82 -29.23 23.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.5 t -76.38 -57.27 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.135 0.493 . . . . 0.0 110.346 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.809 HD12 HG12 ' A' ' 14' ' ' VAL . 11.4 mt -47.64 -34.65 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.724 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -68.14 -38.22 81.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.505 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.7 ttm -52.7 -46.12 67.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.511 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.844 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -89.16 -35.63 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.458 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.61 ' HA ' HD12 ' A' ' 25' ' ' LEU . 48.3 t -56.69 -27.43 58.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.72 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 27' ' ' GLU . 6.8 mpt_? -74.89 -44.3 49.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.168 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.02 -32.44 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.235 0.54 . . . . 0.0 110.01 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 22' ' ' SER . 18.9 mt -60.28 -18.92 52.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -153.43 33.44 0.46 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.839 0.352 . . . . 0.0 111.391 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.7 pt-20 -59.51 -31.41 69.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -159.4 -45.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -98.12 -174.55 2.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -140.54 146.1 37.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.7 m -109.37 176.2 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -102.54 -34.85 8.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.7 mttp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.926 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.804 0.335 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.85 14.41 20.99 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.639 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 2' ' ' LYS . 9.4 t0 -24.18 -51.2 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.089 0.471 . . . . 0.0 110.484 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 2' ' ' LYS . 4.9 mp -117.63 -18.62 9.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.616 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.28 -39.0 69.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.718 0.294 . . . . 0.0 111.098 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.407 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 3.6 t -84.7 4.82 30.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.976 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.468 ' O ' HD23 ' A' ' 7' ' ' LEU . 1.2 tt -112.33 -16.87 12.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.289 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 9' ' ' ILE . 4.8 p -92.86 -45.9 14.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.275 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.648 HD12 HD11 ' A' ' 12' ' ' ILE . 6.3 tp -77.81 -27.25 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.713 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.947 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -62.85 -62.5 5.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.294 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 44.5 Cg_exo -56.56 -52.27 7.35 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.248 1.966 . . . . 0.0 112.255 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.75 ' O ' HD13 ' A' ' 16' ' ' LEU . 2.7 pp -54.22 -24.16 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.52 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.842 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -63.8 -70.58 0.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.762 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.83 HG22 HD12 ' A' ' 18' ' ' LEU . 11.6 p -51.3 -26.86 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.362 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.52 -32.14 47.94 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 12' ' ' ILE . 9.0 mp -83.67 -29.94 27.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.726 0.298 . . . . 0.0 110.96 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.5 t -75.86 -57.51 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.14 0.495 . . . . 0.0 110.372 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.83 HD12 HG22 ' A' ' 14' ' ' VAL . 6.4 mt -47.19 -30.35 2.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.837 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -76.25 -41.06 50.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.599 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.5 ttt -51.46 -41.49 60.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.47 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.836 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.77 -35.43 8.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.366 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.577 ' HA ' HD12 ' A' ' 25' ' ' LEU . 40.8 t -56.38 -28.95 60.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.729 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 27' ' ' GLU . 5.8 mpt_? -74.98 -43.14 55.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.121 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -56.07 -32.37 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.245 0.545 . . . . 0.0 110.117 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.3 mt -60.51 -18.83 54.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.288 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -153.49 32.85 0.46 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.496 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.8 mm-40 -87.88 55.0 3.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -113.71 36.13 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -75.39 86.5 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.34 35.76 1.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.9 t -85.36 95.91 9.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -128.9 32.22 4.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.796 0.332 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.551 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.81 14.47 21.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.687 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.564 ' C ' HD23 ' A' ' 4' ' ' LEU . 4.5 t0 -24.04 -50.78 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.141 0.496 . . . . 0.0 110.493 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.901 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.3 mt -117.55 -23.69 7.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.415 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.63 -45.37 38.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 111.46 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -69.27 -18.44 63.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.211 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.1 tp -98.39 -14.82 19.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.256 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 4' ' ' LEU . 3.4 t -100.28 10.2 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.739 0.304 . . . . 0.0 111.078 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 36.3 mm -125.89 -54.38 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.748 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -44.8 -53.34 15.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.88 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 33.6 Cg_exo -61.4 -43.56 27.44 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.588 2.192 . . . . 0.0 112.876 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.753 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -76.1 -28.01 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.799 -179.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.901 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -69.19 -66.6 0.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.375 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 10' ' ' ALA . 11.6 p -54.41 -22.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.375 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.614 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -84.61 -33.42 19.26 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.701 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.78 -32.5 46.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 111.014 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.8 t -71.75 -50.23 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.246 0.546 . . . . 0.0 110.23 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.614 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -52.2 -30.34 26.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.824 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.77 -42.64 27.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.71 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 ttt -50.42 -41.09 51.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.561 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.836 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.9 -35.49 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.371 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.511 ' HA ' HD12 ' A' ' 25' ' ' LEU . 40.3 t -56.61 -29.05 61.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.749 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -75.32 -43.11 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.176 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.6 t -55.28 -33.11 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 110.118 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.0 mt -59.91 -19.51 52.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.212 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -153.47 34.13 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.377 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . 7.1 pt-20 -66.81 -174.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -106.34 143.5 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -128.12 167.21 17.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.949 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.81 81.63 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 m -65.11 98.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.17 -31.57 21.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 tptt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.862 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mmm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.853 0.358 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.35 21.03 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.658 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' A' ' 2' ' ' LYS . 35.8 t0 -24.28 -51.39 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.127 0.489 . . . . 0.0 110.507 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 2' ' ' LYS . 9.1 mp -117.66 -19.66 9.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.67 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.768 ' O ' HG12 ' A' ' 8' ' ' VAL . 8.5 ttm -53.82 -44.91 70.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.755 0.312 . . . . 0.0 111.163 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 5.5 t -75.44 -15.29 60.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.806 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 tp -97.25 -5.58 36.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.397 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 5' ' ' MET . 5.4 p -81.29 -26.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.581 0.229 . . . . 0.0 111.547 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 1.6 tp -120.82 -6.1 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.664 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -79.95 -63.2 0.37 Allowed Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.664 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 37.4 Cg_endo -66.13 -40.63 15.04 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.608 2.205 . . . . 0.0 112.925 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -60.75 -28.13 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 0.0 111.12 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.881 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -67.97 -70.12 0.28 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.278 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.812 HG22 HD12 ' A' ' 18' ' ' LEU . 10.9 p -55.77 -23.01 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.201 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.63 60.34 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.599 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -92.4 -30.11 15.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.75 0.309 . . . . 0.0 110.97 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.7 t -74.24 -54.63 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.156 0.503 . . . . 0.0 110.232 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.812 HD12 HG22 ' A' ' 14' ' ' VAL . 11.0 mt -47.36 -30.04 2.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.85 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.52 -47.94 18.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.578 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.6 ttp -45.31 -43.32 10.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.627 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.837 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -81.45 -33.09 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.316 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.594 ' HA ' HD12 ' A' ' 25' ' ' LEU . 27.0 t -56.68 -28.37 60.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -74.61 -45.17 46.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.098 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 24' ' ' VAL . 3.8 t -54.67 -32.08 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.181 0.515 . . . . 0.0 110.017 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.594 HD12 ' HA ' ' A' ' 22' ' ' SER . 18.3 mt -61.51 -17.63 55.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.104 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -153.35 32.92 0.46 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.288 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -69.06 70.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 60.01 83.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -80.38 -175.13 4.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -87.96 115.9 25.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.5 p -176.52 79.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -103.66 -35.01 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.886 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.842 0.354 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.83 14.52 21.02 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.674 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.812 ' HB3' HD12 ' A' ' 4' ' ' LEU . 2.7 t0 -24.0 -50.18 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.06 0.457 . . . . 0.0 110.694 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.812 HD12 ' HB3' ' A' ' 3' ' ' ASP . 4.8 mp -117.68 -22.41 8.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.782 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.0 mmt -50.23 -47.08 55.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.823 0.344 . . . . 0.0 111.175 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 9.5 t -67.74 -20.05 65.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.928 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 7' ' ' LEU . 2.3 tt -90.97 -15.4 29.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.97 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 4' ' ' LEU . 23.5 t -95.21 -60.09 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.792 HD12 HD11 ' A' ' 12' ' ' ILE . 8.6 tp -61.45 -22.88 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.648 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.624 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -67.34 -62.45 3.57 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.645 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 27.7 Cg_endo -62.2 -47.55 9.88 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.558 2.172 . . . . 0.0 112.473 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.792 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -55.11 -23.66 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.463 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.845 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.4 t80 -64.59 -65.75 0.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.75 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -49.55 -27.69 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.41 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.7 -33.99 45.19 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.673 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.6 mm? -82.9 -30.19 28.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.653 0.263 . . . . 0.0 110.983 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.45 -56.8 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.194 0.521 . . . . 0.0 110.326 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 14' ' ' VAL . 6.3 mt -47.47 -29.87 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.9 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -81.34 -45.44 16.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.699 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ttm -50.4 -38.67 44.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.567 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.843 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.91 -35.27 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.376 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.538 ' HA ' HD12 ' A' ' 25' ' ' LEU . 27.8 t -56.63 -28.65 60.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.76 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -76.11 -41.81 49.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.214 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.3 t -56.97 -32.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.106 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.3 mt -59.95 -19.22 50.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.168 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -153.46 33.53 0.46 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.845 0.355 . . . . 0.0 111.338 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . 5.2 pt-20 -62.61 -33.51 75.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -60.33 -30.6 69.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.58 37.28 16.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -98.72 31.5 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.3 m -117.98 44.76 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -59.41 113.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 tttp . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.92 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.809 0.337 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.536 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.84 14.46 21.0 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.711 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 2' ' ' LYS . 24.3 t0 -24.14 -51.34 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.094 0.473 . . . . 0.0 110.513 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.741 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.7 mp -117.62 -21.68 8.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.601 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.0 ttp -49.81 -47.83 51.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.715 0.293 . . . . 0.0 111.209 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.406 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 10.6 t -67.03 -21.34 65.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.67 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.471 ' O ' HD23 ' A' ' 7' ' ' LEU . 2.2 tt -88.98 -14.68 36.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.717 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 4' ' ' LEU . 22.6 t -97.03 -63.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.744 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 9.6 tp -55.06 -23.48 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.818 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.63 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -70.53 -63.15 1.76 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.925 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.63 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 17.8 Cg_endo -58.94 -36.65 96.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.656 2.237 . . . . 0.0 112.956 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.77 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.73 -25.59 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.871 ' O ' HG23 ' A' ' 17' ' ' VAL . 5.4 t80 -65.43 -63.7 1.04 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.734 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.6 t -48.85 -27.52 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.566 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.529 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -79.19 -35.18 30.91 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.624 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 12' ' ' ILE . 3.0 mp -79.87 -31.15 40.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.706 0.288 . . . . 0.0 110.969 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.8 t -71.31 -48.7 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.185 0.517 . . . . 0.0 110.292 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.529 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -51.1 -32.03 21.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.856 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -75.63 -40.98 55.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.646 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.423 ' O ' HG23 ' A' ' 24' ' ' VAL . 19.2 ttp -51.64 -25.19 6.6 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.725 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.837 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -113.6 -37.1 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.922 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.414 ' N ' HD13 ' A' ' 21' ' ' ILE . 28.2 t -52.53 -28.77 22.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.745 0.307 . . . . 0.0 111.168 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -29.82 21.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.366 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 21' ' ' ILE . 11.2 t -64.34 -22.73 31.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.5 13.23 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.514 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 24' ' ' VAL . 19.7 t0 -153.53 -50.54 0.1 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.794 0.331 . . . . 0.0 110.783 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 41.51 83.14 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.609 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -71.31 115.26 10.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.69 131.35 55.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.65 -47.75 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.4 p -126.37 105.93 9.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.8 mtp85 -69.28 109.65 4.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.9 mptt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.926 179.948 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptp . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.859 0.361 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.8 14.48 21.05 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.702 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' A' ' 2' ' ' LYS . 23.8 t0 -23.96 -51.2 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.135 0.493 . . . . 0.0 110.482 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.553 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.6 mp -117.53 -23.72 7.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.442 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 -46.14 31.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 111.45 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 14.9 t -67.78 -19.81 65.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.051 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.07 -21.06 22.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 4' ' ' LEU . 40.6 t -83.44 -8.06 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.448 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.623 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 17.3 mm -123.99 -35.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.303 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -50.39 -60.99 4.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 29.7 Cg_endo -63.8 -54.63 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.56 2.173 . . . . 0.0 113.038 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.718 ' O ' HD13 ' A' ' 16' ' ' LEU . 2.7 pp -51.51 -30.07 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 111.848 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.836 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -61.42 -72.68 0.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.772 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.786 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -52.83 -24.95 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.355 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.0 -32.3 49.8 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.605 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 12' ' ' ILE . 9.4 mp -85.28 -30.58 23.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.69 0.281 . . . . 0.0 110.984 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.07 -55.92 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.309 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.786 HD12 HG12 ' A' ' 14' ' ' VAL . 6.0 mt -47.05 -30.34 2.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.909 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -79.53 -44.84 20.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.6 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.569 ' O ' HG23 ' A' ' 24' ' ' VAL . 5.1 ttt -50.45 -26.53 5.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.684 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.815 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -105.89 -37.8 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.383 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 25' ' ' LEU . 28.7 t -56.26 -26.61 52.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.329 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -30.57 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.115 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 20' ' ' MET . 45.2 t -59.3 -34.6 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.012 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 22' ' ' SER . 4.3 mt -59.44 -13.11 7.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.287 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -153.18 28.92 0.5 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 120.8 0.333 . . . . 0.0 111.314 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -60.36 -173.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.98 64.05 7.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.29 51.0 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t0 60.7 107.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 p -147.47 136.25 22.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -36.34 82.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mttp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.835 179.968 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.833 0.349 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.557 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.88 14.58 20.97 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.63 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.557 ' C ' ' O ' ' A' ' 2' ' ' LYS . 25.6 t70 -24.02 -51.26 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.111 0.482 . . . . 0.0 110.545 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.896 ' O ' HG23 ' A' ' 8' ' ' VAL . 8.2 mp -117.66 -21.11 8.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.642 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -49.09 52.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.73 0.3 . . . . 0.0 111.213 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -69.99 -18.77 63.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.748 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 1.0 OUTLIER -91.72 -9.29 44.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 4' ' ' LEU . 19.9 t -102.93 -62.72 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.861 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.0 tp -53.59 -24.95 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.828 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.635 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -71.23 -63.15 1.54 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.846 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.635 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 18.4 Cg_endo -58.83 -36.11 97.53 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.641 2.227 . . . . 0.0 113.075 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.18 -27.93 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 111.076 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.883 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -66.44 -70.07 0.27 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.447 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.948 HG22 HD12 ' A' ' 18' ' ' LEU . 11.5 p -54.42 -23.73 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.351 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.3 -32.43 31.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.617 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.87 -29.45 32.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 111.049 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.5 t -77.52 -60.17 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.212 0.529 . . . . 0.0 110.275 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.948 HD12 HG22 ' A' ' 14' ' ' VAL . 6.9 mt -49.03 -31.94 8.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.732 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.94 -41.35 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.604 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.8 ttp -50.0 -52.85 30.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.305 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.834 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -74.63 -36.83 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.472 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.472 ' N ' HD13 ' A' ' 21' ' ' ILE . 43.3 t -54.45 -26.09 28.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.025 0.441 . . . . 0.0 109.99 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 27' ' ' GLU . 2.2 mmt85 -82.19 -36.67 27.06 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.085 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 21' ' ' ILE . 40.5 t -54.13 -32.93 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.37 0.605 . . . . 0.0 109.597 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.75 -7.14 31.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.375 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -153.36 25.34 0.53 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.77 0.319 . . . . 0.0 111.451 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 23' ' ' ARG . 3.3 mm-40 -66.85 119.08 11.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.962 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -88.62 99.36 12.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -129.09 70.71 1.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.8 88.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.5 p -60.08 -70.24 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 59.46 -178.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mtp . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.777 0.322 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.556 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.45 21.03 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.671 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.647 ' HB3' HD23 ' A' ' 4' ' ' LEU . 38.1 t70 -24.12 -50.45 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.073 0.463 . . . . 0.0 110.644 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -117.65 -21.93 8.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.885 178.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.9 mmm -51.85 -46.44 64.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.693 0.282 . . . . 0.0 111.136 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 6.7 t -72.34 -17.11 61.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.952 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.5 tp -89.91 -13.93 35.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.048 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 4' ' ' LEU . 22.1 t -94.27 -62.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.861 0.363 . . . . 0.0 111.086 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.756 HD12 HD11 ' A' ' 12' ' ' ILE . 8.5 tp -60.28 -21.91 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.641 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.627 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -67.52 -63.0 2.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.688 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 26.9 Cg_endo -62.04 -48.44 8.37 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.542 2.161 . . . . 0.0 112.473 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.756 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -53.08 -28.78 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.327 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.834 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -65.06 -72.66 0.14 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.114 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 18' ' ' LEU . 12.6 p -54.84 -26.82 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.883 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.48 -28.6 73.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.298 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mt -99.13 -24.42 14.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.633 0.254 . . . . 0.0 111.311 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.3 t -85.05 -58.65 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.087 0.47 . . . . 0.0 110.704 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -49.44 -28.74 5.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.805 -179.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -78.11 -45.85 22.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.483 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.1 ttt -47.76 -44.34 28.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.594 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.848 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -78.93 -33.18 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.443 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.603 ' HA ' HD12 ' A' ' 25' ' ' LEU . 26.5 t -56.11 -28.78 59.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -74.58 -44.79 49.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 t -54.64 -31.65 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.186 0.517 . . . . 0.0 110.018 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.603 HD12 ' HA ' ' A' ' 22' ' ' SER . 17.4 mt -62.66 -17.46 60.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.241 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -153.48 32.19 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.802 0.334 . . . . 0.0 111.52 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.5 mm-40 -74.55 -31.3 62.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -76.11 -173.63 2.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -141.11 178.46 7.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.09 78.92 2.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 m 60.47 32.29 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mmt85 -74.45 163.9 27.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.942 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.888 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpp? . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.878 0.37 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.547 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.8 14.45 21.06 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.669 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -23.89 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.128 0.49 . . . . 0.0 110.495 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.852 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.6 mp -117.55 -21.73 8.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.476 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -32.09 30.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.746 0.308 . . . . 0.0 111.375 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.681 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 7.9 t -87.44 -1.44 57.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.474 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -118.34 -6.21 10.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.233 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 4' ' ' LEU . 23.5 t -94.79 -23.88 5.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.582 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.633 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 19.8 mm -124.5 -40.72 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.604 0.24 . . . . 0.0 111.507 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -49.46 -53.99 34.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 41.2 Cg_endo -68.59 -52.28 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.308 2.005 . . . . 0.0 112.868 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.633 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.8 pp -55.04 -29.86 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.762 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.845 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -61.94 -71.96 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.799 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.723 HG12 HD12 ' A' ' 18' ' ' LEU . 24.2 t -52.66 -25.52 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.296 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.4 -30.01 42.54 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 12' ' ' ILE . 9.7 mt -83.64 -30.38 26.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 110.933 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -76.67 -57.81 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.149 0.499 . . . . 0.0 110.537 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.723 HD12 HG12 ' A' ' 14' ' ' VAL . 7.4 mt -47.1 -34.95 6.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.997 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.22 -39.59 71.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.619 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 ttt -50.87 -26.29 5.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.689 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.839 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.86 -37.82 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.033 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.454 ' N ' HD13 ' A' ' 21' ' ' ILE . 29.1 t -51.87 -29.9 21.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.286 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.43 -31.83 21.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.869 0.366 . . . . 0.0 110.458 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.448 HG23 ' HA ' ' A' ' 21' ' ' ILE . 11.3 t -61.19 -23.64 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.343 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 mp -75.17 13.49 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.627 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -153.38 -38.62 0.1 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.7 0.286 . . . . 0.0 111.297 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -47.96 166.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -59.99 165.12 3.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -153.71 -176.44 5.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.99 138.51 58.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -162.99 179.82 7.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -105.81 31.53 4.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.9 tttp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.902 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.791 0.329 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.546 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.78 14.47 21.07 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.669 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 2' ' ' LYS . 23.9 t0 -24.01 -51.11 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.105 0.479 . . . . 0.0 110.541 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.741 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.6 mp -117.58 -22.42 8.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.564 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 8.7 ttm -49.02 -48.14 44.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.309 . . . . 0.0 111.265 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 8.7 t -67.91 -20.04 65.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.805 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 tp -90.42 -14.53 32.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 4' ' ' LEU . 24.8 t -95.23 -61.36 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.98 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.766 HD12 HD11 ' A' ' 12' ' ' ILE . 9.1 tp -60.11 -21.7 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.745 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.643 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -69.0 -62.87 2.46 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.72 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.643 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 29.1 Cg_endo -62.87 -46.86 9.85 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.6 2.2 . . . . 0.0 112.555 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.766 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -53.14 -24.98 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.504 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.871 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -64.42 -69.34 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 11' ' ' PRO . 11.5 p -49.7 -27.21 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.385 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.573 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -79.12 -37.92 23.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.607 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 12' ' ' ILE . 4.0 mm? -75.25 -30.25 60.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.29 . . . . 0.0 111.003 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -73.83 -49.67 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.169 0.509 . . . . 0.0 110.503 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.573 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -49.93 -30.53 10.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.941 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.69 -40.53 55.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.57 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.8 ttt -52.16 -41.54 62.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.406 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.838 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.89 -35.38 8.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.365 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.569 ' HA ' HD12 ' A' ' 25' ' ' LEU . 29.7 t -56.11 -29.03 60.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.739 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -74.86 -43.12 56.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.123 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.1 t -56.18 -32.36 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.225 0.536 . . . . 0.0 110.1 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 22' ' ' SER . 14.8 mt -60.26 -19.2 53.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.301 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -153.46 33.08 0.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.45 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.8 mm-40 -87.65 136.91 32.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.932 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.34 130.23 45.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -108.25 35.9 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -81.59 102.22 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.18 -68.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.2 mtm105 -77.11 85.98 3.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.8 tttp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.891 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.778 0.323 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.49 21.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.636 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.547 ' O ' HD12 ' A' ' 7' ' ' LEU . 24.0 t0 -23.84 -49.83 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.047 0.451 . . . . 0.0 110.705 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 2' ' ' LYS . 6.4 mp -117.6 -17.48 9.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.914 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.9 mmm -56.23 -37.64 69.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.774 0.321 . . . . 0.0 111.003 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.762 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 4.0 t -86.93 7.19 28.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.898 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 3' ' ' ASP . 1.7 mt -118.39 -10.97 10.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.133 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 12' ' ' ILE . 8.7 p -85.03 -29.58 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.619 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 1.6 tp -125.24 -34.91 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -53.9 -57.72 16.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 35.2 Cg_endo -65.48 -53.1 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.249 1.966 . . . . 0.0 112.843 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.619 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -51.29 -29.01 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 0.0 111.64 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.86 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -64.71 -72.19 0.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.503 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.66 HG12 HD12 ' A' ' 18' ' ' LEU . 21.7 t -54.87 -23.56 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.289 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -30.67 56.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.54 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 12' ' ' ILE . 8.1 mt -88.49 -29.8 19.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.768 0.318 . . . . 0.0 111.007 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -76.0 -53.83 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.091 0.472 . . . . 0.0 110.589 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 HG12 ' A' ' 14' ' ' VAL . 10.7 mt -46.22 -30.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.078 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.04 -47.89 15.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.641 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 ttt -45.82 -41.71 11.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.6 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.832 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -82.03 -33.05 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.418 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.524 ' HA ' HD12 ' A' ' 25' ' ' LEU . 26.5 t -56.7 -29.28 62.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -74.24 -46.03 44.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.104 179.306 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 24' ' ' VAL . 4.6 t -52.91 -32.61 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.253 0.549 . . . . 0.0 110.027 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 22' ' ' SER . 18.1 mt -62.48 -17.52 59.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.325 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -153.5 32.44 0.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.772 0.32 . . . . 0.0 111.527 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 3.6 mm-40 -98.89 31.63 2.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.907 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -97.2 -31.03 12.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.54 113.82 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.49 -176.79 3.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 p -115.4 -45.64 2.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -143.17 -46.81 0.3 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.893 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--O 1.232 0.144 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.1 mtm -55.6 -43.11 75.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 111.223 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t -79.38 -2.85 43.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.933 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.3 tp -100.91 -18.94 16.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.341 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 9' ' ' ILE . 6.4 p -91.2 -46.61 14.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 12' ' ' ILE . 6.8 tp -73.6 -30.42 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.577 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.629 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -57.87 -61.69 6.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.632 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 27.9 Cg_endo -62.6 -52.08 2.71 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.65 2.233 . . . . 0.0 112.746 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.785 ' O ' HD13 ' A' ' 16' ' ' LEU . 2.6 pp -50.39 -27.48 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.889 0.376 . . . . 0.0 111.552 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.869 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -66.64 -70.72 0.23 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 179.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.841 HG12 HD12 ' A' ' 18' ' ' LEU . 21.3 t -55.43 -23.01 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.33 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.23 -28.72 39.57 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.628 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.785 HD13 ' O ' ' A' ' 12' ' ' ILE . 8.3 mp -85.66 -30.07 23.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.78 0.324 . . . . 0.0 110.997 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -77.3 -57.77 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.18 0.514 . . . . 0.0 110.278 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.841 HD12 HG12 ' A' ' 14' ' ' VAL . 11.2 mt -48.81 -28.78 3.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.894 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -77.54 -41.24 39.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.567 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.0 ttp -51.29 -40.55 59.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.552 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.842 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -84.31 -32.64 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.687 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.517 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -57.69 -29.93 65.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.859 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.44 -43.45 56.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.092 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 24' ' ' VAL . 6.4 t -55.7 -31.51 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.187 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 22' ' ' SER . 16.3 mt -61.47 -17.85 56.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.475 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -153.45 30.4 0.48 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.699 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.771 179.859 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.8 mm? . . . . . 0 C--O 1.231 0.116 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.7 -50.9 17.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.751 0.31 . . . . 0.0 111.543 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 5.2 t -66.34 -19.98 65.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.9 tp -89.74 -14.35 34.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 4' ' ' LEU . 25.2 t -95.4 -62.29 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.963 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.828 HD12 HD11 ' A' ' 12' ' ' ILE . 9.0 tp -59.4 -21.2 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.75 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.633 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -69.6 -63.07 2.12 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.691 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.633 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 29.2 Cg_endo -62.71 -45.54 13.55 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.558 2.172 . . . . 0.0 112.537 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.828 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -55.79 -22.69 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.539 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.853 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.2 t80 -63.98 -68.43 0.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.694 HG22 HD12 ' A' ' 18' ' ' LEU . 11.7 p -50.34 -26.97 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.418 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.78 -33.85 45.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.589 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.7 mm? -83.11 -30.18 28.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 111.016 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.33 -57.11 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.21 0.528 . . . . 0.0 110.318 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.694 HD12 HG22 ' A' ' 14' ' ' VAL . 7.5 mt -47.56 -29.91 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.903 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -80.52 -44.68 18.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.659 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.4 ttt -50.07 -38.2 37.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.604 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.843 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.71 -35.34 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.377 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.643 ' HA ' HD12 ' A' ' 25' ' ' LEU . 27.5 t -56.67 -28.7 61.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.713 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -75.85 -42.08 50.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.146 179.389 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.8 t -56.63 -32.53 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.186 0.517 . . . . 0.0 110.14 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.7 mt -59.66 -19.62 50.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.194 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -153.46 33.83 0.46 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.397 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . 10.6 pt-20 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.779 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.8 mp . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.7 mmt -52.1 -46.36 65.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.768 0.318 . . . . 0.0 111.138 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 8.6 t -71.73 -17.74 62.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.932 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 7' ' ' LEU . 3.9 tt -89.65 -14.49 34.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.021 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 4' ' ' LEU . 21.9 t -94.72 -62.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 110.989 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.795 HD12 HD11 ' A' ' 12' ' ' ILE . 9.1 tp -59.41 -22.01 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.731 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.636 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -68.31 -63.16 2.54 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.74 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 28.8 Cg_endo -62.73 -47.48 8.89 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.561 2.174 . . . . 0.0 112.574 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.795 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -52.81 -25.64 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.462 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.861 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.2 t80 -66.35 -68.8 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 21.2 t -51.35 -25.89 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.402 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.534 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -79.59 -35.6 28.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.592 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.4 mm? -78.64 -30.48 46.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.728 0.299 . . . . 0.0 110.951 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -73.37 -49.61 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.172 0.511 . . . . 0.0 110.378 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.534 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -50.52 -32.79 19.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.846 -179.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.89 -41.55 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.526 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 5.1 ttt -51.75 -28.39 15.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.612 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.802 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -107.99 -38.19 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.404 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.467 ' HA ' HD12 ' A' ' 25' ' ' LEU . 40.7 t -56.56 -27.73 58.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 0.0 110.235 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -29.79 27.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.099 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' MET . 42.2 t -61.26 -33.44 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.168 0.509 . . . . 0.0 110.051 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 22' ' ' SER . 3.9 mt -59.53 -11.95 5.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.349 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -153.18 27.01 0.52 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.758 0.313 . . . . 0.0 111.409 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.893 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.9 mt . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 mmt -57.58 -46.06 84.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.883 0.373 . . . . 0.0 110.898 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 p -70.18 -19.38 63.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.797 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.431 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 18.0 tp -87.93 -14.98 37.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 4' ' ' LEU . 19.8 t -97.18 -64.11 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.886 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.42 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 9.9 tp -54.1 -23.64 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.888 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.636 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -70.82 -63.29 1.62 Allowed Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.636 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 17.8 Cg_endo -59.0 -36.51 96.62 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.621 2.214 . . . . 0.0 112.961 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.59 -25.96 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 111.175 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.854 ' O ' HG23 ' A' ' 17' ' ' VAL . 7.2 t80 -65.39 -66.21 0.58 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.801 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.766 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -50.66 -26.8 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.424 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.14 -32.29 49.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.557 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 12' ' ' ILE . 4.2 mp -84.93 -29.83 24.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.702 0.287 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.96 -57.71 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.239 0.542 . . . . 0.0 110.332 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.766 HD12 HG12 ' A' ' 14' ' ' VAL . 7.7 mt -47.84 -30.69 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.777 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.92 -41.46 51.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.648 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 ttt -51.23 -41.37 60.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.476 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.841 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.5 -35.34 8.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.335 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.559 ' HA ' HD12 ' A' ' 25' ' ' LEU . 41.6 t -56.65 -28.9 61.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.74 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 27' ' ' GLU . 6.4 mpt_? -75.16 -42.21 56.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.156 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.769 HG13 ' OE2' ' A' ' 27' ' ' GLU . 5.6 t -57.33 -31.99 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 110.061 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.0 mt -59.97 -18.81 48.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.099 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -153.4 33.49 0.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.219 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.769 ' OE2' HG13 ' A' ' 24' ' ' VAL . 14.0 pt-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.915 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.724 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.1 mp . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.547 0.213 . . . . 0.0 111.509 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.4 ttp -49.14 -47.59 45.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.769 0.319 . . . . 0.0 111.332 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 9.6 t -68.11 -19.91 64.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.861 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 7' ' ' LEU . 2.2 tt -90.89 -14.81 31.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.944 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 4' ' ' LEU . 24.5 t -94.73 -60.7 2.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.016 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.767 HD12 HD11 ' A' ' 12' ' ' ILE . 8.7 tp -61.23 -23.06 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.66 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.63 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -66.94 -62.61 3.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.717 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.63 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 28.7 Cg_endo -62.8 -48.47 6.89 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.58 2.187 . . . . 0.0 112.553 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.767 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -52.33 -26.2 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.477 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.848 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -67.01 -69.82 0.29 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.425 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.84 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -54.3 -24.27 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.316 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.81 -29.38 47.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.561 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.5 mt -86.28 -29.33 23.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -78.34 -57.58 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.119 0.485 . . . . 0.0 110.428 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.84 HD12 HG12 ' A' ' 14' ' ' VAL . 13.1 mt -47.28 -34.38 6.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.9 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -70.87 -39.94 72.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.573 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 30.1 ttp -50.57 -26.49 5.35 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.694 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.84 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.6 -38.51 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.961 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.453 ' N ' HD13 ' A' ' 21' ' ' ILE . 32.3 t -50.5 -36.41 33.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.27 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -36.69 39.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.411 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' A' ' 21' ' ' ILE . 18.8 t -53.71 -29.34 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.185 0.517 . . . . 0.0 110.117 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mp -72.39 3.7 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.171 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -153.1 12.93 0.5 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.768 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 120.888 0.375 . . . . 0.0 110.929 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.1 mtp -56.88 -44.32 82.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.75 0.31 . . . . 0.0 111.052 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 t -78.29 -3.6 43.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.0 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.45 -18.63 16.61 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.343 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 9' ' ' ILE . 5.7 p -91.91 -46.74 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.39 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.71 HD12 HD11 ' A' ' 12' ' ' ILE . 6.9 tp -72.92 -29.73 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.618 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -58.98 -61.16 8.37 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.692 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 29.1 Cg_endo -62.88 -50.9 3.41 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.629 2.219 . . . . 0.0 112.683 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.746 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.6 pp -52.53 -25.0 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 111.605 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.844 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -62.85 -69.84 0.24 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.728 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 11' ' ' PRO . 11.5 p -48.0 -28.46 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.407 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.669 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -82.36 -40.46 10.05 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.497 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.746 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.8 mm? -67.56 -30.48 70.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.869 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -76.18 -52.82 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.184 0.516 . . . . 0.0 110.3 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.669 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -52.66 -30.33 31.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.767 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -76.92 -40.95 45.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.596 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.3 ttm -51.35 -41.95 60.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.83 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.74 -35.46 8.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.36 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.476 ' HA ' HD12 ' A' ' 25' ' ' LEU . 42.6 t -56.45 -29.1 61.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.765 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -75.0 -44.25 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.131 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.7 t -53.9 -33.68 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.224 0.535 . . . . 0.0 110.119 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 22' ' ' SER . 16.5 mt -59.9 -19.68 52.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.247 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -153.5 34.29 0.45 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.442 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.5 mm-40 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.5 mtm -55.4 -43.97 75.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.18 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 3.3 t -77.88 -5.15 50.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.992 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 7' ' ' LEU . 2.7 tt -97.97 -19.95 17.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.319 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 9' ' ' ILE . 5.0 p -91.74 -46.62 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.372 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.695 HD12 HD11 ' A' ' 12' ' ' ILE . 6.8 tp -73.22 -30.22 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.558 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.618 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -58.29 -61.38 7.65 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.667 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 28.5 Cg_endo -62.56 -51.5 3.21 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.67 2.247 . . . . 0.0 112.716 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.715 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.6 pp -52.11 -25.56 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.859 0.361 . . . . 0.0 111.494 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.849 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -64.46 -69.5 0.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.711 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -52.26 -25.77 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.371 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.28 -32.33 52.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.566 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.6 mm? -85.67 -30.02 23.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.021 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -75.13 -55.94 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 110.451 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.722 HD12 HG12 ' A' ' 14' ' ' VAL . 8.1 mt -46.74 -33.56 4.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.866 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.81 -39.81 69.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.578 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.457 ' O ' HG23 ' A' ' 24' ' ' VAL . 16.0 ttp -52.22 -25.22 8.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.662 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.824 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.35 -36.98 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.883 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.406 ' N ' HD13 ' A' ' 21' ' ' ILE . 28.7 t -54.12 -28.94 42.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.1 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.35 -31.2 20.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.403 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 21' ' ' ILE . 41.1 t -55.08 -32.97 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 mt -67.21 -3.47 7.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.065 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -153.29 22.27 0.55 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.355 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.889 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.5 mtt -53.52 -48.14 69.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.807 0.337 . . . . 0.0 111.131 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 t -73.05 -13.55 61.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.785 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.431 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 2.4 tt -88.25 -19.09 27.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.427 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 12' ' ' ILE . 2.9 p -96.86 -49.34 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.2 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.45 ' N ' ' CG1' ' A' ' 8' ' ' VAL . 8.8 tp -62.48 -29.24 46.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.728 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.617 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -66.67 -60.26 6.73 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.943 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 37.6 Cg_endo -65.25 -28.89 55.44 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.59 2.193 . . . . 0.0 113.419 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.819 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -77.83 -30.74 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 0.0 111.116 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.893 ' O ' HG23 ' A' ' 17' ' ' VAL . 25.3 t80 -72.74 -66.08 0.71 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.942 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.96 HG12 HD12 ' A' ' 18' ' ' LEU . 20.5 t -57.23 -21.25 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.12 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.14 -26.48 44.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mp -89.42 -29.65 18.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.313 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -77.73 -58.98 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.207 0.527 . . . . 0.0 110.098 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.96 HD12 HG12 ' A' ' 14' ' ' VAL . 15.0 mt -49.69 -29.09 6.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.708 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.21 -40.82 51.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.507 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.7 ttm -51.51 -41.04 60.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.521 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.843 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -84.84 -31.9 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.737 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.539 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.2 p -58.44 -29.85 66.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.891 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 5.6 mpt_? -74.39 -42.5 59.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.144 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.2 t -56.44 -32.18 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.217 0.532 . . . . 0.0 110.197 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.9 mt -60.54 -19.46 57.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.279 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -153.49 33.25 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.809 0.338 . . . . 0.0 111.44 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 20.3 pt-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -47.63 72.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.741 0.305 . . . . 0.0 111.175 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.0 t -74.53 -8.96 58.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.965 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 7' ' ' LEU . 3.3 tt -94.2 -18.83 21.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.302 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 9' ' ' ILE . 3.5 p -96.39 -44.21 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.351 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.439 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 7.7 tp -70.96 -20.6 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.986 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -75.75 -62.02 0.82 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 34.8 Cg_endo -64.56 -22.03 65.29 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.625 2.217 . . . . 0.0 113.202 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.792 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -75.6 -29.81 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 0.0 111.111 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.879 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -66.05 -68.28 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.437 179.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.809 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -53.25 -24.98 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.349 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.76 -32.2 51.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.616 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 12' ' ' ILE . 6.2 mp -85.82 -29.23 23.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.5 t -76.38 -57.27 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.135 0.493 . . . . 0.0 110.346 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.809 HD12 HG12 ' A' ' 14' ' ' VAL . 11.4 mt -47.64 -34.65 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.724 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -68.14 -38.22 81.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.505 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.7 ttm -52.7 -46.12 67.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.511 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.844 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -89.16 -35.63 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.458 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.61 ' HA ' HD12 ' A' ' 25' ' ' LEU . 48.3 t -56.69 -27.43 58.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.72 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 27' ' ' GLU . 6.8 mpt_? -74.89 -44.3 49.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.168 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.02 -32.44 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.235 0.54 . . . . 0.0 110.01 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 22' ' ' SER . 18.9 mt -60.28 -18.92 52.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -153.43 33.44 0.46 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.839 0.352 . . . . 0.0 111.391 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.7 pt-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.28 -39.0 69.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.718 0.294 . . . . 0.0 111.098 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.6 t -84.7 4.82 30.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.976 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 7' ' ' LEU . 1.2 tt -112.33 -16.87 12.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.289 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 9' ' ' ILE . 4.8 p -92.86 -45.9 14.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.275 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.648 HD12 HD11 ' A' ' 12' ' ' ILE . 6.3 tp -77.81 -27.25 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.713 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.947 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -62.85 -62.5 5.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.294 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 44.5 Cg_exo -56.56 -52.27 7.35 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.248 1.966 . . . . 0.0 112.255 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.75 ' O ' HD13 ' A' ' 16' ' ' LEU . 2.7 pp -54.22 -24.16 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.52 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.842 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -63.8 -70.58 0.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.762 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.83 HG22 HD12 ' A' ' 18' ' ' LEU . 11.6 p -51.3 -26.86 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.362 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.52 -32.14 47.94 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 12' ' ' ILE . 9.0 mp -83.67 -29.94 27.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.726 0.298 . . . . 0.0 110.96 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.5 t -75.86 -57.51 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.14 0.495 . . . . 0.0 110.372 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.83 HD12 HG22 ' A' ' 14' ' ' VAL . 6.4 mt -47.19 -30.35 2.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.837 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -76.25 -41.06 50.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.599 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.5 ttt -51.46 -41.49 60.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.47 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.836 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.77 -35.43 8.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.366 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.577 ' HA ' HD12 ' A' ' 25' ' ' LEU . 40.8 t -56.38 -28.95 60.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.729 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 27' ' ' GLU . 5.8 mpt_? -74.98 -43.14 55.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.121 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -56.07 -32.37 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.245 0.545 . . . . 0.0 110.117 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.3 mt -60.51 -18.83 54.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.288 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -153.49 32.85 0.46 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.496 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.901 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.3 mt . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.624 0.249 . . . . 0.0 111.415 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.63 -45.37 38.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 111.46 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -69.27 -18.44 63.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.211 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.1 tp -98.39 -14.82 19.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.256 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 4' ' ' LEU . 3.4 t -100.28 10.2 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.739 0.304 . . . . 0.0 111.078 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 36.3 mm -125.89 -54.38 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.748 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -44.8 -53.34 15.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.88 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 33.6 Cg_exo -61.4 -43.56 27.44 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.588 2.192 . . . . 0.0 112.876 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.753 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -76.1 -28.01 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.799 -179.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.901 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -69.19 -66.6 0.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.375 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 10' ' ' ALA . 11.6 p -54.41 -22.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.375 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.614 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -84.61 -33.42 19.26 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.701 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.78 -32.5 46.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 111.014 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.8 t -71.75 -50.23 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.246 0.546 . . . . 0.0 110.23 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.614 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -52.2 -30.34 26.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.824 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.77 -42.64 27.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.71 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 ttt -50.42 -41.09 51.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.561 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.836 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.9 -35.49 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.371 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.511 ' HA ' HD12 ' A' ' 25' ' ' LEU . 40.3 t -56.61 -29.05 61.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.749 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -75.32 -43.11 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.176 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.6 t -55.28 -33.11 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 110.118 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.0 mt -59.91 -19.51 52.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.212 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -153.47 34.13 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.377 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . 7.1 pt-20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.768 ' O ' HG12 ' A' ' 8' ' ' VAL . 8.5 ttm -53.82 -44.91 70.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.755 0.312 . . . . 0.0 111.163 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 5.5 t -75.44 -15.29 60.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.806 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 tp -97.25 -5.58 36.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.397 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 5' ' ' MET . 5.4 p -81.29 -26.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.581 0.229 . . . . 0.0 111.547 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.467 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 1.6 tp -120.82 -6.1 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.664 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -79.95 -63.2 0.37 Allowed Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.664 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 37.4 Cg_endo -66.13 -40.63 15.04 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.608 2.205 . . . . 0.0 112.925 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -60.75 -28.13 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 0.0 111.12 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.881 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -67.97 -70.12 0.28 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.278 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.812 HG22 HD12 ' A' ' 18' ' ' LEU . 10.9 p -55.77 -23.01 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.201 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.63 60.34 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.599 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -92.4 -30.11 15.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.75 0.309 . . . . 0.0 110.97 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.7 t -74.24 -54.63 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.156 0.503 . . . . 0.0 110.232 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.812 HD12 HG22 ' A' ' 14' ' ' VAL . 11.0 mt -47.36 -30.04 2.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.85 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.52 -47.94 18.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.578 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.6 ttp -45.31 -43.32 10.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.627 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.837 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -81.45 -33.09 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.316 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.594 ' HA ' HD12 ' A' ' 25' ' ' LEU . 27.0 t -56.68 -28.37 60.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -74.61 -45.17 46.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.098 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 24' ' ' VAL . 3.8 t -54.67 -32.08 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.181 0.515 . . . . 0.0 110.017 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.594 HD12 ' HA ' ' A' ' 22' ' ' SER . 18.3 mt -61.51 -17.63 55.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.104 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -153.35 32.92 0.46 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.288 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.717 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.8 mp . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.0 mmt -50.23 -47.08 55.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.823 0.344 . . . . 0.0 111.175 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 9.5 t -67.74 -20.05 65.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.928 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 7' ' ' LEU . 2.3 tt -90.97 -15.4 29.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.97 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 4' ' ' LEU . 23.5 t -95.21 -60.09 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.792 HD12 HD11 ' A' ' 12' ' ' ILE . 8.6 tp -61.45 -22.88 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.648 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.624 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -67.34 -62.45 3.57 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.645 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 27.7 Cg_endo -62.2 -47.55 9.88 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.558 2.172 . . . . 0.0 112.473 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.792 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -55.11 -23.66 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.463 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.845 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.4 t80 -64.59 -65.75 0.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.75 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -49.55 -27.69 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.41 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.7 -33.99 45.19 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.673 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.6 mm? -82.9 -30.19 28.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.653 0.263 . . . . 0.0 110.983 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.45 -56.8 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.194 0.521 . . . . 0.0 110.326 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 14' ' ' VAL . 6.3 mt -47.47 -29.87 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.9 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -81.34 -45.44 16.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.699 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ttm -50.4 -38.67 44.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.567 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.843 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.91 -35.27 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.376 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.538 ' HA ' HD12 ' A' ' 25' ' ' LEU . 27.8 t -56.63 -28.65 60.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.76 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -76.11 -41.81 49.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.214 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.3 t -56.97 -32.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.106 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.3 mt -59.95 -19.22 50.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.168 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -153.46 33.53 0.46 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.845 0.355 . . . . 0.0 111.338 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . 5.2 pt-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.741 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.7 mp . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.0 ttp -49.81 -47.83 51.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.715 0.293 . . . . 0.0 111.209 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.6 t -67.03 -21.34 65.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.67 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 7' ' ' LEU . 2.2 tt -88.98 -14.68 36.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.717 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 4' ' ' LEU . 22.6 t -97.03 -63.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.744 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 9.6 tp -55.06 -23.48 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.818 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.63 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -70.53 -63.15 1.76 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.925 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.63 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 17.8 Cg_endo -58.94 -36.65 96.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.656 2.237 . . . . 0.0 112.956 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.77 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.73 -25.59 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.871 ' O ' HG23 ' A' ' 17' ' ' VAL . 5.4 t80 -65.43 -63.7 1.04 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.734 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.6 t -48.85 -27.52 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.566 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.529 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -79.19 -35.18 30.91 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.624 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 12' ' ' ILE . 3.0 mp -79.87 -31.15 40.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.706 0.288 . . . . 0.0 110.969 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.8 t -71.31 -48.7 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.185 0.517 . . . . 0.0 110.292 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.529 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -51.1 -32.03 21.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.856 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -75.63 -40.98 55.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.646 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.423 ' O ' HG23 ' A' ' 24' ' ' VAL . 19.2 ttp -51.64 -25.19 6.6 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.725 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.837 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -113.6 -37.1 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.922 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.414 ' N ' HD13 ' A' ' 21' ' ' ILE . 28.2 t -52.53 -28.77 22.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.745 0.307 . . . . 0.0 111.168 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -29.82 21.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.366 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 21' ' ' ILE . 11.2 t -64.34 -22.73 31.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.5 13.23 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.514 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 24' ' ' VAL . 19.7 t0 -153.53 -50.54 0.1 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.794 0.331 . . . . 0.0 110.783 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.464 0.238 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.609 179.6 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.553 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.6 mp . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.611 0.243 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 -46.14 31.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 111.45 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 14.9 t -67.78 -19.81 65.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.051 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.07 -21.06 22.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 4' ' ' LEU . 40.6 t -83.44 -8.06 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.448 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.623 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 17.3 mm -123.99 -35.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.303 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -50.39 -60.99 4.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 29.7 Cg_endo -63.8 -54.63 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.56 2.173 . . . . 0.0 113.038 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.718 ' O ' HD13 ' A' ' 16' ' ' LEU . 2.7 pp -51.51 -30.07 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 111.848 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.836 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -61.42 -72.68 0.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.772 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.786 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -52.83 -24.95 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.355 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.0 -32.3 49.8 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.605 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 12' ' ' ILE . 9.4 mp -85.28 -30.58 23.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.69 0.281 . . . . 0.0 110.984 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.07 -55.92 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.309 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.786 HD12 HG12 ' A' ' 14' ' ' VAL . 6.0 mt -47.05 -30.34 2.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.909 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -79.53 -44.84 20.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.6 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.569 ' O ' HG23 ' A' ' 24' ' ' VAL . 5.1 ttt -50.45 -26.53 5.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.684 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.815 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -105.89 -37.8 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.383 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 25' ' ' LEU . 28.7 t -56.26 -26.61 52.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.329 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -30.57 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.115 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 20' ' ' MET . 45.2 t -59.3 -34.6 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.012 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 22' ' ' SER . 4.3 mt -59.44 -13.11 7.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.287 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -153.18 28.92 0.5 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 120.8 0.333 . . . . 0.0 111.314 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.889 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.896 ' O ' HG23 ' A' ' 8' ' ' VAL . 8.2 mp . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -49.09 52.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.73 0.3 . . . . 0.0 111.213 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -69.99 -18.77 63.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.748 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 1.0 OUTLIER -91.72 -9.29 44.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 4' ' ' LEU . 19.9 t -102.93 -62.72 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.861 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.0 tp -53.59 -24.95 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.828 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.635 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -71.23 -63.15 1.54 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.846 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.635 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 18.4 Cg_endo -58.83 -36.11 97.53 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.641 2.227 . . . . 0.0 113.075 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.18 -27.93 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 111.076 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.883 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -66.44 -70.07 0.27 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.447 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.948 HG22 HD12 ' A' ' 18' ' ' LEU . 11.5 p -54.42 -23.73 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.351 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.3 -32.43 31.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.617 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.87 -29.45 32.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 111.049 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.5 t -77.52 -60.17 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.212 0.529 . . . . 0.0 110.275 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.948 HD12 HG22 ' A' ' 14' ' ' VAL . 6.9 mt -49.03 -31.94 8.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.732 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.94 -41.35 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.604 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.8 ttp -50.0 -52.85 30.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.305 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.834 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -74.63 -36.83 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.472 ' N ' HD13 ' A' ' 21' ' ' ILE . 43.3 t -54.45 -26.09 28.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.025 0.441 . . . . 0.0 109.99 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 27' ' ' GLU . 2.2 mmt85 -82.19 -36.67 27.06 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.085 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 21' ' ' ILE . 40.5 t -54.13 -32.93 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.37 0.605 . . . . 0.0 109.597 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.75 -7.14 31.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.375 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -153.36 25.34 0.53 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.77 0.319 . . . . 0.0 111.451 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 23' ' ' ARG . 3.3 mm-40 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.962 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.9 mmm -51.85 -46.44 64.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.693 0.282 . . . . 0.0 111.136 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 6.7 t -72.34 -17.11 61.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.952 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.5 tp -89.91 -13.93 35.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.048 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 4' ' ' LEU . 22.1 t -94.27 -62.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.861 0.363 . . . . 0.0 111.086 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.756 HD12 HD11 ' A' ' 12' ' ' ILE . 8.5 tp -60.28 -21.91 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.641 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.627 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -67.52 -63.0 2.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.688 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 26.9 Cg_endo -62.04 -48.44 8.37 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.542 2.161 . . . . 0.0 112.473 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.756 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -53.08 -28.78 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.327 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.834 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -65.06 -72.66 0.14 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.114 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 18' ' ' LEU . 12.6 p -54.84 -26.82 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.883 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.48 -28.6 73.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.298 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mt -99.13 -24.42 14.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.633 0.254 . . . . 0.0 111.311 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.3 t -85.05 -58.65 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.087 0.47 . . . . 0.0 110.704 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -49.44 -28.74 5.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.805 -179.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -78.11 -45.85 22.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.483 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.1 ttt -47.76 -44.34 28.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.594 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.848 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -78.93 -33.18 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.443 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.603 ' HA ' HD12 ' A' ' 25' ' ' LEU . 26.5 t -56.11 -28.78 59.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -74.58 -44.79 49.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 t -54.64 -31.65 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.186 0.517 . . . . 0.0 110.018 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.603 HD12 ' HA ' ' A' ' 22' ' ' SER . 17.4 mt -62.66 -17.46 60.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.241 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -153.48 32.19 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.802 0.334 . . . . 0.0 111.52 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.5 mm-40 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.852 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.6 mp . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.558 0.218 . . . . 0.0 111.476 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -32.09 30.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.746 0.308 . . . . 0.0 111.375 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.681 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 7.9 t -87.44 -1.44 57.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.474 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.544 ' O ' HD23 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -118.34 -6.21 10.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.233 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 4' ' ' LEU . 23.5 t -94.79 -23.88 5.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.582 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.633 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 19.8 mm -124.5 -40.72 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.604 0.24 . . . . 0.0 111.507 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -49.46 -53.99 34.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 41.2 Cg_endo -68.59 -52.28 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.308 2.005 . . . . 0.0 112.868 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.633 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.8 pp -55.04 -29.86 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.762 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.845 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -61.94 -71.96 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.799 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.723 HG12 HD12 ' A' ' 18' ' ' LEU . 24.2 t -52.66 -25.52 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.296 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.4 -30.01 42.54 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 12' ' ' ILE . 9.7 mt -83.64 -30.38 26.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 110.933 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -76.67 -57.81 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.149 0.499 . . . . 0.0 110.537 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.723 HD12 HG12 ' A' ' 14' ' ' VAL . 7.4 mt -47.1 -34.95 6.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.997 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.22 -39.59 71.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.619 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 ttt -50.87 -26.29 5.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.689 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.839 HD13 ' C ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.86 -37.82 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.033 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.454 ' N ' HD13 ' A' ' 21' ' ' ILE . 29.1 t -51.87 -29.9 21.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.286 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.43 -31.83 21.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.869 0.366 . . . . 0.0 110.458 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.448 HG23 ' HA ' ' A' ' 21' ' ' ILE . 11.3 t -61.19 -23.64 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.343 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 mp -75.17 13.49 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.627 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -153.38 -38.62 0.1 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.7 0.286 . . . . 0.0 111.297 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.148 179.888 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.741 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.6 mp . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 8.7 ttm -49.02 -48.14 44.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.309 . . . . 0.0 111.265 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 8.7 t -67.91 -20.04 65.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.805 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 tp -90.42 -14.53 32.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 4' ' ' LEU . 24.8 t -95.23 -61.36 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.98 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.766 HD12 HD11 ' A' ' 12' ' ' ILE . 9.1 tp -60.11 -21.7 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.745 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.643 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -69.0 -62.87 2.46 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.72 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.643 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 29.1 Cg_endo -62.87 -46.86 9.85 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.6 2.2 . . . . 0.0 112.555 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.766 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -53.14 -24.98 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.504 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.871 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -64.42 -69.34 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 11' ' ' PRO . 11.5 p -49.7 -27.21 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.385 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.573 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -79.12 -37.92 23.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.607 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 12' ' ' ILE . 4.0 mm? -75.25 -30.25 60.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.29 . . . . 0.0 111.003 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -73.83 -49.67 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.169 0.509 . . . . 0.0 110.503 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.573 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -49.93 -30.53 10.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.941 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.69 -40.53 55.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.57 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.8 ttt -52.16 -41.54 62.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.406 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.838 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.89 -35.38 8.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.365 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.569 ' HA ' HD12 ' A' ' 25' ' ' LEU . 29.7 t -56.11 -29.03 60.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.739 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -74.86 -43.12 56.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.123 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.1 t -56.18 -32.36 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.225 0.536 . . . . 0.0 110.1 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 22' ' ' SER . 14.8 mt -60.26 -19.2 53.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.301 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -153.46 33.08 0.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.45 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.8 mm-40 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.9 mmm -56.23 -37.64 69.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.774 0.321 . . . . 0.0 111.003 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.762 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 4.0 t -86.93 7.19 28.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.898 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.7 mt -118.39 -10.97 10.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.133 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 12' ' ' ILE . 8.7 p -85.03 -29.58 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.619 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 1.6 tp -125.24 -34.91 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -53.9 -57.72 16.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 35.2 Cg_endo -65.48 -53.1 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.249 1.966 . . . . 0.0 112.843 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.619 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -51.29 -29.01 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 0.0 111.64 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.86 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -64.71 -72.19 0.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.503 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.66 HG12 HD12 ' A' ' 18' ' ' LEU . 21.7 t -54.87 -23.56 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.289 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -30.67 56.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.54 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 12' ' ' ILE . 8.1 mt -88.49 -29.8 19.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.768 0.318 . . . . 0.0 111.007 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -76.0 -53.83 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.091 0.472 . . . . 0.0 110.589 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 HG12 ' A' ' 14' ' ' VAL . 10.7 mt -46.22 -30.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.078 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.04 -47.89 15.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.641 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 ttt -45.82 -41.71 11.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.6 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.832 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -82.03 -33.05 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.418 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.524 ' HA ' HD12 ' A' ' 25' ' ' LEU . 26.5 t -56.7 -29.28 62.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -74.24 -46.03 44.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.104 179.306 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 24' ' ' VAL . 4.6 t -52.91 -32.61 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.253 0.549 . . . . 0.0 110.027 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 22' ' ' SER . 18.1 mt -62.48 -17.52 59.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.325 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -153.5 32.44 0.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.772 0.32 . . . . 0.0 111.527 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 3.6 mm-40 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.907 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 mtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.832 0.348 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.79 14.5 21.06 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.639 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.548 ' C ' ' O ' ' A' ' 2' ' ' LYS . 44.2 t0 -23.8 -50.39 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 110.765 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 2' ' ' LYS . 7.7 mp -117.78 -19.73 9.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.06 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.1 mtm -55.6 -43.11 75.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 111.223 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t -79.38 -2.85 43.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.933 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.3 tp -100.91 -18.94 16.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.341 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 9' ' ' ILE . 6.4 p -91.2 -46.61 14.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 12' ' ' ILE . 6.8 tp -73.6 -30.42 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.577 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.629 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -57.87 -61.69 6.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.632 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 27.9 Cg_endo -62.6 -52.08 2.71 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.65 2.233 . . . . 0.0 112.746 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.785 ' O ' HD13 ' A' ' 16' ' ' LEU . 2.6 pp -50.39 -27.48 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.889 0.376 . . . . 0.0 111.552 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.869 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -66.64 -70.72 0.23 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 179.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.841 HG12 HD12 ' A' ' 18' ' ' LEU . 21.3 t -55.43 -23.01 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.33 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.23 -28.72 39.57 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.628 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.785 HD13 ' O ' ' A' ' 12' ' ' ILE . 8.3 mp -85.66 -30.07 23.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.78 0.324 . . . . 0.0 110.997 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -77.3 -57.77 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.18 0.514 . . . . 0.0 110.278 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.841 HD12 HG12 ' A' ' 14' ' ' VAL . 11.2 mt -48.81 -28.78 3.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.894 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -77.54 -41.24 39.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.567 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.0 ttp -51.29 -40.55 59.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.552 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.842 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -84.31 -32.64 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.687 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.517 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -57.69 -29.93 65.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.859 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.44 -43.45 56.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.092 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 24' ' ' VAL . 6.4 t -55.7 -31.51 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.187 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 22' ' ' SER . 16.3 mt -61.47 -17.85 56.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.475 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -153.45 30.4 0.48 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.699 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.09 71.18 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.771 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -78.65 -75.03 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -114.04 144.42 43.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -94.88 -50.61 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.6 m -176.7 147.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -92.42 117.05 29.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.797 0.332 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.86 14.58 20.99 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.678 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.573 ' C ' HD22 ' A' ' 4' ' ' LEU . 34.5 t0 -23.33 -49.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.904 0.383 . . . . 0.0 111.057 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.8 mm? -117.79 -28.74 5.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.309 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.447 ' HB2' ' HA ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -46.7 -50.9 17.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.751 0.31 . . . . 0.0 111.543 -179.389 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 5.2 t -66.34 -19.98 65.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.894 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.9 tp -89.74 -14.35 34.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 4' ' ' LEU . 25.2 t -95.4 -62.29 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.963 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.828 HD12 HD11 ' A' ' 12' ' ' ILE . 9.0 tp -59.4 -21.2 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.75 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.633 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -69.6 -63.07 2.12 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.691 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.633 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 29.2 Cg_endo -62.71 -45.54 13.55 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.558 2.172 . . . . 0.0 112.537 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.828 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -55.79 -22.69 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.539 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.853 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.2 t80 -63.98 -68.43 0.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.694 HG22 HD12 ' A' ' 18' ' ' LEU . 11.7 p -50.34 -26.97 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.418 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.78 -33.85 45.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.589 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.7 mm? -83.11 -30.18 28.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 111.016 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.33 -57.11 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.21 0.528 . . . . 0.0 110.318 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.694 HD12 HG22 ' A' ' 14' ' ' VAL . 7.5 mt -47.56 -29.91 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.903 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -80.52 -44.68 18.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.659 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.4 ttt -50.07 -38.2 37.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.604 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.843 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.71 -35.34 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.377 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.643 ' HA ' HD12 ' A' ' 25' ' ' LEU . 27.5 t -56.67 -28.7 61.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.713 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -75.85 -42.08 50.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.146 179.389 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.8 t -56.63 -32.53 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 121.186 0.517 . . . . 0.0 110.14 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.7 mt -59.66 -19.62 50.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.194 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -153.46 33.83 0.46 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.397 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . 10.6 pt-20 -68.95 -33.07 73.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -143.82 162.12 36.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t70 60.29 93.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -96.71 128.22 43.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 m -114.63 -39.2 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -70.2 147.23 50.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.866 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttm . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.804 0.335 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.77 14.46 21.09 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.658 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.8 t70 -23.97 -50.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.076 0.465 . . . . 0.0 110.648 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.779 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.8 mp -117.62 -20.9 8.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.832 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.7 mmt -52.1 -46.36 65.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.768 0.318 . . . . 0.0 111.138 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 8.6 t -71.73 -17.74 62.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.932 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 7' ' ' LEU . 3.9 tt -89.65 -14.49 34.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.021 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 4' ' ' LEU . 21.9 t -94.72 -62.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 110.989 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.795 HD12 HD11 ' A' ' 12' ' ' ILE . 9.1 tp -59.41 -22.01 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.731 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.636 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -68.31 -63.16 2.54 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.74 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.636 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 28.8 Cg_endo -62.73 -47.48 8.89 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.561 2.174 . . . . 0.0 112.574 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.795 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -52.81 -25.64 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.462 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.861 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.2 t80 -66.35 -68.8 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.457 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 21.2 t -51.35 -25.89 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.402 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.534 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -79.59 -35.6 28.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.592 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.4 mm? -78.64 -30.48 46.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.728 0.299 . . . . 0.0 110.951 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -73.37 -49.61 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.172 0.511 . . . . 0.0 110.378 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.534 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -50.52 -32.79 19.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.846 -179.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.89 -41.55 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.526 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 5.1 ttt -51.75 -28.39 15.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.612 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.802 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -107.99 -38.19 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.404 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.467 ' HA ' HD12 ' A' ' 25' ' ' LEU . 40.7 t -56.56 -27.73 58.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 0.0 110.235 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -29.79 27.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.099 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' MET . 42.2 t -61.26 -33.44 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.168 0.509 . . . . 0.0 110.051 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 22' ' ' SER . 3.9 mt -59.53 -11.95 5.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.349 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -153.18 27.01 0.52 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.758 0.313 . . . . 0.0 111.409 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -62.14 -43.33 99.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -176.16 151.75 1.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.99 140.93 56.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -60.14 151.11 27.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.9 p -112.58 31.05 6.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.48 -173.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.904 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtp . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.539 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.44 21.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.676 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.544 ' C ' HD23 ' A' ' 4' ' ' LEU . 4.6 t0 -24.25 -51.12 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.042 0.448 . . . . 0.0 110.619 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.893 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.9 mt -117.83 -14.87 10.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.026 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 mmt -57.58 -46.06 84.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.883 0.373 . . . . 0.0 110.898 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 p -70.18 -19.38 63.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.797 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.431 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 18.0 tp -87.93 -14.98 37.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.829 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 4' ' ' LEU . 19.8 t -97.18 -64.11 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.886 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.42 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 9.9 tp -54.1 -23.64 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.888 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.636 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -70.82 -63.29 1.62 Allowed Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.636 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 17.8 Cg_endo -59.0 -36.51 96.62 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.621 2.214 . . . . 0.0 112.961 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.59 -25.96 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 111.175 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.854 ' O ' HG23 ' A' ' 17' ' ' VAL . 7.2 t80 -65.39 -66.21 0.58 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.801 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.766 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -50.66 -26.8 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.424 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.14 -32.29 49.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.557 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 12' ' ' ILE . 4.2 mp -84.93 -29.83 24.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.702 0.287 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.96 -57.71 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.239 0.542 . . . . 0.0 110.332 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.766 HD12 HG12 ' A' ' 14' ' ' VAL . 7.7 mt -47.84 -30.69 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.777 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.92 -41.46 51.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.648 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 ttt -51.23 -41.37 60.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.476 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.841 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.5 -35.34 8.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.335 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.559 ' HA ' HD12 ' A' ' 25' ' ' LEU . 41.6 t -56.65 -28.9 61.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.74 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 27' ' ' GLU . 6.4 mpt_? -75.16 -42.21 56.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.156 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.769 HG13 ' OE2' ' A' ' 27' ' ' GLU . 5.6 t -57.33 -31.99 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 110.061 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.0 mt -59.97 -18.81 48.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.099 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -153.4 33.49 0.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.219 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.769 ' OE2' HG13 ' A' ' 24' ' ' VAL . 14.0 pt-20 -71.14 -35.89 71.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.915 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.98 162.77 5.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -152.68 170.83 19.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -88.45 -48.38 7.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.4 t 61.79 152.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -112.34 -35.26 5.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.895 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.8 mtm . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.84 0.352 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.9 14.5 20.93 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.663 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' A' ' 2' ' ' LYS . 8.2 t0 -23.88 -51.5 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.106 0.479 . . . . 0.0 110.494 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.724 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.1 mp -117.67 -22.91 7.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.509 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.4 ttp -49.14 -47.59 45.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.769 0.319 . . . . 0.0 111.332 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 9.6 t -68.11 -19.91 64.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.861 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 7' ' ' LEU . 2.2 tt -90.89 -14.81 31.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.944 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 4' ' ' LEU . 24.5 t -94.73 -60.7 2.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.016 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.767 HD12 HD11 ' A' ' 12' ' ' ILE . 8.7 tp -61.23 -23.06 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.66 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.63 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -66.94 -62.61 3.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.717 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.63 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 28.7 Cg_endo -62.8 -48.47 6.89 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.58 2.187 . . . . 0.0 112.553 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.767 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -52.33 -26.2 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.477 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.848 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -67.01 -69.82 0.29 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.425 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.84 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -54.3 -24.27 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.316 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.81 -29.38 47.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.561 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.5 mt -86.28 -29.33 23.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -78.34 -57.58 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.119 0.485 . . . . 0.0 110.428 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.84 HD12 HG12 ' A' ' 14' ' ' VAL . 13.1 mt -47.28 -34.38 6.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.9 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -70.87 -39.94 72.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.573 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 30.1 ttp -50.57 -26.49 5.35 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.694 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.84 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.6 -38.51 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.961 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.453 ' N ' HD13 ' A' ' 21' ' ' ILE . 32.3 t -50.5 -36.41 33.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.27 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -36.69 39.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.411 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' A' ' 21' ' ' ILE . 18.8 t -53.71 -29.34 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.185 0.517 . . . . 0.0 110.117 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mp -72.39 3.7 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.171 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -153.1 12.93 0.5 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.768 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -102.75 30.65 4.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.888 0.375 . . . . 0.0 110.929 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.37 -37.71 18.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -68.78 121.47 16.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -104.05 -35.15 8.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.6 p -174.47 36.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -114.41 91.54 3.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mttp . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.906 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.781 0.324 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.55 21.03 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.635 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.749 ' OD1' HD12 ' A' ' 4' ' ' LEU . 11.5 t0 -23.83 -49.86 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.08 0.467 . . . . 0.0 110.72 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.749 HD12 ' OD1' ' A' ' 3' ' ' ASP . 4.2 mp -117.66 -16.2 10.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.973 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.1 mtp -56.88 -44.32 82.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.75 0.31 . . . . 0.0 111.052 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.402 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 3.3 t -78.29 -3.6 43.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.0 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.9 tp -100.45 -18.63 16.61 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.343 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 9' ' ' ILE . 5.7 p -91.91 -46.74 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.39 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.71 HD12 HD11 ' A' ' 12' ' ' ILE . 6.9 tp -72.92 -29.73 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.618 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -58.98 -61.16 8.37 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.692 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 29.1 Cg_endo -62.88 -50.9 3.41 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.629 2.219 . . . . 0.0 112.683 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.746 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.6 pp -52.53 -25.0 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 111.605 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.844 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -62.85 -69.84 0.24 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.728 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 11' ' ' PRO . 11.5 p -48.0 -28.46 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.407 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.669 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -82.36 -40.46 10.05 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.497 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.746 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.8 mm? -67.56 -30.48 70.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.869 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -76.18 -52.82 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.184 0.516 . . . . 0.0 110.3 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.669 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -52.66 -30.33 31.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.767 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -76.92 -40.95 45.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.596 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.3 ttm -51.35 -41.95 60.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.83 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.74 -35.46 8.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.36 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.476 ' HA ' HD12 ' A' ' 25' ' ' LEU . 42.6 t -56.45 -29.1 61.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.765 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -75.0 -44.25 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.131 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.7 t -53.9 -33.68 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.224 0.535 . . . . 0.0 110.119 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 22' ' ' SER . 16.5 mt -59.9 -19.68 52.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.247 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -153.5 34.29 0.45 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.442 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.5 mm-40 -79.15 -46.5 17.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.21 112.1 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -126.09 162.12 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.55 157.5 15.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -144.36 -55.71 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -133.15 106.69 7.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.796 0.331 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.75 14.38 21.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.718 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.545 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.6 t0 -23.86 -50.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.069 0.461 . . . . 0.0 110.699 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 2' ' ' LYS . 7.1 mp -117.78 -19.21 9.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.989 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.489 ' HE2' ' HA ' ' A' ' 2' ' ' LYS . 29.5 mtm -55.4 -43.97 75.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.764 0.316 . . . . 0.0 111.18 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 3.3 t -77.88 -5.15 50.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.992 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 7' ' ' LEU . 2.7 tt -97.97 -19.95 17.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.319 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 9' ' ' ILE . 5.0 p -91.74 -46.62 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.372 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.695 HD12 HD11 ' A' ' 12' ' ' ILE . 6.8 tp -73.22 -30.22 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.558 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.618 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -58.29 -61.38 7.65 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.667 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 28.5 Cg_endo -62.56 -51.5 3.21 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.67 2.247 . . . . 0.0 112.716 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.715 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.6 pp -52.11 -25.56 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.859 0.361 . . . . 0.0 111.494 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.849 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -64.46 -69.5 0.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.711 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -52.26 -25.77 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.371 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.28 -32.33 52.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.566 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.6 mm? -85.67 -30.02 23.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.021 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -75.13 -55.94 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 110.451 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.722 HD12 HG12 ' A' ' 14' ' ' VAL . 8.1 mt -46.74 -33.56 4.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.866 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -71.81 -39.81 69.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.578 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.457 ' O ' HG23 ' A' ' 24' ' ' VAL . 16.0 ttp -52.22 -25.22 8.69 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.662 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.824 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.35 -36.98 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.883 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.406 ' N ' HD13 ' A' ' 21' ' ' ILE . 28.7 t -54.12 -28.94 42.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.1 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.35 -31.2 20.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.403 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 21' ' ' ILE . 41.1 t -55.08 -32.97 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.196 0.522 . . . . 0.0 109.963 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 mt -67.21 -3.47 7.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.065 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -153.29 22.27 0.55 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.355 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.47 92.57 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.889 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 63.53 141.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -60.07 147.3 39.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -168.76 80.17 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 t -85.73 117.58 24.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 -112.39 -35.3 5.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.925 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpp? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.849 0.357 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.541 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.83 14.47 21.02 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.614 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.674 ' OD1' HD12 ' A' ' 4' ' ' LEU . 11.9 t70 -23.94 -51.14 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.038 0.447 . . . . 0.0 110.693 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.674 HD12 ' OD1' ' A' ' 3' ' ' ASP . 4.3 mp -117.77 -19.77 9.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.945 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 38.5 mtt -53.52 -48.14 69.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.807 0.337 . . . . 0.0 111.131 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 t -73.05 -13.55 61.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.785 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.431 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 2.4 tt -88.25 -19.09 27.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.427 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 12' ' ' ILE . 2.9 p -96.86 -49.34 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.2 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.45 ' N ' ' CG1' ' A' ' 8' ' ' VAL . 8.8 tp -62.48 -29.24 46.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.728 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.617 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -66.67 -60.26 6.73 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.943 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 37.6 Cg_endo -65.25 -28.89 55.44 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.59 2.193 . . . . 0.0 113.419 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.819 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -77.83 -30.74 16.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 0.0 111.116 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.893 ' O ' HG23 ' A' ' 17' ' ' VAL . 25.3 t80 -72.74 -66.08 0.71 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.942 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.96 HG12 HD12 ' A' ' 18' ' ' LEU . 20.5 t -57.23 -21.25 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.12 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.14 -26.48 44.19 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mp -89.42 -29.65 18.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.756 0.313 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -77.73 -58.98 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.207 0.527 . . . . 0.0 110.098 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.96 HD12 HG12 ' A' ' 14' ' ' VAL . 15.0 mt -49.69 -29.09 6.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.708 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -76.21 -40.82 51.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.507 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.7 ttm -51.51 -41.04 60.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.521 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.843 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -84.84 -31.9 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.737 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.539 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.2 p -58.44 -29.85 66.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.891 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 5.6 mpt_? -74.39 -42.5 59.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.144 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.2 t -56.44 -32.18 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.217 0.532 . . . . 0.0 110.197 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.9 mt -60.54 -19.46 57.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.279 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -153.49 33.25 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.809 0.338 . . . . 0.0 111.44 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 20.3 pt-20 -63.48 -31.34 72.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.04 127.14 49.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.933 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -172.38 168.82 5.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -103.92 141.73 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.73 106.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.933 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 mtt85 -95.37 -179.61 4.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mtp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.852 0.358 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.553 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -108.25 14.36 25.0 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.73 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.553 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.7 t0 -24.68 -51.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.108 0.48 . . . . 0.0 110.618 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 2' ' ' LYS . 4.6 mp -117.66 -17.89 9.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.712 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -47.63 72.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.741 0.305 . . . . 0.0 111.175 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.0 t -74.53 -8.96 58.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.965 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 7' ' ' LEU . 3.3 tt -94.2 -18.83 21.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.302 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 9' ' ' ILE . 3.5 p -96.39 -44.21 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.351 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.439 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 7.7 tp -70.96 -20.6 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.986 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -75.75 -62.02 0.82 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 34.8 Cg_endo -64.56 -22.03 65.29 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.625 2.217 . . . . 0.0 113.202 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.792 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -75.6 -29.81 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 0.0 111.111 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.879 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -66.05 -68.28 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.437 179.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.809 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -53.25 -24.98 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.349 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.76 -32.2 51.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.616 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 12' ' ' ILE . 6.2 mp -85.82 -29.23 23.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.5 t -76.38 -57.27 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.135 0.493 . . . . 0.0 110.346 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.809 HD12 HG12 ' A' ' 14' ' ' VAL . 11.4 mt -47.64 -34.65 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.724 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -68.14 -38.22 81.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.505 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.7 ttm -52.7 -46.12 67.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.511 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.844 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -89.16 -35.63 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.458 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.61 ' HA ' HD12 ' A' ' 25' ' ' LEU . 48.3 t -56.69 -27.43 58.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.72 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 27' ' ' GLU . 6.8 mpt_? -74.89 -44.3 49.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.168 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.02 -32.44 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.235 0.54 . . . . 0.0 110.01 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 22' ' ' SER . 18.9 mt -60.28 -18.92 52.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -153.43 33.44 0.46 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.839 0.352 . . . . 0.0 111.391 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.7 pt-20 -59.51 -31.41 69.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -159.4 -45.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -98.12 -174.55 2.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -140.54 146.1 37.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.7 m -109.37 176.2 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -102.54 -34.85 8.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.7 mttp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.926 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.804 0.335 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.85 14.41 20.99 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.639 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 2' ' ' LYS . 9.4 t0 -24.18 -51.2 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.089 0.471 . . . . 0.0 110.484 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 2' ' ' LYS . 4.9 mp -117.63 -18.62 9.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.616 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.28 -39.0 69.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.718 0.294 . . . . 0.0 111.098 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.407 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 3.6 t -84.7 4.82 30.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.976 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 7' ' ' LEU . 1.2 tt -112.33 -16.87 12.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.289 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 9' ' ' ILE . 4.8 p -92.86 -45.9 14.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.275 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.648 HD12 HD11 ' A' ' 12' ' ' ILE . 6.3 tp -77.81 -27.25 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.713 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.947 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -62.85 -62.5 5.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.294 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 44.5 Cg_exo -56.56 -52.27 7.35 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.248 1.966 . . . . 0.0 112.255 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.75 ' O ' HD13 ' A' ' 16' ' ' LEU . 2.7 pp -54.22 -24.16 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.52 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.842 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -63.8 -70.58 0.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.762 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.83 HG22 HD12 ' A' ' 18' ' ' LEU . 11.6 p -51.3 -26.86 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.362 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.52 -32.14 47.94 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 12' ' ' ILE . 9.0 mp -83.67 -29.94 27.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.726 0.298 . . . . 0.0 110.96 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.5 t -75.86 -57.51 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.14 0.495 . . . . 0.0 110.372 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.83 HD12 HG22 ' A' ' 14' ' ' VAL . 6.4 mt -47.19 -30.35 2.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.837 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -76.25 -41.06 50.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.599 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.5 ttt -51.46 -41.49 60.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.47 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.836 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.77 -35.43 8.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.366 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.577 ' HA ' HD12 ' A' ' 25' ' ' LEU . 40.8 t -56.38 -28.95 60.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.729 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 27' ' ' GLU . 5.8 mpt_? -74.98 -43.14 55.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.121 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -56.07 -32.37 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.245 0.545 . . . . 0.0 110.117 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.3 mt -60.51 -18.83 54.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.288 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -153.49 32.85 0.46 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.496 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.8 mm-40 -87.88 55.0 3.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -113.71 36.13 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -75.39 86.5 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.34 35.76 1.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.9 t -85.36 95.91 9.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -128.9 32.22 4.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.796 0.332 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.551 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.81 14.47 21.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.687 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.564 ' C ' HD23 ' A' ' 4' ' ' LEU . 4.5 t0 -24.04 -50.78 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.141 0.496 . . . . 0.0 110.493 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.901 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.3 mt -117.55 -23.69 7.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.415 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.63 -45.37 38.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 111.46 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -69.27 -18.44 63.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.211 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.1 tp -98.39 -14.82 19.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.256 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 4' ' ' LEU . 3.4 t -100.28 10.2 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.739 0.304 . . . . 0.0 111.078 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 36.3 mm -125.89 -54.38 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.748 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -44.8 -53.34 15.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.88 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 33.6 Cg_exo -61.4 -43.56 27.44 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.588 2.192 . . . . 0.0 112.876 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.753 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -76.1 -28.01 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.799 -179.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.901 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -69.19 -66.6 0.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.375 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 10' ' ' ALA . 11.6 p -54.41 -22.99 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.375 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.614 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -84.61 -33.42 19.26 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.701 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.78 -32.5 46.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 111.014 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.8 t -71.75 -50.23 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.246 0.546 . . . . 0.0 110.23 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.614 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -52.2 -30.34 26.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.824 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.77 -42.64 27.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.71 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 ttt -50.42 -41.09 51.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.561 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.836 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.9 -35.49 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.371 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.511 ' HA ' HD12 ' A' ' 25' ' ' LEU . 40.3 t -56.61 -29.05 61.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.749 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -75.32 -43.11 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.176 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.6 t -55.28 -33.11 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.205 0.526 . . . . 0.0 110.118 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.0 mt -59.91 -19.51 52.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.212 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -153.47 34.13 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.377 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ARG . 7.1 pt-20 -66.81 -174.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -106.34 143.5 34.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -128.12 167.21 17.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.949 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.81 81.63 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 m -65.11 98.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.17 -31.57 21.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 tptt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.862 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mmm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.853 0.358 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.35 21.03 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.658 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' A' ' 2' ' ' LYS . 35.8 t0 -24.28 -51.39 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.127 0.489 . . . . 0.0 110.507 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 2' ' ' LYS . 9.1 mp -117.66 -19.66 9.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.67 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.768 ' O ' HG12 ' A' ' 8' ' ' VAL . 8.5 ttm -53.82 -44.91 70.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.755 0.312 . . . . 0.0 111.163 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 5.5 t -75.44 -15.29 60.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.806 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 tp -97.25 -5.58 36.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.397 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 5' ' ' MET . 5.4 p -81.29 -26.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.581 0.229 . . . . 0.0 111.547 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 1.6 tp -120.82 -6.1 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.664 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -79.95 -63.2 0.37 Allowed Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.664 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 37.4 Cg_endo -66.13 -40.63 15.04 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.608 2.205 . . . . 0.0 112.925 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.768 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -60.75 -28.13 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 0.0 111.12 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.881 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -67.97 -70.12 0.28 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.278 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.812 HG22 HD12 ' A' ' 18' ' ' LEU . 10.9 p -55.77 -23.01 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.201 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.63 60.34 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.599 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -92.4 -30.11 15.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.75 0.309 . . . . 0.0 110.97 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.7 t -74.24 -54.63 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.156 0.503 . . . . 0.0 110.232 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.812 HD12 HG22 ' A' ' 14' ' ' VAL . 11.0 mt -47.36 -30.04 2.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.85 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.52 -47.94 18.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.578 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.6 ttp -45.31 -43.32 10.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.627 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.837 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -81.45 -33.09 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.316 179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.594 ' HA ' HD12 ' A' ' 25' ' ' LEU . 27.0 t -56.68 -28.37 60.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.95 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -74.61 -45.17 46.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.098 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 24' ' ' VAL . 3.8 t -54.67 -32.08 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.181 0.515 . . . . 0.0 110.017 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.594 HD12 ' HA ' ' A' ' 22' ' ' SER . 18.3 mt -61.51 -17.63 55.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.104 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -153.35 32.92 0.46 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.288 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -69.06 70.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 60.01 83.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -80.38 -175.13 4.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -87.96 115.9 25.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.5 p -176.52 79.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -103.66 -35.01 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.886 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.842 0.354 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.83 14.52 21.02 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.674 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.812 ' HB3' HD12 ' A' ' 4' ' ' LEU . 2.7 t0 -24.0 -50.18 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.06 0.457 . . . . 0.0 110.694 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.812 HD12 ' HB3' ' A' ' 3' ' ' ASP . 4.8 mp -117.68 -22.41 8.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.782 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.0 mmt -50.23 -47.08 55.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.823 0.344 . . . . 0.0 111.175 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 9.5 t -67.74 -20.05 65.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.928 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 7' ' ' LEU . 2.3 tt -90.97 -15.4 29.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.97 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 4' ' ' LEU . 23.5 t -95.21 -60.09 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.792 HD12 HD11 ' A' ' 12' ' ' ILE . 8.6 tp -61.45 -22.88 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.648 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.624 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -67.34 -62.45 3.57 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.645 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 27.7 Cg_endo -62.2 -47.55 9.88 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.558 2.172 . . . . 0.0 112.473 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.792 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -55.11 -23.66 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.463 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.845 ' O ' HG23 ' A' ' 17' ' ' VAL . 1.4 t80 -64.59 -65.75 0.63 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.75 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -49.55 -27.69 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.41 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.7 -33.99 45.19 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.673 HD23 ' O ' ' A' ' 12' ' ' ILE . 3.6 mm? -82.9 -30.19 28.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.653 0.263 . . . . 0.0 110.983 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.45 -56.8 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.194 0.521 . . . . 0.0 110.326 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 14' ' ' VAL . 6.3 mt -47.47 -29.87 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.9 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -81.34 -45.44 16.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.699 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.0 ttm -50.4 -38.67 44.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.567 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.843 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.91 -35.27 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.376 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.538 ' HA ' HD12 ' A' ' 25' ' ' LEU . 27.8 t -56.63 -28.65 60.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.76 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -76.11 -41.81 49.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.214 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.3 t -56.97 -32.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.106 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 22' ' ' SER . 15.3 mt -59.95 -19.22 50.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.168 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -153.46 33.53 0.46 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.845 0.355 . . . . 0.0 111.338 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 23' ' ' ARG . 5.2 pt-20 -62.61 -33.51 75.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -60.33 -30.6 69.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 61.58 37.28 16.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -98.72 31.5 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.3 m -117.98 44.76 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -59.41 113.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 tttp . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.92 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.809 0.337 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.536 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.84 14.46 21.0 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.711 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 2' ' ' LYS . 24.3 t0 -24.14 -51.34 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.094 0.473 . . . . 0.0 110.513 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.741 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.7 mp -117.62 -21.68 8.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.601 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.0 ttp -49.81 -47.83 51.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.715 0.293 . . . . 0.0 111.209 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.406 ' CB ' ' CE ' ' A' ' 2' ' ' LYS . 10.6 t -67.03 -21.34 65.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.67 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 7' ' ' LEU . 2.2 tt -88.98 -14.68 36.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.717 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 4' ' ' LEU . 22.6 t -97.03 -63.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.744 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 9.6 tp -55.06 -23.48 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.818 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.63 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -70.53 -63.15 1.76 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.925 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.63 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 17.8 Cg_endo -58.94 -36.65 96.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.656 2.237 . . . . 0.0 112.956 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.77 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.73 -25.59 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.871 ' O ' HG23 ' A' ' 17' ' ' VAL . 5.4 t80 -65.43 -63.7 1.04 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.734 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.6 t -48.85 -27.52 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.566 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.529 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -79.19 -35.18 30.91 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.624 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 12' ' ' ILE . 3.0 mp -79.87 -31.15 40.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.706 0.288 . . . . 0.0 110.969 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.8 t -71.31 -48.7 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.185 0.517 . . . . 0.0 110.292 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.529 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -51.1 -32.03 21.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.856 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -75.63 -40.98 55.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.646 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.423 ' O ' HG23 ' A' ' 24' ' ' VAL . 19.2 ttp -51.64 -25.19 6.6 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.725 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.837 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -113.6 -37.1 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.922 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.414 ' N ' HD13 ' A' ' 21' ' ' ILE . 28.2 t -52.53 -28.77 22.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.745 0.307 . . . . 0.0 111.168 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -29.82 21.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.366 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 21' ' ' ILE . 11.2 t -64.34 -22.73 31.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.5 13.23 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.514 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 24' ' ' VAL . 19.7 t0 -153.53 -50.54 0.1 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.794 0.331 . . . . 0.0 110.783 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 41.51 83.14 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.609 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -71.31 115.26 10.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.69 131.35 55.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.65 -47.75 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.4 p -126.37 105.93 9.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.8 mtp85 -69.28 109.65 4.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.9 mptt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.926 179.948 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptp . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.859 0.361 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.8 14.48 21.05 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.702 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' A' ' 2' ' ' LYS . 23.8 t0 -23.96 -51.2 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.135 0.493 . . . . 0.0 110.482 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.553 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.6 mp -117.53 -23.72 7.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.442 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 -46.14 31.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 111.45 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 14.9 t -67.78 -19.81 65.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.051 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.07 -21.06 22.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 4' ' ' LEU . 40.6 t -83.44 -8.06 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.448 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.623 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 17.3 mm -123.99 -35.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.303 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -50.39 -60.99 4.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 29.7 Cg_endo -63.8 -54.63 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.56 2.173 . . . . 0.0 113.038 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.718 ' O ' HD13 ' A' ' 16' ' ' LEU . 2.7 pp -51.51 -30.07 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 111.848 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.836 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -61.42 -72.68 0.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.772 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.786 HG12 HD12 ' A' ' 18' ' ' LEU . 21.4 t -52.83 -24.95 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.355 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.0 -32.3 49.8 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.605 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 12' ' ' ILE . 9.4 mp -85.28 -30.58 23.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.69 0.281 . . . . 0.0 110.984 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -74.07 -55.92 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.309 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.786 HD12 HG12 ' A' ' 14' ' ' VAL . 6.0 mt -47.05 -30.34 2.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.909 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -79.53 -44.84 20.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.6 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.569 ' O ' HG23 ' A' ' 24' ' ' VAL . 5.1 ttt -50.45 -26.53 5.17 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.684 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.815 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -105.89 -37.8 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.383 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 25' ' ' LEU . 28.7 t -56.26 -26.61 52.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.329 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -30.57 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.115 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 20' ' ' MET . 45.2 t -59.3 -34.6 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.143 0.497 . . . . 0.0 110.012 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 22' ' ' SER . 4.3 mt -59.44 -13.11 7.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.287 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -153.18 28.92 0.5 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 120.8 0.333 . . . . 0.0 111.314 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -60.36 -173.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.98 64.05 7.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.29 51.0 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.8 t0 60.7 107.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 p -147.47 136.25 22.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -36.34 82.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mttp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.835 179.968 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.833 0.349 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.557 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.88 14.58 20.97 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.63 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.557 ' C ' ' O ' ' A' ' 2' ' ' LYS . 25.6 t70 -24.02 -51.26 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.111 0.482 . . . . 0.0 110.545 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.896 ' O ' HG23 ' A' ' 8' ' ' VAL . 8.2 mp -117.66 -21.11 8.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.642 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -49.09 52.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.73 0.3 . . . . 0.0 111.213 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.3 t -69.99 -18.77 63.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.748 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 11' ' ' PRO . 1.0 OUTLIER -91.72 -9.29 44.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 4' ' ' LEU . 19.9 t -102.93 -62.72 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.861 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.0 tp -53.59 -24.95 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.828 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.635 ' HB3' ' CD ' ' A' ' 11' ' ' PRO . . . -71.23 -63.15 1.54 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.846 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.635 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 18.4 Cg_endo -58.83 -36.11 97.53 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.641 2.227 . . . . 0.0 113.075 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -69.18 -27.93 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 111.076 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.883 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -66.44 -70.07 0.27 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.447 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.948 HG22 HD12 ' A' ' 18' ' ' LEU . 11.5 p -54.42 -23.73 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.351 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.3 -32.43 31.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.617 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.87 -29.45 32.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.72 0.295 . . . . 0.0 111.049 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.5 t -77.52 -60.17 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.212 0.529 . . . . 0.0 110.275 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.948 HD12 HG22 ' A' ' 14' ' ' VAL . 6.9 mt -49.03 -31.94 8.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.732 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.94 -41.35 64.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.604 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.8 ttp -50.0 -52.85 30.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.305 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.834 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -74.63 -36.83 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.472 ' N ' HD13 ' A' ' 21' ' ' ILE . 43.3 t -54.45 -26.09 28.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.025 0.441 . . . . 0.0 109.99 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 27' ' ' GLU . 2.2 mmt85 -82.19 -36.67 27.06 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.085 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 21' ' ' ILE . 40.5 t -54.13 -32.93 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.37 0.605 . . . . 0.0 109.597 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.1 mt -68.75 -7.14 31.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.375 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -153.36 25.34 0.53 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.77 0.319 . . . . 0.0 111.451 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 23' ' ' ARG . 3.3 mm-40 -66.85 119.08 11.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.962 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -88.62 99.36 12.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -129.09 70.71 1.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.8 88.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.5 p -60.08 -70.24 0.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 59.46 -178.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mtp . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.777 0.322 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.556 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.45 21.03 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.671 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.647 ' HB3' HD23 ' A' ' 4' ' ' LEU . 38.1 t70 -24.12 -50.45 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.073 0.463 . . . . 0.0 110.644 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -117.65 -21.93 8.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.885 178.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.9 mmm -51.85 -46.44 64.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.693 0.282 . . . . 0.0 111.136 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 6.7 t -72.34 -17.11 61.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.952 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.5 tp -89.91 -13.93 35.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.048 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 4' ' ' LEU . 22.1 t -94.27 -62.8 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.861 0.363 . . . . 0.0 111.086 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.756 HD12 HD11 ' A' ' 12' ' ' ILE . 8.5 tp -60.28 -21.91 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.641 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.627 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -67.52 -63.0 2.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.688 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 26.9 Cg_endo -62.04 -48.44 8.37 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.542 2.161 . . . . 0.0 112.473 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.756 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -53.08 -28.78 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.327 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.834 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -65.06 -72.66 0.14 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.114 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 18' ' ' LEU . 12.6 p -54.84 -26.82 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.883 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.48 -28.6 73.76 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.298 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mt -99.13 -24.42 14.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.633 0.254 . . . . 0.0 111.311 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.3 t -85.05 -58.65 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.087 0.47 . . . . 0.0 110.704 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -49.44 -28.74 5.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.805 -179.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -78.11 -45.85 22.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.483 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.1 ttt -47.76 -44.34 28.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.594 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.848 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -78.93 -33.18 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.443 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.603 ' HA ' HD12 ' A' ' 25' ' ' LEU . 26.5 t -56.11 -28.78 59.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -74.58 -44.79 49.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 t -54.64 -31.65 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.186 0.517 . . . . 0.0 110.018 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.603 HD12 ' HA ' ' A' ' 22' ' ' SER . 17.4 mt -62.66 -17.46 60.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.241 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -153.48 32.19 0.46 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.802 0.334 . . . . 0.0 111.52 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.5 mm-40 -74.55 -31.3 62.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -76.11 -173.63 2.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -141.11 178.46 7.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.09 78.92 2.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 m 60.47 32.29 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mmt85 -74.45 163.9 27.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.942 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.888 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpp? . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.878 0.37 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.547 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.8 14.45 21.06 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.669 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -23.89 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.128 0.49 . . . . 0.0 110.495 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.852 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.6 mp -117.55 -21.73 8.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.476 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -32.09 30.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.746 0.308 . . . . 0.0 111.375 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.681 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 7.9 t -87.44 -1.44 57.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.474 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -118.34 -6.21 10.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.233 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 4' ' ' LEU . 23.5 t -94.79 -23.88 5.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.582 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.633 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 19.8 mm -124.5 -40.72 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.604 0.24 . . . . 0.0 111.507 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -49.46 -53.99 34.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 41.2 Cg_endo -68.59 -52.28 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.308 2.005 . . . . 0.0 112.868 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.633 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.8 pp -55.04 -29.86 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.762 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.845 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -61.94 -71.96 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.799 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.723 HG12 HD12 ' A' ' 18' ' ' LEU . 24.2 t -52.66 -25.52 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.296 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.4 -30.01 42.54 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 12' ' ' ILE . 9.7 mt -83.64 -30.38 26.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 0.0 110.933 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.4 t -76.67 -57.81 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 121.149 0.499 . . . . 0.0 110.537 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.723 HD12 HG12 ' A' ' 14' ' ' VAL . 7.4 mt -47.1 -34.95 6.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.997 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -71.22 -39.59 71.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.619 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 ttt -50.87 -26.29 5.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.689 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.839 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -115.86 -37.82 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.033 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.454 ' N ' HD13 ' A' ' 21' ' ' ILE . 29.1 t -51.87 -29.9 21.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.286 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.43 -31.83 21.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.869 0.366 . . . . 0.0 110.458 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.448 HG23 ' HA ' ' A' ' 21' ' ' ILE . 11.3 t -61.19 -23.64 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.343 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 mp -75.17 13.49 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.627 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -153.38 -38.62 0.1 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.7 0.286 . . . . 0.0 111.297 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -47.96 166.51 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -59.99 165.12 3.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -153.71 -176.44 5.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.99 138.51 58.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -162.99 179.82 7.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -105.81 31.53 4.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.9 tttp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.902 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.791 0.329 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.546 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.78 14.47 21.07 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.669 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 2' ' ' LYS . 23.9 t0 -24.01 -51.11 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.105 0.479 . . . . 0.0 110.541 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.741 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.6 mp -117.58 -22.42 8.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.564 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 8.7 ttm -49.02 -48.14 44.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.309 . . . . 0.0 111.265 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 8.7 t -67.91 -20.04 65.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.805 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 tp -90.42 -14.53 32.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 4' ' ' LEU . 24.8 t -95.23 -61.36 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.98 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.766 HD12 HD11 ' A' ' 12' ' ' ILE . 9.1 tp -60.11 -21.7 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.745 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.643 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -69.0 -62.87 2.46 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.72 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.643 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 29.1 Cg_endo -62.87 -46.86 9.85 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.6 2.2 . . . . 0.0 112.555 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.766 HD11 HD12 ' A' ' 9' ' ' ILE . 2.6 pp -53.14 -24.98 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.504 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.871 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -64.42 -69.34 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 11' ' ' PRO . 11.5 p -49.7 -27.21 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.385 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.573 ' HA2' HD23 ' A' ' 18' ' ' LEU . . . -79.12 -37.92 23.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.607 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 12' ' ' ILE . 4.0 mm? -75.25 -30.25 60.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.29 . . . . 0.0 111.003 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -73.83 -49.67 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-O 121.169 0.509 . . . . 0.0 110.503 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.573 HD23 ' HA2' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -49.93 -30.53 10.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.941 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.69 -40.53 55.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.57 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.8 ttt -52.16 -41.54 62.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.406 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.838 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -86.89 -35.38 8.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.365 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.569 ' HA ' HD12 ' A' ' 25' ' ' LEU . 29.7 t -56.11 -29.03 60.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.739 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.5 OUTLIER -74.86 -43.12 56.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.123 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.1 t -56.18 -32.36 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.225 0.536 . . . . 0.0 110.1 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 22' ' ' SER . 14.8 mt -60.26 -19.2 53.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.301 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -153.46 33.08 0.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.45 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.8 mm-40 -87.65 136.91 32.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.932 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.34 130.23 45.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -108.25 35.9 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -81.59 102.22 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.18 -68.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.2 mtm105 -77.11 85.98 3.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.8 tttp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.891 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.778 0.323 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -111.82 14.49 21.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.636 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.547 ' O ' HD12 ' A' ' 7' ' ' LEU . 24.0 t0 -23.84 -49.83 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.047 0.451 . . . . 0.0 110.705 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 2' ' ' LYS . 6.4 mp -117.6 -17.48 9.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.914 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.9 mmm -56.23 -37.64 69.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.774 0.321 . . . . 0.0 111.003 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.762 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 4.0 t -86.93 7.19 28.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.898 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 3' ' ' ASP . 1.7 mt -118.39 -10.97 10.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.133 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 12' ' ' ILE . 8.7 p -85.03 -29.58 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.619 ' HA ' ' CG1' ' A' ' 12' ' ' ILE . 1.6 tp -125.24 -34.91 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -53.9 -57.72 16.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 35.2 Cg_endo -65.48 -53.1 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.249 1.966 . . . . 0.0 112.843 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.619 ' CG1' ' HA ' ' A' ' 9' ' ' ILE . 2.6 pp -51.29 -29.01 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.912 0.387 . . . . 0.0 111.64 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.86 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -64.71 -72.19 0.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.503 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.66 HG12 HD12 ' A' ' 18' ' ' LEU . 21.7 t -54.87 -23.56 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.289 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -30.67 56.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.54 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 12' ' ' ILE . 8.1 mt -88.49 -29.8 19.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.768 0.318 . . . . 0.0 111.007 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 13' ' ' PHE . 1.6 t -76.0 -53.83 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.091 0.472 . . . . 0.0 110.589 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.66 HD12 HG12 ' A' ' 14' ' ' VAL . 10.7 mt -46.22 -30.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.078 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.04 -47.89 15.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.641 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 ttt -45.82 -41.71 11.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.6 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.832 ' C ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -82.03 -33.05 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.418 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.524 ' HA ' HD12 ' A' ' 25' ' ' LEU . 26.5 t -56.7 -29.28 62.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -74.24 -46.03 44.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.104 179.306 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 24' ' ' VAL . 4.6 t -52.91 -32.61 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.253 0.549 . . . . 0.0 110.027 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 22' ' ' SER . 18.1 mt -62.48 -17.52 59.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.325 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -153.5 32.44 0.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.772 0.32 . . . . 0.0 111.527 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . 3.6 mm-40 -98.89 31.63 2.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.907 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -97.2 -31.03 12.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.54 113.82 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.49 -176.79 3.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 p -115.4 -45.64 2.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -143.17 -46.81 0.3 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.893 -179.993 . . . . . . . . 0 0 . 1 stop_ save_